| Title | Collaboration Type | HHS Participating Agencies | NIH Participating Institutes, Centers, and Offices | Description |
|---|---|---|---|---|
| 2012 NIAID Sponsored Behavioral and Social Science in HIV Prevention Workshop | Meeting/ Workshop | CDC | NIAID, NIMH, OD/DPCPSI/OAR | The workshop continued discussions and activities initiated at the 2011 meeting addressing Risk Assessment and Adherence in HIV Prevention Trials. The focus of the meeting was to continue to develop a reference or points-to-consider document which would provide to clinicians and researchers guidance on how to enhance the integration of behavioral and social sciences in HIV prevention research. |
| 2012 Science of Eliminating Health Disparities Summit | Meeting/ Workshop | FDA | NIDA, CC, CIT, CSR, FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/DPCPSI/ORIP, OD/DPCPSI/ORWH, OD/DPCPSI/OSC, OD/OCPL, OD/OER, OD/OIR, OD/OIR/OTT, OD/OLPA, OD/OM/OB, OD/OSP | An HHS-wide endeavor involving a broad spectrum of the federal government that seeks to advance activities to eliminate health disparities. http://www.nimhd.nih.gov/summit_site/about.html |
| A Biomarker Substudy of Contraceptive Efficacy of the Women''s Condom | Research Initiative | CDC | NICHD | The purpose of this IAA is to conduct prostate-specific antigen (PSA) biomarker testing on approximately 1800 samples post-coital vaginal fluids and female condoms as part of a contraceptive efficacy trial being conducted by NICHD. |
| A Pilot Exposure Assessment for 1-Chloro-4-(trifluoromethyl) benzene | Research Initiative | CDC | NIEHS | These studies are being conducted to evaluate potential human exposure for manufacturing compounds that have high production, increasing use and/or structural similarity to other known toxicants. There is limited environmental and occupational exposure data available in the scientific literature to assess the acute exposure/ response relationship, and potential chronic long-term adverse effects of PCBTF exposure. |
| A Pilot Exposure Assessment for Ethylene Glycol 2-Ethylhexyl Ether | Research Initiative | CDC | NIEHS | These studies are being conducted to evaluate potential human exposure for manufacturing compounds that have high production, increasing use and/or structural similarity to other known toxicants. There is limited environmental and occupational exposure data available in the scientific literature to assess the acute exposure/ response relationship, and potential chronic long-term adverse effects of EGEHE exposure. |
| A study of markers of cosmic radiation exposure and effect among flight crews | Research Initiative | CDC | NCI | A cross-sectional study of 83 airline pilots and 50 university faculty to assess the relation of stable chromosome translocations with cosmic radiation exposure. |
| A5295 Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of Tuberculosis and Tuberculosis Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects | Research Initiative | CDC | NIAID | This initiative will estimate the sensitivity of a single Xpert MTB/RIF assay (performed on sputum #1 which is the first of two specimens collected for Xpert testing) in Tuberculosis suspects with at least one acid fast bacilli (AFB) sputum smear positive result and at least one culture result positive for M. tuberculosis. |
| Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT) | Committee, Work group, Advisory group, or Task Force | FDA | NIDA | Public-private partnership with the University of Rochester that was initially intended to focus on improving analgesic clinical trial design in order to assure the development of novel, safer analgesic products. The purpose is to create a classification scheme to be applied to clinical trial adverse event data and to post-marketing adverse event reports that will help identify incidents of drug abuse or emergence of drug addiction, as distinct from other types of behaviors and incidents that would be more properly categorized as drug misuse, medication error, or other types of events. http://www.acttion.org/ |
| ACCORD Follow-On Study (ACCORDION) -- Health Related Quality of Life and Cost Effectiveness Substudies | Research Initiative | CDC | NHLBI | The ACCORD study was primarily composed of three clinical trials that tested treatment approaches to determine the best ways to decrease the high rate of major CVD events – heart attack, stroke, or death from CVD – among people with type 2 diabetes who are at especially high risk of having a CVD event, like a heart attack or stroke. ACCORDION (the ACCORD Follow-up Study) is a prospective, observational follow-up study of approximately 8000 participants who were treated and followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. It is designed to further elucidate and clarify the long-term effects of the ACCORD treatment strategy and provide additional data on the long-term relationships among various cardiovascular and diabetic risk factors. ACCORD participants had type 2 diabetes and were at high risk for a CVD event. Those who agree to participate in ACCORDION will continue to be followed through clinic and phone visits for an average of 3.5 years in the period 2011 through 2014. Participants will be seen in 76 clinics across the United States and Canada. The CDC is contributing intellectually and financially to the Health Related Quality of Life and Cost Effectiveness substudies of the trial. https://www.accordionstudy.org/public/dspHome.cfm |
| Action for Health in Diabetes (Look AHEAD) | Research Initiative | CDC, IHS | NIDDK, NHLBI | This study is a 16-center, randomized clinical trial investigating the long-term health consequences of weight loss. Enrollment occurred between 2001-2004 with a planned follow-up of up to 13.5 years. The Look AHEAD cohort comprises approximately 5,000 overweight or obese participants with type 2 diabetes, aged 45-76. Participants were randomized to one of two interventions: an intensive lifestyle intervention designed to produce and sustain weight loss over the long term or a diabetes support and education arm. The study intervention was discontinued in Sept. 2012 on the recommendation of the Data Safety Monitoring Board (DSMB), as there were no differences between the two groups after up to 11 years of follow-up. The study will continue to follow participants for study outcomes. http://www.lookaheadtrial.org |
| Action to Control Cardiovascular Risk in Diabetes (ACCORD) | Research Initiative | CDC | NHLBI, NIDDK | The ACCORD was a large clinical study primarily composed of three clinical trials that tested treatment approaches to determine the best ways to decrease the high rate of major CVD events – heart attack, stroke, or death from CVD – among people with type 2 diabetes who were at especially high risk of having a CVD event. http://www.accordtrial.org/web/public/index.cfm |
| Addiction Technology Transfer Center | Resource Development | SAMHSA | NIDA | Accelerating the dissemination of research-based drug abuse treatment into clinical practice is a priority for the National Institute on Drug Abuse (NIDA) and represents the core mission of the Blending Initiative. NIDA and the Substance Abuse and Mental Health Services Administration (SAMHSA) joined together to create the Blending Initiative in 2001 to reduce the gap that exists between the publication of research results and impact on treatment delivery. This initiative incorporates collaboration between clinicians, scientists, and experienced trainers to catalyze the creation of user-friendly treatment tools and products and facilitate the adoption of research-based interventions into front-line clinical settings. Through this initiative, NIDA and SAMHSA’s Addiction Technology Transfer Centers (ATTCs) disseminate treatment and training products based on results from studies conducted by the National Drug Abuse Clinical Trials Network (CTN) as well as other NIDA-supported research. http://www.drugabuse.gov/blending-initiative |
| Addressing Mental Disorders: The Missing Link to Effective HIV Prevention, Care, Treatment, and Support | Committee, Work group, Advisory group, or Task Force | SAMHSA | NIMH | NIMH co-hosted a meeting titled, "Addressing Mental Disorders: The Missing Link to Effective HIV Prevention Care, Treatment, and Support," in collaboration with the HHS Office of Global Affairs and other supporting organizations. The forum brought together researchers, policy makers, advocates, and implementers working in the fields of HIV/AIDS and mental health to share promising models for the integration of mental health services into HIV/AIDS care programs and to reducing the treatment gap for mental illnesses affecting people living with HIV in high-, middle-, and low-income countries. http://www.nimh.nih.gov/health/topics/hiv-aids/nimh-at-the-xix-international-aids-conference-july-22-27-2012-washington-dc.shtml |
| Administration of Comprehensive Assessment of Occupationally-Relevant Exposures | Research Initiative | CDC | NIEHS | This task order provides financial support to the National Institute for Occupations Safety and Health (NIOSH) personnel to travel to, attend, and participate in several National Toxicology Programs (NTP) meetings held in Research Triangle Park, NC and Washington, DC. These included Interagency Committee for Chemical Evaluation and Coordination meetings, NTP Technical Report meetings, NTP Board of Scientific Counselors meetings, Report on Carcinogen meetings, NTP Executive Committee Meetings, and ad hoc meetings addressing specific NTP issues. All of these meetings were aimed at investigating, defining, or reporting hazards associated exposure to environmental chemicals. Many of the exposures are occupational and NIOSH personnel provide expert opinion on chemical exposures linked to cancer, respiratory disease, development and reproductive disorders, neurotoxicity, and immunological toxicity. |
| Adolescent Health Working Group | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA | OD/OSP, NIAAA, NICHD, NIDA, NIMH | This interagency working group was established in January 2010 within the Office of the Assistant Secretary for Health as a forum for HHS agencies to share updates on adolescent health activities and address cross-cutting issues. The Adolescent Health Working Group focuses on three current near-term priorities: (1) Enrolling eligible adolescents in Medicaid and Children''s Health Insurance Program; (2) Preventing and addressing mental disorders and promoting mental wellness in adolescents; and (3) Youth Engagement. NIMH staff worked with SAMHSA to produce a draft framework of strategies to advance priority 2: Preventing and Addressing mental disorders and promoting mental wellness in adolescents. This framework identified opportunities that could be implemented with existing resources, and proposed ideas would need additional resources. |
| Adult Questions on Voice, Speech, Swallowing and Language (VSSL) and Children’s Questions on Speech-Language Development and Balance/Dizziness Problems on the 2012 National Health Interview Survey | Health Survey | CDC | NIDCD | The purpose of this agreement is to provide funding for a collaborative effort with the National Center for Health Statistics (NCHS) to develop a Voice, Speech, and Language Supplement to include in the 2012 National Health Interview Survey (NIHS), which is conducted by U.S. Census workers under contractual agreement with the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). NIDCD funds will support the gathering of current, reliable prevalence data for disorders of voice (+ swallowing), speech, and language (VSL) that have been missing from our national statistics. Questions on balance/dizziness problems experienced by children will also be included. (ADC12007001-1-0-0) http://www.cdc.gov/nchs/nhis.htm |
| Advanced Anticonvulsant System Interagency Product Team | Committee, Work group, Advisory group, or Task Force | FDA, OS | NINDS, NIAID | The Advanced Anticonvulsant System Interagency Product Team is a Department of Defense-led effort to facilitate activities, both research and regulatory, related to the FDA approval of midazolam for use in treating nerve agent exposure. |
| Advancing Regulatory Science through Novel Research and Science-Based Technologies | Research Initiative | FDA | OD/OSP, NCATS, NEI, NHLBI, NIBIB, NIDDK, NINDS, OD/DPCPSI/OSC | NIH and FDA have formed an interagency partnership to foster regulatory science, a specialized and inter-disciplinary area of biomedical research that serves to generate new knowledge and tools for assessing experimental therapies, preventives, and diagnostics. A key goal of this Regulatory Science program is to accelerate the development and use of new tools, standards and approaches to efficiently develop products and to more effectively evaluate product safety, efficacy, and quality. http://commonfund.nih.gov/regulatoryscience/ |
| Advisory Committee on Childhood Lead Poisoning Prevention | Committee, Work group, Advisory group, or Task Force | CDC | NIEHS | The overall goal of the Advisory Committee on Childhood Lead Poisoning (ACCLPP) is to provide advice that will assist the nation in reducing the incidence and prevalence of childhood lead poisoning. http://www.cdc.gov/nceh/lead/ACCLPP/acclpp_main.htm |
| Advisory Committee on Organ Transplantation | Meeting/ Workshop | HRSA | NIAID | The Advisory Committee on Organ Transplantation (ACOT) was established to assist the HHS Secretary in: Enhancing organ donation, ensuring that the system of organ transplantation is grounded in the best available medical science, assuring the public that the system is as effective and equitable as possible, and thereby Increasing public confidence in the integrity and effectiveness of the transplantation system. |
| Aging with Disability | Research Initiative | ACL | NIA | The collaboration among NIA, ACL and the Department of Education''s National Institute on Disability and Rehabilitation Research (NIDRR) is to explore issues of aging with disability through research, policy analysis, and data development, including joint Funding Opportunity Announcements (FOAs). |
| Agricultural Health Study | Research Initiative | CDC | NCI | A study exploring potential causes of cancer and other diseases among farmers and their families and among commercial pesticide applicators. http://aghealth.nci.nih.gov/index.html |
| Agricultural Health Study: Health Follow-up Survey (Phase 4) | Health Survey | CDC | NIEHS | Collaborate on long-term follow-up of the Agricultural Health Study Cohort - a cohort of pesticide applicators and spouses. This project includes active follow-up with participants to identify long-term health effects potentially linked to agricultural exposures. Funding provided by NIEHS; scientific input provided by NIOSH and NCI. http://aghealth.nci.nih.gov/ |
| Agricultural Health Study: Lung Health Study | Health Survey | CDC | NIEHS | This is a field study nested within the Agricultural Health Study to explore genetic and agricultural risk factors for respiratory disease. Participants with and without questionnaire-defined asthma are visited at home to complete clinical studies to classify respiratory disease and quantify extent of respiratory dysfunction, provide additional questionnaire data, and provide environmental and biological samples. http://niehs.nih.gov/epi |
| Agricultural Health Study: Respiratory disease studies | Health Survey | CDC | NIEHS, NCI | Collaboration on respiratory disease analyses from the Agricultural Health Study. The National Institute for Occupational Safety and Health (NIOSH) contributes to survey implementation and provides an American Public Health Association (APHA) fellow to conduct analysis. http://aghealth.nci.nih.gov/ |
| AIDS International Training and Research Program (AITRP) Supplements | Training Initiative | CDC | FIC, NCI, NIAID, NIDA, NIDCR, NINR | The goal of the AIDS International Training and Research (AITRP) program is to build multi-disciplinary biomedical, behavioral, and social science research capacity for the prevention, care, and treatment of HIV/AIDS and HIV-related conditions in adults and children in low-and middle-income countries. Research training will be provided to scientists at institutions in countries defined by the World Bank criteria as low- and middle-income. PEPFAR/CDC-COP FY12 funded supplements to parent AITRP awards in Zambia through Vanderbilt; Uganda and Vietnam through Berkeley; Tanzania through Baylor, Dartmouth/Boston University; South Africa through Columbia, and Ukraine through SUNY Medical Center Downstate. http://www.fic.nih.gov/Programs/Pages/hiv-aids.aspx |
| AIDSinfo/InfoSIDA | Public Education Campaign | CDC, CMS, FDA, HRSA | OD/OSP, NIAID, NLM, OD/DPCPSI/OAR | AIDSinfo, a service of the U.S. Department of Health and Human Services (HHS), offers access to the latest, federally approved HIV/AIDS medical practice guidelines, HIV treatment and prevention clinical trials, and other research information for health care providers, researchers, people affected by HIV/AIDS, and the general public. These English- and Spanish-language websites (InfoSIDA) assist in the dissemination of the Public Health Service Treatment Guidelines. http://aidsinfo.nih.gov/ |
| Alaska Native Tumor Registry | Resource Development | CDC, IHS | NCI | In collaboration with CDC and IHS, NCI, with technical assistance from Surveillance, Epidemiology and End Results (SEER), collects information on cancer cases among Alaskan Native populations residing in Alaska. http://seer.cancer.gov/registries/alaska.html |
| Alcohol Clinical Trial Initiative (ACTIVE) | Committee, Work group, Advisory group, or Task Force | FDA | NIAAA, NIDA | Consortium that includes academia and representatives from the FDA, NIAAA, NIDA and the pharmaceutical industry working together to identify and clarify clinical trials methodology to evaluate medications for treating alcohol dependence. http://www.ncbi.nlm.nih.gov/pubmed/21900883 |
| All-Hazards Playbook | Resource Development | OS | NLM, NIAID, OD/DPCPSI/OAR | This activity is to develop an interactive tool to assist state and local health departments prepare for and respond to disasters in their regions. |
| Alternative methods for Chemical allergen Identification | Research Initiative | CDC | NIEHS | In chemico alternatives to contact allergen identification are being developed |
| Alzheimer''s Disease Neuroimaging Initiative | Research Initiative | FDA | OD/OSP, NIA, NIBIB | To develop biomarkers of Alzheimer’s Disease in elderly subjects. A major goal of the study has been to establish and validate MRI and PET images, cerebral spinal fluid, and blood biomarkers as predictors of the disease. http://adni.loni.ucla.edu/ |
| America''s Children Forum on Health and Family Statistics | Resource Development | SAMHSA | NIDA | NIDA contributes data from the Monitoring the Future survey on illicit drugs, alcohol and tobacco trends. http://www.childstats.gov/index.asp |
| American Association of Blood Banks (AABB) Interorganizational Biovigilance Network Task Force | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI | The task force is a collaboration between the American Association of Blood Banks and government and other agencies focused on tracking and analyzing adverse reactions and incidents associated with blood collection and transfusion, as well as organ and cell donation and transplantation. |
| American Conference for the Treatment of HIV (ACTHIV) | Meeting/ Workshop | CDC | OD/DPCPSI/OAR | American Conference for the Treatment of HIV (ACTHIV) is state-of-the-science conference for frontline health care professionals, in scientific collaboration with multiple federal and independent agencies. The conference is designed for all frontline clinicians providing HIV care for various population groups. http://www.acthiv.org/conference2011.asp |
| Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks | Committee, Work group, Advisory group, or Task Force | FDA | NINDS, NCATS, NCI | The mission of the Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership funded by the United States Food and Drug Administration (FDA) is to identify, prioritize, sponsor, coordinate, and promote innovative activities — with a special interest in optimizing clinical trials — that will expedite the discovery and development of improved analgesic treatments for the benefit of the public health. http://www.acttion.org/ |
| Analysis of mycotoxins in dust samples from a water damaged building | Research Initiative | CDC | NIEHS | These studies are developing methods to quantitate the levels of fungal products in dust samples from water damaged buildings so that biomarkers of effect, such as fungal specific antibodies, can be correlated with biomarkers of exposure. |
| Anti-Infective Drugs Advisory Committee | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/default.htm |
| Antiretroviral Pregnancy Registry | Other | CDC, FDA | NICHD | This is a registry of use of antiretroviral drugs in pregnancy that is sponsored by the various pharmaceutical companies and has a Committee of external experts and government staff from NIH, CDC and FDA. http://www.apregistry.com/ |
| AoA-NIA Partnership | Other | ACL | NIA, NIDCR, NIMH, NIMHD, NINDS, NINR | This group is made up of representatives from the Administration on Aging and the National Institute on Aging who are working to identify evidence-based interventions that are ready for dissemination and implementation in community programs and to work more collaboratively on their translation into the community. These efforts may also include setting up ways to evaluate the success of these dissemination and implementation efforts. Areas of interest identified to date include Family Caregiving, Exercise/Physical Activity, Nutrition, Elder Mistreatment/Abuse/Financial Fraud, Falls, Driving, Sleep, Medication Management, Depression/Mental Health, Living with Long-Term Disability, Stroke, and Alzheimer’s Disease. |
| AREDS2 Nutritional Biochemistry Substudy | Research Initiative | CDC | NEI | Age-Related Eye Disease Study 2 (AREDS2) is an NEI-funded multi-center randomized trial designed to assess the effects of oral supplementation of high doses of macular xanthophylls and/or omega-3 for the treatment of Age related macular degeneration (AMD) and cataract. This will be accomplished by collecting and assessing the data on approximately 4,000 AREDS2 participants aged 50 to 85 years, who at the time of enrollment have either: 1) bilateral large drusen or 2) large drusen in one eye and advanced AMD in the fellow eye. The CDC serves as the AREDS2 Central Laboratory for the Nutritional Biochemistry Substudy. Serum and plasma samples for all AREDS2 participants at participating Clinical Centers are sent to the Central Laboratory for measurement of concentrations of vitamins A and E (alpha - & gamma - tocopherol), lutein, zeaxanthin, α - and β - carotene, β - cryptoxanthin, lycopene (trans - and total), selected fatty acids (including DHA and EPA), lipids (including cholesterol and triglycerides), zinc and copper. https://web.emmes.com/study/areds2/resources/areds2_mop.pdf |
| Assistance for Orphans and Other Vulnerable Children in Developing Countries Act of 2005 (PL 109-95) Interagency Work Group | Other | ACF, CDC, HRSA | NICHD, FIC, NIMH | This congressionally mandated workgroup evaluates efforts on behalf of orphans and underserved children worldwide. |
| Asthma Outcomes Workshop | Meeting/ Workshop | AHRQ, CDC, CMS, FDA, HRSA | NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR | This workshop established standard definitions and data collection methodologies for validated outcome measures in asthma clinical research. The workshop also identified promising outcome measures and discussed the status of their development and validation. |
| Asthma Supplement to the National Ambulatory Medical Care Survey (NAMCS) | Health Survey | CDC | OD/OSP, NHLBI, NIAID, NICHD, NIEHS | The National Ambulatory Medical Care Survey (NAMCS) Asthma Supplement is a national survey of physician''s opinions about and use of the National Asthma Education and Prevention Program (NAEPP) Guidelines for the Diagnosis and Management of Asthma. The NIH and the CDC''s National Center for Health Statistics collaborate on this activity. http://www.cdc.gov/nchs/ahcd.htm |
| Auditory (Hearing) Screening Supplement for the Early Childhood Longitudinal Study -Kindergarten Cohort | Health Survey | CDC | NIDCD | The objective of this Inter-Agency Agreement is to develop a hearing examination protocol to implement hearing tests in the Early Childhood Longitudinal Study of the Kindergarten Class of 2010–11. This is a large (n=20,000), nationally representative school-based exam and interview survey sponsored by the National Center for Education Statistics (NCES), U.S. Department of Education. The last NCES longitudinal cohort study of school age children began with the 1998 Kindergarten Class. In this earlier cohort, there were no hearing exams (nor vision exams) and the number of young children with hearing loss (reported by parents or teachers) shrank considerably after the initial enrollment of Kindergarteners. In the U.S., the last comprehensive national study of children with hearing exam measures was the 1963–1965 National Health Examination Survey (NHANES predecessor) for children aged 6 to 11 years. The Epidemiology Branch, NEI, is sponsoring development of a vision exam protocol to be used in conjunction with the hearing exam protocol. Visual refractive error will be tested with the automated objective refraction device, Retinomax K-plus 2, using the manufacturer’s directions. When children are identified with hearing (or vision) loss early in the study, they will be included in a “selected” (protected) subsample for more intensive tracking in follow-up waves of the survey. Children in the selected subsample will be tracked to new schools if they are subsequently enrolled in a school that was not in the original school sample, e.g., when families relocate. In addition to hearing and vision, the ECLS-K:2010-11 will track several other outcome measures (e.g., general health, social and physical development, achievement scores, and communication problems) associated with educational performance. Hearing and vision will be tested when the children are examined in the school setting. NCES has awarded a contract to WESTAT to conduct the field operations, including selection of sample schools, data collection, and preparation of user-friendly research data files. The contractor will obtain measures of hearing sensitivity, middle ear function, and visual refractive errors of Kindergartners once during the Kindergarten year. Hearing thresholds will be recorded from each ear separately. In addition, the contractor will obtain tympanometric traces to assess middle ear function. (ADC12005001-1-0-0) |
| Autoimmune Diseases Coordinating Committee (ADCC) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | OD/OSP, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR | The purpose of the Autoimmune Diseases Coordinating Committee (ADCC) is to provide a forum for the coordination of research efforts in autoimmunity and autoimmune diseases among various stakeholders including the NIH, other federal agencies such as the FDA and the CDC, and private organizations with an interest in autoimmune diseases. The ADCC meets twice yearly to discuss a broad range of basic, preclinical and clinical endeavors. http://www.niaid.nih.gov/topics/autoimmune/research/Pages/coordComm.aspx |
| Avian Influenza Collaborative Project | Research Initiative | CDC, OS | FIC | This multinational research is aimed at modeling the transmission dynamics of Avian Influenza (AI) spill-over from birds to humans using field data from different regions (Asia, Africa, Latin America). The expected project output is an ecological model for AI spill-over which will help us predict these events as well as inform and focus our global Avian and Pandemic Influenza prevention and response activities. This project, supported through Global Influenza funding from HHS, is one of the few multi-national ecological studies to develop an understanding of the critical elements of spillover and transmission of influenza which integrates diverse fields of expertise (ecologists, geospatial technology experts, modelers, virologists, and epidemiologists) and which is intended to produce a predictive model. It also supports capacity building for collaborating scientists on these three continents. By providing supplements to Fogarty grantees, this activity leverages FIC''s multi-disciplinary network of current grantees, and it promotes sample and data sharing. |
| Basic Social and Behavioral Research on Culture, Health, and Wellbeing | Committee, Work group, Advisory group, or Task Force | AHRQ | OD/DPCPSI/OBSSR, FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM | Planning group to explore opportunity for joint funding opportunity among NIH/OppNet, US National Endowment for the Humanities, UK''s Arts and Humanities Research Council, and the Wellcome Trust (UK) http://oppnet.nih.gov/news-102810.asp |
| Behavioral Aspects of Prep Counseling HIV Prevention Trials Network (HPTN) Protocol #067: The ADAPT Study (Y01-MH-0315) | Research Initiative | CDC | NIMH, NIAID | This behavioral research study is evaluating whether non-daily medication regimens for HIV Pre-Exposure Prophylaxis (PrEP) may be more acceptable and foster better adherence to product. PrEP represents a novel biomedical approach to HIV prevention, in which individuals at-risk for HIV take antiretroviral medications to help prevent HIV infection. The HPTN 067 study is conducted through the NIAID-led HIV Prevention Trials Network. An Inter-Agency Agreement between NIMH and CDC supports the implementation of this international research study at a clinical research site in Bangkok Thailand. http://www.hptn.org/research_studies/hptn067.asp |
| Best Pharmaceuticals for Children Act | Research Initiative | FDA, HRSA | NICHD, NHLBI, NIMH | The Best Pharmaceuticals for Children Act (BPCA) Program is a major activity for the Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB) at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). OPPTB is responsible for developing and supporting a comprehensive national research and training effort to increase the knowledge base for understanding how to appropriately treat disease during pregnancy, infancy, and childhood using pharmaceuticals that are appropriately tested within their target populations. NICHD activities related to BPCA are intended to improve pediatric drug therapeutics through preclinical and clinical testing that lead to drug labeling changes. We are performing pediatric clinical trials in order to submit data to FDA for labeling changes. BPCA is a partnership with FDA, to a degree. http://bpca.nichd.nih.gov/ |
| Best Pharmaceuticals for Children Act Activities | Committee, Work group, Advisory group, or Task Force | FDA | NIMH, NHLBI, NICHD | NIH, FDA, and non-Federal experts in pediatric pharmacology meet several times a year to identify important unmet needs for conducting research on the efficacy and safety of medications in children. http://bpca.nichd.nih.gov/ |
| Biomarkers of Nutrition for Development (BOND) Meetings | Meeting/ Workshop | CDC, FDA, HRSA, OS | NICHD, FIC, NCI, NHLBI, NIDDK, OD/DPCPSI/ODP | NICHD held six conferences concerning an initiative entitled Biomarkers of Nutrition for Development (BOND). The goal of the BOND initiative is to provide information and service to support the entire nutrition research and global health enterprise and to include core elements of discovery, development and delivery/implementation. Each BOND conference focused on one of the six case study nutrients - Vitamin A, Iron, Zinc, Folate, Iodine and Vitamin B12. These nutrients were selected by the BOND Steering Committee based on their perceived public health importance and unique challenges related to the biomarker agenda. |
| Bioresource Development, Validation Tools, and Integrating HTS Technology Standards in CAM Product Use in Children | Research Initiative | CDC, HRSA, SAMHSA | NCCAM, NICHD | Collaborative efforts between the FDA/CBER and the NIH/NCCAM for substantiating health benefit claims for probiotics under INDs were placed in the framework of U01 Cooperative Agreements that began in 2008. The successful evaluation of the initiative has recently developed into an invitation to develop a Memorandum of Understanding to promote resource sharing and exchange of research expertise; development of demonstration project(s); and the initiation of trans-agency research initiatives focused on the integration of advanced molecular technologies that lead to harmonization standards and improved diagnostics for safety and substantiation of the health benefits of probiotic interventions. In 2011, a collaboration with FDA/CFSAN was initiated to expand the validation tool. In 2012, a Materials Transfer Agreement [MTA] was approved and the FDA/CFSAN received the entire data collection to undergo testing employing their novel microarray multi-loci sequence testing system [MLST]. |
| Board of Scientific Counselors, CDC''s National Center for Injury Prevention and Control | Committee, Work group, Advisory group, or Task Force | CDC | NIA | A member of the NIA staff serves on the Board of Scientific Counselor''s for CDC''s National Center for Injury Prevention and Control. NIA''s staffer brings expertise in research on older adults. http://www.cdc.gov/injury/ |
| Body Mass and Mortality Relationships | Research Initiative | CDC | NCI | A study of the relationships between categories of body mass and mortality in the U.S. population. |
| Brain Attack Coalition | Meeting/ Workshop | CDC | NINDS | The Brain Attack Coalition is a group of professional, voluntary and governmental entities dedicated to reducing the occurrence, disabilities and death associated with stroke. The goal of the Coalition is to strengthen and promote the relationships among its member organizations in order to help people who have had a stroke or are at risk for a stroke. http://www.stroke-site.org/index.html |
| caNanoLab | Resource Development | FDA | NCI, NIBIB, NIEHS | cancer Nanotechnology Laboratory (caNanoLab) is a data sharing portal designed to facilitate information sharing in the biomedical nanotechnology research community to expedite and validate the use of nanotechnology in biomedicine. caNanoLab provides support for the annotation of nanomaterials with characterizations resulting from physico-chemical and in vitro assays and the sharing of these characterizations and associated nanotechnology protocols in a secure fashion. https://cananolab.nci.nih.gov/caNanoLab/welcome.do |
| Cancer Control and Cancer Survivorship in the Sister Studies | Health Survey | CDC | NIEHS | A workshop was held focusing on research priorities for understanding breast cancer in young women, and 2 surveys were conducted within NIEHS'' Sister Study: 1) looking at high risk women without breast cancer to understand the impact of breast cancer in a family member on women and their daughters, including screening and lifestyle behaviors; 2) survey of young breast cancer survivors to identify issues related to treatment and follow-up, barriers to care, quality of life, discrimination, and other factors post-diagnosis. The survey was also focused on special needs of young survivors including fertility. http://sisterstudy.niehs.nih.gov |
| Cancer Control P.L.A.N.E.T. | Resource Development | AHRQ, CDC, SAMHSA | NCI | Cancer control planners, program staff, and researchers have the same goals: to reduce cancer risk, the number of new cancer cases, and the number of deaths from cancer, as well as enhance the quality of life for cancer survivors. While many share the same goals, all do not have easy access to resources that can facilitate the transfer of evidence-based research findings into practice. This Cancer Control P.L.A.N.E.T. portal provides access to data and resources that can help planners, program staff, and researchers to design, implement and evaluate evidence-based cancer control programs. http://ccplanet.cancer.gov/index.html |
| Carrier Screening Work Group | Other | HRSA | NICHD | The purpose of the committee is to make recommendations to the Secretary Advisory Committee for Heritable Disorders in infants and children related to screenable disorder. |
| CDC Chronic Kidney Disease Surveillance | Health Survey | CDC | NIDDK | NIDDK assists CDC in their surveillance program of chronic kidney disease. http://www.cdc.gov/diabetes/projects/kidney.htm |
| CDC Community Guide: Review various interventions to reduce alcohol-related problems | Resource Development | CDC, SAMHSA | NIAAA, NIDA | The Community Guide is a free resource to help people choose the most effective programs and policies to improve health and prevent disease in their communities. http://www.thecommunityguide.org/index.html |
| CDC Elimination of Pediatric HIV in US Stakeholders Group | Other | CDC | NICHD | Working group of federal and non-federal individuals to assist CDC in developing initiatives to eliminate mother to child HIV transmission in the US. |
| CDC Pediatric HIV Case Definition Working Group | Other | CDC | NICHD | Advises on development of new pediatric HIV surveillance definition. |
| CDC Sexually Transmitted Diseases Guidelines | Other | CDC | NICHD | Working group of CDC that develops guidelines for treatment of STD. |
| CDC-NIH Lyme Disease Serum Sample Repository | Other | CDC, OS | NIAID | Initiated in 2008, this resource was made available to the scientific community on a broad basis in late 2011. Lyme disease and related serum samples are available upon request for testing and comparison of new and current diagnostic tests with a common serum sample set for standardization. Samples are distributed by the CDC. CDC and NIH both provided support to acquire the samples and continue to work together to ensure the scientific community has access to samples needed for Lyme disease diagnostic test development. |
| CDC-NIOSH (For Audiometric Support for Two NIDCD-Sponsored, Population-Based Hearing Examination Surveys) | Health Survey | CDC | NIDCD | The purpose of this agreement is to provide funding for scientific and technical support as well as quality assurance of two large audiometric examination surveys funded by NIDCD. The two surveys are: The National Health and Nutrition Examination Survey (NHANES) and (ii) Age, Gene/Environment Susceptibility Study–Reykjavik Study (AGES–RS). The Audiometry Components of both the NHANES and AGES–RS were previously developed by NIDCD in collaboration with NIOSH and other consultants. NIOSH collaborated on the design of the experimental protocol and provided the equipment specifications, oversight of maintenance and calibration, technician training and oversight, operations manual development, and quality assurance for the NHANES. As well, NIOSH provided similar support to AGES, including site visits for training and observation, technical assistance, and limited quality assurance. The NHANES scientific goals are to establish a statistically accurate, demographically representative baseline on the general health (including Hearing Health) of the U.S. population. NHANES is now a continuous survey and while general health issues are always under investigation such as height, weight and blood pressure, there are also elements that track individual health outcomes that move in and out of the NHANES as it cycles. NHANES consists of two major components: the household interview and the physical examination in the NHANES Mobile Examination Centers (MECs) that are set up in various areas around the country. The data from the NHANES elements are collected, weighted, and made available to the government and the public as a database on which analysis may be performed. Recently, the data have been released every two years with collaborating agencies receiving the data six months prior to the public release of the data sets. The AGES–RS scientific goals are: 1) to identify genetic and new risk factors for selected diseases including atherosclerosis, cognitive impairment, dementia, stroke, hearing loss, visual impairment, sarcopenia, osteoporosis, and obesity, 2) to characterize phenotypes for these diseases and conditions, and 3) to identify contributory molecular markers associated with these conditions. Both AGES–RS and NHANES share a similar hearing component, developed collaboratively by NIDCD, NIOSH, NCHS, and the Icelandic Heart Association Research Institute. The hearing component consists of: 1) a set of questionnaires relating to hearing, noise exposure, and other factors relating to hearing, and 2) audiometric examinations consisting of otoscopy, acoustic immittance (bilateral tympanometry and screening for ipsilateral acoustic reflexes at 1000 and 2000 Hz), and pure-tone, air-conduction audiometry to determine the hearing thresholds in each ear at 500, 1000, 2000, 3000, 4000, 6000, and 8000 Hz. A repeat threshold test is obtained at 1000 Hz as a measure of test reliability. When significant inter-ear differences are found, then retests are performed using insert earphones to maximize the inter-aural attenuation rather than using a noise masker of the non-test ear to obtain what is referred to as masked threshold in the in the test ear, thus avoiding a “shadow audiogram” from the better non-test ear. http://www.cdc.gov/nchs/nhis.htm |
| CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT) | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | OD/DPCPSI/OAR | The CDC / HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment shall advise the Secretary; the Director, CDC; and the Administrator and Associate Administrator for HIV/AIDS, HRSA, regarding objectives, strategies, policies, and priorities for HIV and STD/hepatitis prevention and treatment efforts including surveillance of HIV infection, AIDS, STDs/hepatitis, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV/AIDS and STDs/hepatitis; identification of policy issues related to HIV/STD/hepatitis professional education, patient healthcare delivery, and prevention services; agency policies about prevention of HIV/AIDS and other STDs, treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV and STDs/hepatitis; and support to the agencies in their development of responses to emerging health needs related to HIV and other STDs/hepatitis. http://www.cdc.gov/maso/FACM/facmCHACHSPT.htm |
| CDC/NIH Urine Calibration Study | Research Initiative | CDC | NHLBI, OD/DPCPSI | Because of the logistic complexity, high respondent burden, and high cost of conducting 24-hour urine collections in national surveys, alternative strategies to monitor sodium intake at the population level need to be evaluated. This study is designed to assess the ability to characterize population sodium intake from one or more timed-spot urines calibrated to a 24-hour urine collection. NHLBI convened a working group in 2011 to advise us on the design of the study. One of two studies was conducted in 2012 in younger adults and led by CDC. The second study in older adults is planned for 2013 and will be led by NHLBI. Several manuscripts authored by CDC and NIH staff based on the first study are in preparation or have been submitted. |
| CDC’s Field Epidemiology Training Program (FELP) Cancer Curriculum | Training Initiative | CDC | NCI | CDC and NCI (CGH and Cancer Prevention Fellowship Program) are collaborating to add a cancer curriculum to CDC’s Field Epidemiology Training Program. https://www.tephinet.org |
| Cell Therapy for Lung Diseases | Meeting/ Workshop | FDA | NHLBI | Acute and chronic lung diseases are leading causes of morbidity, mortality, and health care expenditures. Innovative approaches for therapies are urgently needed. Increasingly, patients who suffer from chronic lung diseases are seeking stem cell therapies outside the U.S. due to limited opportunities to participate in clinical studies of stem cells in the U.S. The current NHLBI portfolio on lung stem and progenitor cells has focused primarily on basic research to build fundamental knowledge of the role of stem/progenitor cells in lung disease and injury/repair. However, clinical application of cell therapy for lung diseases will require a more focused approach that coordinates basic research with translational research to facilitate cell-based clinical trials. Therefore, the NHLBI convened a Cell Therapy for Lung Diseases working group on November 13-14, 2012 to make recommendations for future research directions. The workshop brought together investigators who study basic mechanisms including cell therapy in preclinical models of lung injury/disease along with clinical trial experts in cell therapy for cardiovascular indications and experts from NHLBI’s Production Assistance for Cell Therapy (PACT) program. The overall objective was to discuss the current status of basic investigations in lung cell therapy, identify the scientific gaps in current knowledge regarding cell therapy in the treatment of lung diseases, and develop recommendations to the NHLBI and the research community on scientific priorities that would facilitate high quality, rigorous first-in-human trials of lung cell therapy. http://www.nhlbi.nih.gov/meetings/workshops/cell-therapy.htm |
| CFAR Enhanced Comprehensive HIV Prevention Planning (ECHPP) Administrative Supplement: Project 2 | Research Initiative | CDC | NIAID, NIMH | The purpose of this administrative supplement to the NIH Centers for AIDS Research (CFAR) is to provide funding to conduct operational research around the ECHPP funded by the CDC. This supplement provided funds to stimulate collaboration between the CFARs and the local health departments in the ECHPP project to help implement the National HIV/AIDS Strategy. |
| Characterizations of Fungal Exposures | Research Initiative | CDC | NIEHS | These studies address the limitations in traditional methods for assessing fungal exposures by using molecular techniques to identify fungi in dust samples and biological fluids. |
| Chemical Integrated Program Team (IPT) | Other | CDC, FDA, OS | NICHD | This workgroup is a Public Health Energy Enterprise. The Integrated Program Team (IPT) working group provides an end-to-end vision of medical countermeasures needed for a particular threat type (e.g., anthrax, rad/nuc, etc.). The scope of their work includes setting requirements for the stockpiling of medical countermeasures (MCMs), MCM delivery and dispensing and monitoring MCM development. The IPTs also advise the Enterprise Executive Committee as to threat- or capability-specific MCM priorities for improving preparedness, to inform leadership consideration of cross-threat prioritizations and strategic goal setting. |
| CHEMM (Chemical Hazards Emergency Medical Management) | Resource Development | ATSDR, CDC, OS | NLM | This activity is to develop a comprehensive web resource: Chemical Hazards Emergency Medical Management (CHEMM) is a tool designed to provide access to comprehensive sets of information about chemical hazards via a user-friendly interface. http://chemm.nlm.nih.gov |
| Child Abuse and Neglect Working Group (CANWG) | Other | ACF, HRSA, SAMHSA | NICHD, CSR, NIAAA, NIDA, NIMH, NINDS, OD/DPCPSI/OBSSR | The NIH Child Abuse and Neglect Working Group (CANWG) was established in response to a recent directive by the House Committee on Appropriations, which requested that NIH report on current NIH efforts, accomplishments, and future plans for research on child abuse and neglect. The CANWG is co-chaired by program staff from NICHD and NIDA (formally NIMH). The working group is also a subcommittee of the Federal Interagency Workgroup on Child Abuse and Neglect. http://obssr.od.nih.gov/funding_opportunities/requests_for_applications/child_neglect_RFA.aspx |
| Children''s HHS Interagency Leadership on Disasters (CHILD) working group | Other | ACF, OS | NICHD | The potential impact of disasters on children can extend from the immediate response phase of a disaster through the recovery phase, creating many challenges but also many opportunities to mitigate the effects. The U.S. Department of Health and Human Services (HHS) established the Children’s HHS Interagency Leadership on Disasters (CHILD) Working Group in 2010 to identify and comprehensively integrate the activities related to the needs of children across all HHS inter- and intra-governmental disaster planning activities and operations. Co-led by the Administration for Children and Families (ACF) and the Assistant Secretary for Preparedness and Response (ASPR), the group developed recommendations for how HHS can improve the delivery of care to children who are impacted by disasters. The Working Group is divided into four subcommittees: 1) Mental and Behavioral Health, 2) Medical Countermeasures, 3) Child Physical Health, Emergency Medical Services, and Pediatric Transport, and 4) Child Care and Child Welfare. http://www.phe.gov/Preparedness/planning/abc/Documents/2011-children-disasters.pdf |
| Children’s Mental Health: Surveillance of mental disorders among children in the United States (CDC MMWR Special Report) | Other | CDC, HRSA, SAMHSA | NIMH | The Centers for Disease Control and Prevention initiated a special Morbidity and Mortality Weekly Report (MMWR) on child mental health surveillance. This report will provide a first and comprehensive look at surveillance systems that collect data on mental health issues. The report summarizes information about ongoing federal surveillance systems that can provide estimates of the prevalence of mental disorders and indicators of mental health among children living in the United States, and presents estimates of childhood mental disorders and indicators from these systems during 2005-2011. |
| Chronic Fatigue Syndrome Advisory Committee (CFSAC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, OS | OD/DPCPSI/ORWH, CSR, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIDCR, NIDDK, NIEHS, NIMH, NINDS, NINR, NLM | The Chronic Fatigue Syndrome Advisory Committee (CFSAC) provides advice and recommendations to the Secretary of Health and Human Services via the Assistant Secretary for Health of the U.S. Department of Health and Human Services on issues related to chronic fatigue syndrome (CFS). These include: 1) factors affecting access and care for persons with CFS; 2) the science and definition of CFS; and 3) broader public health, clinical, research and educational issues related to CFS. http://www.hhs.gov/advcomcfs/ |
| Clinical and Translational Research Course for PhD Students | Training Initiative | FDA | CC, NCATS, NCI, NHLBI, NIAID, NIDDK, NIGMS, NIMH | The Clinical and Translational Research Course for Ph.D. Students is a two-week intensive introductory course for graduate students in the basic biomedical sciences who have at least one year of graduate study. The purpose of the course is to demonstrate and highlight the roles of PhD scientists in clinical and translational research, to provide an overview and examples of how basic science and clinical observations lead to translational research, and to increase awareness and access to Ph.D. role models, research resources, and potential career opportunities at the NIH. http://www.cc.nih.gov/training/phdcourse |
| Clinical Decision Support (CDS) Federal Collaboratory and Inventory of Federal Clinical Decision Support Activities | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, HRSA, IHS, OS | NLM, CC | A federal community of interest focused on clinical decision support, and a compilation of project summaries describing CDS activities that are either funded by the US Federal government, or that are being executed by agencies of the government. The term Clinical Decision Support (CDS) describes a variety of tools and technologies that are used within electronic clinical information systems to improve the quality, safety, efficiency and effectiveness of patient care. CDS provides clinicians, staff, patients, and other key decision makers with knowledge and person-specific information, intelligently filtered at appropriate times, to enhance health and health care. CDS encompasses computerized alerts and reminders, clinical guidelines, order sets, order entry feedback, patient data reports and dashboards, documentation templates, diagnostic support, and the presentation of contextually relevant reference information within clinical information systems. NLM has submitted to the Collaboratory and Inventory summaries of NLM projects involving Clinical Decision Support. http://healthit.hhs.gov/portal/server.pt/community/healthit_hhs_gov__cds/1218 |
| Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIAID | This Working Group discusses a range of issues relevant to the development of antiviral drugs for the treatment of influenza. |
| Clinical Islet Transplantation Consortium | Research Initiative | CMS, FDA | NIDDK, NIAID | "The Clinical Islet Transplantation (CIT) Consortium is a network of clinical centers and a data coordinating center established in 2004 to conduct studies of islet transplantation in people with type 1 diabetes. Studies conducted by the CIT Consortium will focus on improving the safety and long-term success of methods for transplanting islets, the insulin-producing cells of the pancreas, in people whose own islets have been destroyed by the autoimmune process that characterizes type 1 diabetes. One clinical trial, in particular, is studying the efficacy of islet transplantation after kidney transplantation. Participants may include Medicare beneficiaries. This study was mandated in the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. " http://www.citisletstudy.org |
| Clinical studies in fecal incontinence committee | Other | CDC | NICHD | The purpose of this committee was to plan a meeting to present the research world with information on the state of fecal incontinence research and generate discussion about how to move forward research that will improve treatment and outcomes in people with fecal incontinence. |
| Clinical Vocabulary and Standards Development for Meaningful Use of Electronic Medical Records | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, OS | NLM | NLM is collaborating with OS and HHS Office of the National Coordinator for Health Information Technology (ONC) on developing and disseminating regulatory language related to health information technology, meaningful use, and standards and certification criteria related to electronic health records and messaging. Collaboration includes serving as members of the Vocabulary Task Force and Clinical Operations Workgroup of the Health IT Standards Committee. The HIT Standards Committee is a Federal advisory committee that was created by the Health Information Technology for Economic and Clinical Health (HITECH) Act to provide input to HHS on the policies and technologies needed to improve health and care. http://www.nlm.nih.gov/healthit.html |
| Clinical Vocabulary and Standards Development for Quality Measures | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, OS | NLM | We are developing and assessing the feasibility of standards-based quality measures that will utilize EMR data. In 2012, NLM developed a system for validating value sets used in Meaningful Use Stage 2 clinical quality measures. http://ushik.ahrq.gov/MeaningfulUseMeasures?system=mu&Referer=measures&enableAsynchronousLoading=true |
| ClinicalTrials.gov | Resource Development | FDA | NLM, CC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, OD/OSP | ClinicalTrials.gov is an NLM-operated database of summary protocol and results information from publicly and privately funded clinical research. As of February 2013, the database included over 141,000 studies conducted in 182 countries with over 8,200 summary results. NLM originally collaborated with FDA on implementing Section 113 of the Food and Drug Administration Modernization Act. It is currently collaborating with FDA and other parts of NIH to implement the statutory requirements of Section 801 of the Food and Drug Administration Amendments Act of 2007. http://www.clinicaltrials.gov/ |
| CMS-NIH Collaborations on CMS Innovation Center | Committee, Work group, Advisory group, or Task Force | CMS | OD/OSP, CC, CSR, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP | The Innovation Center aims to test innovative payment and service delivery models to reduce program expenditures under Medicare, Medicaid, and CHIP, while preserving or enhancing the quality of care furnished. CMS and NIH have been discussing potential collaborations including: • Development of an RFA on “Promotion of Clinically Integrated Randomized Controlled Trials (in process) • Implementation of NIH-supported Research Findings: NIH has proposed high impact research results that could be rapidly and successfully implemented on a larger scale. Initiatives under active consideration include implementation of research findings in the arena of early intervention in schizophrenia episodes and post-acute stroke care. |
| CMS-NIH Data Access Committee | Committee, Work group, Advisory group, or Task Force | CMS | OD/OSP, CC, CSR, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP | Observational studies based, in part, on available CMS data could generate important knowledge and policy relevant findings. NIH and CMS established a Data Access Committee to identify and pursue short and long term priorities. The group convened one formal meeting last year, but touches base informally via email and phone. Current initiatives include: • Exploration of an agreement wherein NIH directly purchases blanket access to CMS data from CMS, instead of paying grantees to access these data individually(which incurs high indirect cost rates for NIH). • Quarterly meetings of the CMS-NIH Data Access Committee discuss data policy and access issues. Future meetings will include presentations by NIH-funded investigators and in-house CMS data analyses. |
| CMS-NIH Senior Leadership Forum | Committee, Work group, Advisory group, or Task Force | CMS | OD/OSP, NCI, NHLBI, NIA, NIDDK, NINDS | A “CMS-NIH Senior Leadership Forum” comprised of NIH Director Francis Collins, CMS Acting Administrator Marilyn Tavenner, and Senior Staff from both agencies, convenes quarterly. Topics include: • NIH-supported research findings of interest to CMS in high impact conditions such as diabetes, schizophrenia, post-acute stroke care, prevention of pre-term birth, tobacco cessation, etc. • Enhancing investigator access to CMS data through the use of Data Enclaves. • Development of common data elements (CDEs) to enhance the conduct of clinical research. • Collaborative development of an RFA, “Promotion of Clinically-Integrated Randomized Controlled Trials”, to be issued and funded by NIH. |
| Collaboration with the CDC-funded Childhood Obesity Research Demonstration (CORD) Project | Meeting/ Workshop | CDC | NHLBI, NICHD, OD/DPCPSI/OBSSR | The NIH is collaborating with Childhood Obesity Research Demonstration (CORD) project officers to 1) develop a symposium proposal for the Obesity Society (TOS) annual meeting coming up in November 2013 and 2) to discuss Childhood Obesity Research and the NHLBI/NICHD/OBSSR funded study- COPTR (childhood obesity prevention and treatment research). The proposal for the TOS meeting, developed by COPTR and CORD (NHLBI and CDC staff) is for a collaborative symposium on childhood obesity research with the goal of advancing health and well being of America’s children. |
| Collaboration with the Center for Emergency Medical Research | Other | OS | NICHD, NINDS | Consultant to Research Subcommittee for needs of children in disasters, surge capacity, and some consultative efforts on specific problems/conditions/diseases in disaster preparedness. The Office of Coordination of emergency research was officially formed as a result of this subcommittee. The committee didn''t have regular meetings in FY2012, but the members still interacted during the year. Staff from NICHD are frequently asked to interact with the newly formed office. |
| Collaborative Islet Transplant Registry Ad Hoc Scientific Advisory Committee | Meeting/ Workshop | FDA, HRSA | NIAID | This committee provides scientific direction to the Registry on an ad hoc basis. |
| Collaborative Pediatric Critical Care Research Network (CPCCRN) | Other | HRSA | NICHD | The goal of the Collaborative Pediatric Critical Care Research Network (CPCCRN) is to develop an infrastructure to have well-designed collaborative clinical trials and meaningful descriptive studies in pediatric critical care medicine. The Network seeks to reduce morbidity and mortality in pediatric critical illness and injury, and to provide a framework for the development of the scientific basis of pediatric critical care practice. http://www.cpccrn.org/index.html |
| Collection and Characterization of HIV Variant Strains in Cameroon for an HIV Panels Project | Research Initiative | FDA | NIAID | Funding is being requested to continue research at the FDA lab on the global viral panels project to analyze multiple, diverse isolates from different parts of the world. This activity is part of NIAID’s ongoing efforts to develop a well characterized repository for diagnostics, drug, and vaccine studies. http://eqapol.dhvi.duke.edu/viral-diversity-program |
| Committee to review National Institute for Occupational Safety and Health (NIOSH) decisions on special exposure cohorts | Other | OS | NCI | NCI was a panel member for administrative review of National Institute for Occupational Safety and Health (NIOSH) decisions to create special exposure cohorts in response to claimants. |
| Common Data Elements (CDE) for Patient-Centered Outcomes Research | Resource Development | OS | NLM, CC, CIT, NCATS, NCI, NEI, NHGRI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIEHS, NIMH, NINDS, NINR, OD/OER | This project is related to development of a repository and search tool for identification of Common Data Elements (CDE) for Patient-Centered Outcomes Research. Led by NLM, a work-group of the Trans-NIH BioMedical Informatics Coordinating Committee (BMIC) and others are working to promote data sharing and reuse and use of electronic health record (EHR)- derived data among the PCOR community supported by NIH and other Federal organizations. Work has produced a portal of NIH projects that use CDEs and, with the assistance of funding to develop data infrastructure to promote patient-centered outcomes research (OS PCOR Trust Fund), will contribute to development of a search, retrieval, and repository mechanism that will support and reflect the standards work of the S&I Framework Structured Data Capture Initiative. http://www.nlm.nih.gov/cde/ |
| Community Health Worker Initiative | Public Education Campaign | HRSA, IHS | NHLBI | The Community Health Worker (CHW) Initiative supports activities to reduce disparities in cardiovascular risk factors and asthma in African American, Latino, American Indian, and Filipino population groups. The project uses formative research (literature reviews, focus groups, and workshops) to inform the development and implementation of approaches that integrate CHW activities into the broader health workforce to improve cardiovascular health and reduce asthma disparities. http://www.nhlbi.nih.gov/health/pubs/pub_slctpro.htm |
| Community Participation in Research (R01) | Research Initiative | CDC | NICHD, NCI, NHLBI, NIAAA, NIDA, NIDCD, NIDCR, NIEHS, NINR | Solicit grant applications that propose intervention research on health promotion, disease prevention, and health disparities that communities and researchers jointly conduct. |
| Comparative Effectiveness Research Coordinating Committee | Committee, Work group, Advisory group, or Task Force | AHRQ, CMS, FDA | OD/OSP, CC, CSR, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP | The NIH Comparative Effectiveness Research Coordinating Committee (CER CC) was established in 2008 at the request of the NIH Director. Its members include NIH Institute and Center (IC) Directors and high level senior staff. Its charge is to coordinate ongoing CER initiatives across the agency, develop a long term research vision for CER, implement collaborative initiatives with sister agencies, determine appropriate definitions, policies and guidance relative to CER, administer the CER funds awarded through the American Recovery & Reinvestment Act (ARRA), and track the outcomes of those projects. The CER CC has organized meetings with AHRQ, CMS, the VA, FDA and Office of the National Coordinator for Health Information Technology to discuss potential strategic collaborations. |
| Comparison of Age-related Macular Degeneration (AMD) Treatment Trials | Research Initiative | CMS | NEI | Head-to-head Comparative Effectiveness Trial between two chemically related anti-VEGF treatments for Age-related Macular Degeneration. http://www.nei.nih.gov/catt/ |
| Comprehensive Assessment of Occupationally-Relevant Exposures- Welding Fume | Research Initiative | CDC | NIEHS | The purpose of these studies is to identify possible candidate industries, labor unions and workplaces with occupational exposures to welding fumes (WF) with special emphasis on manganese (MN) and recruit their participation in an exposure assessment study. |
| Computational Toxicology for NIH Medications Discovery | Research Initiative | FDA | NIDA | Through an Inter-Agency Agreement, the FDA provides structure-activity relationship-based toxicity predictions for compounds that are under evaluation in the NIDA Addiction Treatment Discovery Program. On a limited basis, other NIH institutes and centers may utilize this resource by working through NIDA. |
| Computer Models and Validation for Medical Devices Workshop | Meeting/ Workshop | FDA | NHLBI, NIBIB | This has been an annual summer workshop organized by the FDA, NIH, and NSF on computer models of medical devices, although the workshop was suspended in 2012. Planning for the 2013 workshop began in 2012, and will focus on identifying the conditions under which computer-simulated human-response data can be used to support a regulatory submission to the FDA. |
| Computer-aided Diagnosis for Radiology Images | Research Initiative | FDA | CC | The collaboration focuses on the improvement of computer-aided diagnosis for radiology images. Specific applications include computer-aided polyp detection for CT colonography, improvements in the conduct and analysis of observer performance experiments using radiology images and the use and development of advanced machine learning and receiver operating characteristics methods with application to computer-aided diagnosis. None |
| Conducting Comprehensive Toxicological Assessments | Research Initiative | FDA | NIEHS | The purpose of this Agreement is to conduct, at FDA/NCTR, comprehensive toxicological assessments on FDA priority chemicals/agents nominated to the National Toxicology Program. Studies can include range finding sub-chronic and chronic, compound-specific mechanistic studies, and consideration of the use of alternate test systems. This combination of studies is designed to facilitate the interpretation of study results in support of comprehensive quantitative human health risk assessments. The primary goal of this program is to develop a comprehensive scientific data base that can be utilized to reduce the uncertainty in risk assessment/risk benefit analysis for specific chemicals with high FDA impact. |
| Congenital Heart Disease Expert Meeting | Meeting/ Workshop | CDC | NHLBI | The goal of this CDC-sponsored meeting was to develop a public health research agenda for congenital heart disease. An NHLBI representative participated on the committee with CDC members that planned and oversaw the meeting. Fifty invited experts attended the meeting representing diverse expertise in content (congenital heart disease, adult heart disease, statistics), methods (public health strategies), and personal experience. The group included persons from varied backgrounds (physicians, surgeons, epidemiologists, public health officials, advocates, and patients), with a broad representation of public health, professional, and CHD advocacy organizations. The meeting focused on four specific areas including epidemiology, health services, long term morbidity and mortality, and long term psychosocial and neurodevelopmental outcomes. The findings from the meeting were summarized in a manuscript which will be published in a cardiology or public health journal. |
| Congenital Heart Public Health Consortium | Resource Development | AHRQ, CDC | NHLBI | The Congenital Heart Public Health Consortium (CHPHC) is a group of organizations uniting resources and efforts in public health activities. The mission of the CHPHC is to prevent congenital heart defects and improve outcomes for affected children and adults. The consortium achieves its mission by providing leadership and a unified voice for public health priorities, expanding opportunities for surveillance and public health research, and informing public policy priorities that benefit public health and affected persons. The CHPHC represents various federal, state, and community organizations, including those representing patient/family, clinical, and research interests. It is pooling expertise and experience and using a public health model to address CHD issues across the lifespan. http://www.medicalhomeinfo.org/national/pehdic/chphc.aspx |
| Consensus Development Conference: Diagnosing Gestational Diabetes Mellitus | Meeting/ Workshop | AHRQ | OD/DPCPSI/ODP, NICHD | Gestational diabetes mellitus (GDM) is a condition in which women without previously diagnosed diabetes exhibit high blood glucose levels during pregnancy (especially during the third trimester of pregnancy). In collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the NIH Office of Disease Prevention organized a Consensus Development Conference to better understand the benefits and risks of various GDM screening and diagnostic approaches. After weighing the evidence presented by speakers and an evidence report, an unbiased, independent panel prepared and presented a consensus statement addressing the key questions. The conference was held on March 4-6, 2013. http://prevention.nih.gov/cdp/conferences/2013/gdm/default.aspx |
| Consortium for Tuberculosis (TB) Biomarkers (CTB2) | Research Initiative | FDA | NIAID | The Consortium seeks to establish a robust biorepository of well-documented clinical specimens to support the discovery and qualification of biomarkers of Tuberculosis (TB) drug effect, especially surrogate markers for stable cure vs. relapse, and to facilitate development of rapid, reliable TB diagnostics, including tests for drug-susceptibility that would be practical for use in resource poor settings. . |
| Council on Emergency Medical Care | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | OD/OSP, NCATS, NHLBI, NICHD, NIGMS, NIMH, NINDS, NLM | The Council on Emergency Medical Care (CEMC) is a coalition comprised of subject-matter experts and policy makers in emergency medical care from organizations across the Federal Government. The CEMC provides strategic and operational support to the HHS Emergency Care Coordinating Committee (ECCC) through policy-level guidance and interdepartmental and interagency collaboration for ongoing and future Federal efforts that address daily emergency medical care issues in the US. This entity contributes to the development, advancement, and coordination of Federal strategies, policies, and priorities relating to emergency medical care to improve the nation''s emergency care system. |
| Countermeasures Against Chemical Threats (CounterACT) Research Network Annual Symposium | Meeting/ Workshop | CDC, FDA, OS | OD/OSP, NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS | This workshop was organized by NINDS as part of the Countermeasures Against Chemical Threats (CounterACT) Research Network, a group formed to conduct basic, translational, and clinical research aimed at the discovery and/or identification of better therapeutic and diagnostic medical countermeasures against chemical threat agents. The 3-day meeting allowed researchers to share information, encouraged collaboration, and enabled NIH staff to evaluate the group’s progress on themes such as nerve agents, seizure detection technology, cyanide, and sulfur mustard. http://www.ninds.nih.gov/research/counterterrorism/counterACT_home.htm |
| Countermeasures Against Chemical Threats (CounterACT) Research Network Working Group | Other | OS | NICHD, NEI, NIAID, NIAMS, NIEHS, NIGMS, NINDS | Function is to prioritize/fund/manage studies focusing on the development of medical countermeasures (MCMs) for protection against chemical agents. http://www.ninds.nih.gov/research/counterterrorism/counterACT_home.htm |
| Creutzfeldt-Jakob Disease Surveillance in Recipients of Human Growth Hormone, National Hormone and Pituitary Program (NHPP) | Resource Development | CDC, FDA | NIDDK | From 1963 to 1985, the National Hormone and Pituitary Program (NHPP), funded by the U.S. Department of Health and Human Services (HHS), sent human growth hormone (hGH) made from human pituitary glands to hundreds of doctors across the country. As a part of research studies, doctors used the hormone to treat nearly 7,700 children for failure to grow. In 1985, the HHS learned that three people treated with pituitary hGH died of CJD, a rare, incurable brain disease. The HHS immediately stopped distributing the hormone and began a national study to learn more about how pituitary hGH treatment may have caused this problem. http://endocrine.niddk.nih.gov/pubs/creutz/update.htm |
| Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS) | Research Initiative | SAMHSA | NIDA | Research network seeking to determine the best way to integrate evidence-based drug abuse treatment into criminal justice settings including practices related to screening and assessment, HIV intervention, and medication assisted treatment for opioid dependence. http://www.cjdats.org/Wiki%20Pages/Home.aspx |
| DAIDS (NIH/NIAID) and DTBE (CDC/NCHHSTP) Partnership for Tuberculosis (TB) and TB/HIV Research | Research Initiative | CDC | NIAID | This research initiative will conduct pyrazinamide (PZA) resistance profiling. |
| DailyMed | Resource Development | FDA | NLM | DailyMed provides high quality information about marketed drugs, including FDA labels (package inserts). The Web site provides health information providers and the public with a standard, comprehensive, up-to-date, look-up and download resource of medication content and labeling as found in medication package inserts. NLM provides this DailyMed a public service, free of advertising. http://dailymed.nlm.nih.gov |
| Data Access for Grantees | Resource Development | CMS | NIA | NIA developed a Memorandum of Understanding (MOU) to assist grantees with accessing CMS data. It is anticipated that this initiative will create a more user friendly and more cost efficient means for grantees to access CMS data especially the need to access Part D data. Specifically, this MOU gives CMS''s Privacy Board justification to release Part D data to NIA grantees with Data Use Agreements. Researchers pay for data use. |
| Data Mining on FDA''s 510K Documents for Laboratory Tests | Research Initiative | FDA | NLM | U.S. Food and Drug Administration (FDA) provides a large corpus of text about decision summaries on the applications for in vitro diagnostic (laboratory) products. This corpus of text contains valuable information about the nature of laboratory testing devices and test products such as analyte and specimen names that are tested, unit of measures, and analyte detection limits of the presented devices and products. In this project NLM is trying to recognize and extract this information algorithmically and provide them to the operators who are responsible to collect this information and enter it into the LOINC database manually. |
| Data Quality Reviews of ARRA s 1512 Recipient Reports | Resource Development | ACF, AHRQ, CDC, CMS, HRSA, OS | OD/OER | Participate in review of the quarterly reports submitted to www.federalreporting.gov in compliance with s.1512 of the American Recovery and Reinvestment Act (ARRA) of 2009. http://www.federalreporting.gov |
| Defining Appropriate Outcome Measures for Older Persons with Multiple Chronic Conditions | Meeting/ Workshop | AHRQ | NIA | Inter-Agency Agreement between Agency for Healthcare Research & Quality and National Institute on Aging, NIH. The purpose of this Inter-Agency Agreement (IAA) is to authorize the transfer of funds appropriated for the Agency for Healthcare Research and Quality (AHRQ) to the National Institute on Aging (NIA/NIH), in order to support an expert panel meeting, as well as products and activities resulting from this event, that will assess the current state of available metrics for individuals with multiple chronic conditions, prioritize usable measures based upon stakeholder needs, and foster the development or refinement of additional promising outcome measures. The findings from this event should have broad applicability and uptake in research, clinical care, and program evaluation efforts to improve the health of the population burdened by multiple chronic conditions. |
| Demand Reduction Interagency Working Groups | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | OD/OSP, NIAAA, NIDA | To encourage greater cross-talk and Agency participation in developing the National Drug Control Strategy, White House Office of National Drug Control Policy (ONDCP) reconstituted its demand reduction workgroups focusing on prevention, emerging threats, healthcare delivery, justice systems, military veterans and their families, and performance and accountability measures. These working groups aim to prevent substance abuse and related negative consequences by implementing a prevention framework to serve as a foundation for collaboration among Federal agencies in the development of joint initiatives that serve States and communities across the Nation. http://www.whitehouse.gov/open/around/eop/ondcp/plan |
| Detail with Environmental Health Team at the Office of the Assistant Secretary for Health | Other | OS | NICHD | This detail with with an Public Program Analyst in the Science Policy, Planning and Evaluation Branch/NICHD detailing with the Environmental Health Team at the Office of the Assistant Secretary for Health. This collaboration involved seeking to improve health among minority, low-income, and Tribal Indian populations and promoting a "Health In All Policies" (children, pregnant women, families, individuals living with disabilities, LGBTI). The Public Program Analyst reviewed America''s Children and the Environment (clearance), drafted abstracts about the Environmental Justice Strategy for health disparities meetings, coordinated crosscutting groups, helped plan/prepare Environmental Justice Stakeholders Implementation meeting, and the Environmental Strategy strategic planning alignment. |
| Detection of Cognitive Impairment: The Search for an Evidence-Based Screening Tool | Other | AHRQ, CDC, CMS | NIA, NIMH, NINDS, NINR | In January 2011, a New Requirement in the Medicare Annual Wellness Visit is for an Evidence-Based Screening Tool for the Detection of Cognitive Impairment. This new requirement was included in Public Law 111 - 148, the Patient Protection and Affordable Care Act as an additional element under Sec. 4103: Medicare Coverage of Annual Wellness Visit Providing a Personalized Prevention Plan. The Centers for Medicaid and Medicare Services (CMS) noted that in their solicitation for public comments before implementing the new regulation, the definition of cognitive impairment in the statute “was vague and commenters suggested adding a standardized screening tool.” The law only stipulates that providers assess an individual’s cognitive function by “direct observation, with due consideration of information obtained by way of patient report, concerns raised by family members, friends, caretakers, or others.” Most providers routinely use these methods during outpatient visits to assess general well-being and function, but are not always effective in specifically detecting cognitive impairment. Other concerns with this subjective method include false positive findings and questionable, expensive neurological workups. CMS and others, therefore, have identified the need for some standardized instrument or set of tools that could be used by providers. Since the annual wellness visit is scheduled for 45 minutes and has other required elements, the tool would need to be short, with no associated cost, easy to administer, sensitive to change over time, and normed for use in the Medicare beneficiary population. The National Institute on Aging (NIA) at the National Institutes of Health completed a comprehensive review of over 140 published cognitive screening tools to determine the level of evidence to support an instrument or set of instruments that could be used by providers. The review included the critical components identified by CMS as well as other psychometric properties. On October 31, 2011, NIA presented its findings to a large group of researchers, providers, federal policy staff, and other stakeholders for evaluation. Based on the questions raised and input provided by this group, NIA is continuing to add to the information on each tool and will provide additional information as it becomes available. |
| Detection of viral particles using RNA-Seq | Research Initiative | CDC | NHLBI | NexGen sequencing for unknown microbial agents in encephalitides, a fever of unknown origin in Kenyan patients. |
| Determining Autism in Somali Immigrants in the Minneapolis Region | Research Initiative | CDC | NICHD, NIEHS, NIMH, NIMHD | Several ICs at NIH are providing funds to CDC to support surveillance of Autism Spectrum Disorder (ASD) in select children who live in Minneapolis, with the goal of determining whether children of Somali descent have a higher ASD prevalence. |
| Developing Clinical Vocabulary Standards for Public Health Reporting | Resource Development | CDC | NLM | This collaboration between NLM and CDC is to develop Logical Observation Identifiers Names and Codes (LOINC) for use public health reporting, including tumor registry reporting, and reportable disease reporting. http://www.nlm.nih.gov/research/umls/loinc_main.html |
| Development and Use of a Non-human Primate Model of Pertussis Diseases and Transmission | Research Initiative | FDA | NIAID | NIH has been working with the FDA for development and use of a non-human primate (NHP) model of pertussis diseases and transmission. |
| Development of Chemical Emergency Medical Management Website | Other | OS | NICHD, NEI, NIA, NIDA, NINDS | This websites development is under the auspices of the National Library of Medicine SIS Division. Additional funding is provided by the Biomedical Advanced Research and Development Authority (HHS). NICHD staff is detailed to assist the NLM in its development with primary responsibility for the creation of the medical management guidelines component. |
| Development of In-Vitro Assays to Assess the Potency of Botulinum Neurotoxin Type A | Research Initiative | FDA | NINDS, NIAID | This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new non-animal-based assays to assess the potency of botulinum neurotoxin type A (BoNT/A) in a Good Manufacturing Practice (GMP) commercial environment. (STTR [R41/R42]) [PA-09-178], (SBIR [R43/R44]) [PA-09-179]. http://grants.nih.gov/grants/guide/pa-files/PA-09-179.html |
| Development of the HHS Framework for Guiding Funding Decisions about Research Proposals with the Potential for Generating Highly Pathogenic Avian Influenza H5N1 Viruses that are Transmissible among Mammals by Respiratory Droplets | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NIAID | Development of HHS policy regarding the funding of research with the potential for generating HPAI H5N1 viruses that are transmissible among mammals by respiratory droplets. Also began planning an international consultative workshop to solicit international and multidisciplinary perspectives on the issue of HPAI H5N1 gain-of-function research and the framework for guiding funding decisions on proposals (submitted to HHS and its operating divisions) that have the potential for generating HPAI H5N1 viruses that are transmissible among mammals by respiratory droplets. |
| DHHS Advisory Council on Blood Stem Cell Transplantation | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | NHLBI, NCI, NIAID | The working group seeks to address questions and challenges in stem cell transplantation, identify barriers to diverse donor populations, and identify any existing safety gaps. |
| DHHS Health Care Personnel Influenza Vaccination Interagency Working Group | Committee, Work group, Advisory group, or Task Force | OS | CC | This committee is charged with developing strategies to improve the fraction of healthcare professionals who are vaccinated with the influenza vaccine. http://www.hhs.gov/ash/initiatives/hai/hcpflu.html |
| DHHS Healthcare Infection Control Practices Advisory Committee (HICPAC) | Committee, Work group, Advisory group, or Task Force | OS | CC | This committee serves as the major policy advisory committee in the nation for healthcare epidemiology. |
| DHHS Steering Committee for the Prevention of Healthcare-Associated Infections | Committee, Work group, Advisory group, or Task Force | OS | CC | This committee is charged with developing a national action plan for addressing the important problem of healthcare-associated infections. http://www.hhs.gov/ash/initiatives/hai/actionplan/ |
| Diabetes Mellitus Interagency Coordinating Committee (DMICC) | Other | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS | OD/OSP, CSR, NCATS, NCCAM, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM | The Diabetes Mellitus Interagency Coordinating Committee (DMICC) facilitates cooperation, communication, and collaboration on diabetes among these government entities. DMICC meetings, held several times a year, help members identify emerging issues and opportunities and develop ways in which different government components can work together and build upon each other’s expertise and resources. This approach helps ensure that federal diabetes activities are coordinated and not duplicated, as well as stimulates collaborations where appropriate. http://www2.niddk.nih.gov/AboutNIDDK/CommitteesAndWorkingGroups/DMICC/ |
| Diabetes Prevention Program (DPP) and Diabetes Prevention Program Outcomes Study (DPPOS) | Research Initiative | CDC, IHS | NIDDK, NCATS, NCMHD, NEI, NHLBI, NIA, NICHD | The Diabetes Prevention Program (DPP) showed that lifestyle change or metformin delay the development of type 2 diabetes. The Diabetes Prevention Program Outcomes Study is studying the long term effect of diet and exercise and the diabetes medication, metformin, on the delay of type 2 diabetes in participants of the DPP. http://www.bsc.gwu.edu/dpp/index.html |
| Diabetic Retinopathy Clinical Research Network | Research Initiative | OS | NEI, NIDDK | The Diabetic Retinopathy Clinical Research Network (DRCR.net) is a collaborative network dedicated to facilitating multicenter clinical research of diabetic retinopathy, diabetic macular edema and associated conditions. The DRCR.net supports the identification, design, and implementation of multicenter clinical research initiatives focused on diabetes-induced retinal disorders. Principal emphasis is placed on clinical trials, but epidemiologic outcomes and other research may be supported as well. The network is funded by the NEI, and co-funded by OS, through NIDDK, with the Special Funding Program for Type 1 Diabetes Research. http://drcrnet.jaeb.org/ViewPage.aspx?PageName=Home |
| Diagnosis, Treatment, and Medical Service Utilization in Medicare and Medicaid Population | Research Initiative | CMS | CC | CMS and NIH CC/RMD agree to collaborate in data-sharing for research the results of which may be helpful to improve medical-service quality, utilization, and effectiveness for Medicare and Medicaid beneficiaries. CMS will provide electronic data to NIH CC/RMD who will perform analyses that are agreed to by both parties. |
| Dietary Guidelines for Children 0-2 Years: Exploring the Evidence | Meeting/ Workshop | OS | NICHD | The Dietary Guidelines for Americans (DGA) are issued jointly every five years by HHS and USDA but traditionally have focused on Americans ages 2 and above. Specific recommendations for infants and toddlers have not been addressed since the 1985 edition, although some general guidance was included in the 1990 DGA. The National Institute for Child Health and Human Development, the USDA, and ODPHP have developed a project intended to help identify questions and begin scoping the scientific literature related to dietary (not nutrient) recommendations for ages 0-2 to build an analytic framework for a systematic evidence based review. Two meetings were held, one early in the process consisting of members of 4 workgroups to understand the project and clarify issues (request already submitted). The following workshop, culminated in publication of the workshop proceedings in a peer reviewed journal. |
| Dietary Guidelines for Mothers and Infants | Research Initiative | OS | NICHD | This Intra-agency Agreement (IAA) is to support the Project "Dietary Guidelines for Mother and Infants 0-2 years: Exploring the Evidence." |
| Dietary Supplements Ingredient Database (DSID) | Research Initiative | CDC, FDA | OD/DPCPSI/ODP, NCI | The database provides statistical estimates—based on chemical analysis—of the nutrient content of selected ingredients in dietary supplements, compared with label-reported ingredient levels. Currently the Dietary Supplements Ingredient Database (DSID) provides estimated levels of 18 vitamin and mineral ingredients derived from analytical data for 115 representative unspecified adult multivitamin/multimineral supplements (MVMs). Additional dietary supplement ingredients will be included in future releases of the database. http://dietarysupplementdatabase.usda.nih.gov/ |
| Digital Quantitation of Plasma Cells in Marrow Biopsies | Research Initiative | FDA | CC | Collaboration with M Choi, WC Cheng, and A Badano from the Imaging Physics Lab, Division of Imaging and Applied Mathematics, Office of Science and Engineering Labs, Center for Devices and Radiological Health (CDRH), FDA. The project consists of developing software and establish validations for the automated determination of marrow cellularity and enumeration of plasma cells identified by immunohistochemistry (IHC) using a CD138 antibody. This initial effort should serve as proof of principle for a broader plan to utilize IHC-based automated quantitation of different types of cells in bone marrow core biopsies for diagnosis, prognosis and therapy monitoring of marrow disorders. |
| Domestic and International Adoption: Strategies to Improve Behavioral Health Outcomes for Youth and Their Families | Meeting/ Workshop | ACF, CDC, SAMHSA | NIMH | On August 29-30, 2012 staff from the NIMH partnered with representatives from other NIH Institutes, SAMHSA, the Centers for Disease Control and Prevention (CDC), and the Administration for Children and Families (ACF) to plan and coordinate a meeting focused on the behavioral health needs of adopted youth. Researchers, practitioners, policymakers, as well as family and youth leaders were brought together in an interdisciplinary forum to discuss several key areas, including: the convergence/divergence of experience of internationally and domestically adopted youth with respect to behavioral health concerns; outcomes and trajectories for adopted youth; interventions and services available to address behavioral health needs and/or gaps in meeting the needs of this population; and the challenges and opportunities moving forward. http://www.nimh.nih.gov/about/advisory-boards-and-groups/namhc/2012/september/directors-report-to-the-232nd-national-advisory-mental-health-council.shtml |
| Domestic Scheduling to Control New Drugs of Abuse, with NIDA-Funded Testing Conducted in Support of DEA Scheduling Recommendations to the FDA | Research Initiative | FDA, OS | NIDA | HHS depends upon NIDA contracts to generate the in vitro and animal behavioral data that are required to support the domestic scheduling of new street drugs. The long-standing agreement is that DEA provides the drugs (or the funds to cover drug synthesis) to NIDA, and NIDA covers the cost of pharmacological testing. |
| Dominantly Inherited Alzheimer’s Network (DIAN): International network for the identification, evaluation, and follow up of families with early onset dominantly inherited Alzheimer’s Disease | Research Initiative | FDA | NIA | To set up an international network consisting of a consortium of scientific investigators that will have the responsibility to identify, recruit, evaluate, and follow-up individuals from families with early onset dominantly inherited Alzheimer’s disease [i.e., families with the amyloid precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (PS2) mutations or duplications or others still to be discovered]. http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-08-002.html |
| Drug Induced Liver Injury Network (DILIN) | Other | FDA | NIDDK | Both a prospective and retrospective database containing cases of drug-induced liver disease, Drug Induced Liver Injury Network (DILIN) is funded by a cooperative agreement and includes eight clinical centers and a central data coordinating center. One of the goals of DILIN is to establish a database of well-characterized cases of drug-induced liver injury along with serum, DNA, and tissue samples that will facilitate research on the mechanisms of hepatic injury due to drugs. Cases of liver injury due to herbal medications are also included. DILIN will develop standardized definitions of drug-induced liver disease and standardization of scoring systems for causality. Three employees of FDA serve as ad hoc members on the committee overseeing the network activities. https://dilin.dcri.duke.edu |
| Durability of Nanoscale Cellulose Fibers in Artificial Human Lung Fluids | Research Initiative | CDC | NIEHS | The purpose of this study is to investigate the in vitro durability of nanocellulose materials in artificial lung fluids. Data generated from this study will be used to inform larger studies that will investigate the toxicity of different nanocellulose materials |
| Dynamics of Health, Aging, and Body Composition (Health ABC) | Research Initiative | CDC | NIA, NCCAM, NIDDK | Major objectives relate to observations that change in body composition in old age, particularly the increase in body fat and the decline in lean mass and bone mineral, represent a common pathway by which multiple diseases contribute to disability. There are many unanswered questions regarding the patterns and health impact of changes in weight and body composition in old age. Weight generally increases over the lifetime until late middle age, then tends to decrease into old age with changes in muscle, fat and bone. It has been postulated that the accelerated loss of muscle and strength in old age contributes to the onset of disability. Studies of weight and its relationship to mortality in older persons have yielded contradictory findings, leading to controversy regarding public health recommendations for weight in old age. Few studies have examined weight-related morbidity in old age, especially among African-Americans. |
| Early Hearing Detection and Intervention | Meeting/ Workshop | CDC | NIDCD | Teleconference sponsored by CDC. http://www.cdc.gov/ncbddd/hearingloss/index.html |
| Early Learning Interagency Policy Board (IPB) | Other | ACF | NICHD | The purpose of this workgroup is to collaborate with the Administration for Children and Families in order to coordinate efforts in the area of preschool education, including research. |
| Elder Justice Interagency Working Group | Committee, Work group, Advisory group, or Task Force | ACL, IHS | NIA | The Elder Justice Interagency Working Group was established to protect older adults from abuse including self-neglect. NIA was a founding member of the group along with the Administration on Aging (AoA). The group brings together federal officials responsible for carrying out elder justice activities, including elder abuse prevention, research, grant and program-funding, and prosecutions. Members meet regularly to discuss emerging issues, promising practices, and ways to coordinate their efforts. AoA has also put together a working group to lay the foundation for a study that will determine the prevalence of elder exploitation, and the adequacy of current Federal and State legal protections in this area. http://report.nih.gov/crs/View.aspx?Id=884 |
| Electronic Research Administration (eRA) | Other | AHRQ, CDC, FDA, SAMHSA | OD/OER, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM | The Electronic Research Administration (eRA) provides information technology solutions and support for the full life cycle of grants administration functions for the NIH as well as the Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the Veterans Health Administration (VHA). eRA offers vital solutions to manage the receipt, processing, review, award and monitoring of over $30 billion in research and non-research grants awarded annually by NIH and other grantor agencies in support of the collective mission of improving human health. eRA helps NIH meet a vital mission: the support of cutting-edge biomedical research via grants to scientists at universities and other research institutions. Over 4,600 NIH staff, 700 partner agency staff, and 166,000 active external users depend on eRA daily. Used by Federal staff and applicants at over 12,500 research institutions worldwide, eRA has helped eliminate the hundreds of millions of pieces of paper previously required to: • Record, review and process over 80,000 applications each year. • Support more than 3,500 review meetings held annually. • Administer more than 55,000 awarded competing and non-competing grants. • Maintain patent and invention records for 25 Federal agencies (see the iEdison website). • Support thousands of applicant interactions with the Federal Government before and after the grant award, through the eRA online interface. eRA''s focus is on supporting the mission of serviced agencies by providing tools to electronically manage and report on grants in a way that maximizes efficiencies, provides a strong and scaleable infrastructure, is responsive to evolving customer needs and employs sound management controls. eRA systems align with Grants.gov (the one-stop web portal for finding and applying for federal grants), allowing for full electronic processing of grant applications from application submission through closeout of the grant award and reporting thereafter. http://era.nih.gov/ |
| Emergency Preparedness, medical countermeasures | Other | OS | NCI | NCI provides expertise in radiation biology and radiation oncology to help guide the research and development for medical countermeasures for radiation injury and for biomarkers for assessing injury, dose and who needs treatment. http://www.phe.gov/about/barda/Pages/default.aspx |
| Endemic and Emerging Infectious Diseases of Priority in the Middle East and North Africa: Research Opportunities and Biosafety in a Changing Environment | Meeting/ Workshop | CDC | NIAID | This meeting explored ways to foster Innovative biomedical methodologies and training in biosafety and biosecurity. |
| Endocrinologic and Metabolic Drugs Advisory Committee | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the FDA for drug approval. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/default.htm |
| Enhanced Comprehensive HIV Prevention Planning (ECHPP) Cross-Agency Programmatic Workgroup | Other | CDC, HRSA, IHS, OS | NIAID, NIMH | The purpose of this group is to enhance federal coordination in support of the National HIV AIDS Strategy, specifically related to the Enhanced Comprehensive HIV/AIDS Prevention Plan funded by the CDC. |
| Enhanced Comprehensive HIV Prevention Planning (ECHPP)/12-Cities Initiatives | Committee, Work group, Advisory group, or Task Force | CDC, HRSA, IHS, SAMHSA | NIMH, NIAID | NIMH staff have participated in workgroups to inform the implementation of the Enhanced Comprehensive HIV Prevention Planning (ECHPP)/HHS Twelve Cities Project. This project is funded by the CDC''s Division of HIV/AIDS Prevention. The project aims to maximize the impact of HIV prevention in the twelve metropolitan areas with the highest AIDS prevalence in the United States. http://www.cdc.gov/hiv/strategy/echpp/index.htm |
| Enhancements to the U.S. Life Table Program | Research Initiative | CDC | NIA | The objectives of this research project are the enhancement and expansion of the U.S. life table program. This will consist of the production of national life tables by detailed race, Hispanic origin, nativity status, and educational status of the U.S. population. |
| Ethical, Legal and Social Issues (ELSI) sub-study in the Biospecimen Pre-Analytical Variables (BPV) project | Research Initiative | OS | NCI, CC | This Substudy is part of ongoing efforts by the Cancer Human Biobank (caHUB) program to improve effectiveness and generate best practices for the biospecimen research community. The Biospecimen Pre-Analytical Variables (BPV) Ethical Legal and Social Implications (ELSI) Substudy is a study of the ethical, legal and social implications related to the informed consent process for biobanking. The ELSI study will be designed to address current issues related to informed consent for biobanking, particularly the issue of consent for broad future research use, and will be approached in a two-step fashion. The objective of the ELSI Substudy is to assess research participant comprehension and concerns related to informed consent for biobanking across the diverse patient populations included in the BPV program. The intent of this evaluation is to improve our understanding of the issues that impact donor participation in such programs and to identify factors that may result in decreased rates of donor participation. This study will provide a unique and unprecedented opportunity to address these issues in a diverse patient population of actual biospecimen contributors approached for consent using a highly harmonized informed consent document. Each Biospecimen Source Site (BSS) collecting tumor tissue from surgical procedures shall ensure participation in the ELSI study. Both BPV participants and decliners will be surveyed, using two different survey instruments. |
| European-US Pediatric Formulations Excipients Committee | Other | FDA | NICHD | Multinational academic, industry and regulatory group convened to determine toxicity of excipients in pediatrics. |
| Evaluate the Efficacy of an Antiviral Drug | Research Initiative | CDC | NICHD | The purpose of this Intra-agency Agreement (IAA) is to establish a formal working relationship between CDC and NICHD as co-sponsors of a multicenter clinical study to evaluate the efficacy of an antiviral drug, tenofovir, for prevention of hepatitis B virus (HBV) mother-to-child transmission from HBV-infected mothers with high HBV viral load. The study evaluates the critical issue of prevention of mother-to-child transmission (MTCT) of HBV in the high risk situation of elevated maternal HBV virus load [HBV e antigen positive (HBeAf+] mothers). Infants infected at birth with HBV are at high risk of both cirrhosis and liver cancer during adulthood. |
| Evaluation of Patient Reported Outcomes Following LASIK Surgery. | Research Initiative | FDA | NEI | This will be a prospective, questionnaire-based study conducted by the U.S. Navy Refractive Surgery Center San Diego in collaboration with the U.S. Food and Drug Administration’s Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices. The primary purpose is to quantify the satisfaction and health related quality of life of 500 active duty patients over a period of six months following state-of-the-art laser in situ keratomileusis (LASIK). The questionnaire to be used will be a new instrument which, once validated in this study, might be employed in future clinical studies that include civilian refractive surgery centers in the U.S. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/SurgeryandLifeSupport/LASIK/ucm190291.htm |
| Evidence-based Methodology Workshop on Polycystic Ovary Syndrome | Meeting/ Workshop | AHRQ | OD/DPCPSI/ODP, NICHD | The Office of Disease Prevention coordinates the development of Evidence-based Methodology Workshops (EbMW) that seek to identify methodological and scientific weaknesses in a scientific area and move the field forward through an unbiased and evidence-based assessment of a complex clinical issue. The first workshop in this program focused on polycystic ovary syndrome, a common hormone disorder that affects approximately 5 million reproductive-aged women in the United States. The workshop was designed to clarify: 1) benefits and drawbacks of using the Rotterdam Criteria, 2) the condition’s causes, predictors, and long-term consequences, and 3) optimal prevention and treatment strategies. The workshop was sponsored by the Office of Disease Prevention and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. A multidisciplinary steering committee developed the workshop agenda. The NIH Library created an extensive, descriptive bibliography on PCOS to facilitate workshop discussion. During the 2½-day workshop, invited experts discussed the body of evidence and attendees provided comments during open discussion periods. After weighing the evidence, an unbiased, independent panel prepared a report that summarized the workshop and identified future research priorities. The workshop was held on December 3-5, 2012. http://prevention.nih.gov/workshops/2012/pcos/default.aspx |
| Evidence-based Review & Report Program | Resource Development | AHRQ | OD/DPCPSI/ODP, NCCAM | This Congressionally mandated program reviews current scientific evidence on the efficacy and safety of dietary supplements; identifies research needs; and prepares reports of their findings. http://ods.od.nih.gov/Research/Evidence-Based_Review_Program.aspx |
| Exposure Assessment of Engineered Nanoparticles | Research Initiative | CDC | NIEHS | The purpose of this project is to identify workplaces engaged in the synthesis, manufacture and use of engineered nanomaterials, and to characterize the potential for worker exposure to selected engineered nanoparticles. |
| Family Health History | Health Survey | OSG | NCI, NHGRI | The "My Family Health Portrait" tool is a Web-enabled program that runs on any computer that is connected to the Web and running an up-to-date version of any major Internet browser. The Web-based tool helps users organize family history information and then print it out for presentation to their family doctor. In addition, the tool helps users save their family history information to their own computer and even share family history information with other family members. http://www.hhs.gov/familyhistory/ |
| FDA /Cancer Diagnosis Program (CDP) monthly meeting | Other | FDA | NCI | Participants discuss proposed integral markers and process for regulatory input into integral markers/assays for clinical trials. |
| FDA Arthritis Drugs Advisory Committee Meeting | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NIMH | An NIMH Program Officer was invited to serve as a voting ad hoc member of one of the FDA''s standing advisory committees, which met to review a new drug application for the treatment of Chronic Fatigue Syndrome. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/ucm286552.htm |
| FDA Blood Products Advisory Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA | OD/OSP, CC, NHLBI | The FDA Blood Products Advisory Committee advises the FDA regarding issues of blood safety and efficacy. The committee reviews and evaluates available data concerning the safety, effectiveness, and appropriate use of blood, products derived from blood and serum, or biotechnology which are intended for use in the diagnosis, prevention, or treatment of human diseases. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/default.htm |
| FDA Center for Tobacco Products (CTP) funding opportunity: Development of a cingulate-striatal addiction circuit in a rodent model of nicotine dependence | Research Initiative | FDA | NIDA | This project is designed to address question #30: What novel biological and physiological markers (including genetic and epigenetic markers) are predictive of smoking related and smokeless tobacco related health outcomes? Since we also address biomarker magnitude changes, the project also overlaps with #29. |
| FDA Center of Drug Evaluation and Research (CDER) Workgroup | Other | FDA | CC | The joint CC-CDER collaborative working team is aimed at developing new processes to consider exceptions to existing Center of Drug Evaluation and Research (CDER) policies and procedures for extraordinary clinical circumstances. Over the past few years, CC investigators have encountered instances in which regulatory barriers may have precluded novel pharmacological interventions for severely ill patients. Leaders at the FDA CDER became aware of the concern of some NIH intramural investigators and approached CC leadership to understand the issues. |
| FDA Drug Safety Oversight Board | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS | OD/OSP, NCI | The FDA Drug Safety Oversight Board (DSB), created in 2005 and mandated by law in the FDA Amendments Act of 2007, advises the FDA''s Center for Drug Evaluation and Research (CDER) Center Director on the handling and communicating of important and often emerging drug safety issues and regulatory science. The DSB is composed of representatives from two FDA Centers and eight other federal government agencies, the Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services (CMS), Department of Defense (DOD), Health Resources and Services Administration (HRSA), Indian Health Service (IHS), National Institutes of Health (NIH), and Department of Veterans Affairs (VA). An important role of the DSB is to help FDA assess the impact of their safety decisions on the healthcare systems of its Federal Partners. The Board, with its broad representation from federal healthcare organizations, can provide valuable input and allows FDA to hear other perspectives on drug safety issues. http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm082129.htm |
| FDA Medical Countermeasures initiative (MCMi) Regulatory Science Steering Committee | Meeting/ Workshop | FDA | NIAID | This committee provides guidance to Medical Countermeasures initiative (MCMi) stakeholders. |
| FDA Pediatric Advisory Committee | Other | FDA | NICHD | This is a committee of ad hoc pediatric clinical pharmacologists and pediatricians. |
| FDA Substance Registry System Public Interface | Resource Development | FDA | NLM | The National Library of Medicine and the Food and Drug Administration established a collaborative effort to provide an interface for public access to the FDA’s Substance Registration System (SRS). The FDASRS utilizes an existing NLM database backend architecture to provide public search capability for FDA substances and medicinal products. http://fdasis.nlm.nih.gov/srs/srs.jsp |
| FDA-NCI Monthly Meeting | Meeting/ Workshop | FDA | NCI | A monthly meeting to enhance communication between the two agencies, thereby expediting the development of new anti-cancer agents. General topics discussed include patient safety, clinical efficacy, and regulatory pathways to licensure; as well as an understanding of the operations of the sister agencies. |
| Federal Breastfeeding Working Group | Other | CDC, FDA | NICHD | The purpose of this workgroup is to develop strategies to implement the Surgeon General''s call to action to support breastfeeding. |
| Federal Collaboration on Rural Health | Meeting/ Workshop | AHRQ, HRSA, SAMHSA | NIMH, NIA, NIDA, NINR | On May 17, 2012, NIMH participated in a workshop entitled "Opportunities and Programs in Rural Communities" during the National Association for Rural Mental Health (NARMH) and AgriWellness Annual Meeting. The meeting brought together researchers, persons in recovery, healthcare providers, family members, advocates, and policy makers to learn about effective rural health programs and practices as well as new discoveries. In addition, participants discussed rural behavioral health policy, rural mental health research, and how best to reduce health disparities in rural populations. NIMH provided an overview of opportunities and programs supporting Rural Health at NIH. |
| Federal Dietary Reference Intakes Steering Committee | Other | AHRQ, CDC, FDA, OS | NIDDK | This committee serves as an interagency forum to provide oversight on the process used to establish the Dietary Reference Intakes. These values serve as a basis for many federal nutrition programs and policies. |
| Federal Education and Training Interagency Group | Other | HRSA | NICHD, NLM | This group''s mission is to overview the development of national standards for disaster preparedness education and training. |
| Federal HIV/AIDS Web Council (AIDS.gov) | Resource Development | CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | OD/DPCPSI/OAR, NCI, NIAID, NIDA, NLM | Expand visibility of timely and relevant Federal HIV policies, programs, and resources to the American public. Increase use of new media tools by government, minority, and other community partners to extend the reach of HIV programs to communities at greatest risk. Increase knowledge about HIV and access to HIV services for people most at-risk for, or living with, HIV. http://aids.gov/ |
| Federal Interagency Committee on Relationships | Other | ACF, AHRQ, CDC | NICHD | Interagency group established to improve the information base about children and families. |
| Federal Interagency Committee on Traumatic Brain Injury | Other | AHRQ, CDC, HRSA, SAMHSA | OD/OSP, NCCAM, NIDA, NIDCR, NIMH, NINDS | The charge of the Interagency Committee includes promoting collaboration among federal agencies. A goal of this committee is to develop a national “Roadmap” for Traumatic Brain Injury (TBI). This strategic planning effort will represent the collective expertise of providers, educators, advocates, federal/state/national organizations, and individuals with TBI and their families and will result in a consensus document outlining the critical elements of a successful system of care for TBI service delivery. Additional goals include creating and contributing to a centralized online repository of Federal resources pertaining to Traumatic Brain Injury; reviewing agency strategic plans, materials, and funding opportunities to facilitate collaboration, minimize duplication of efforts and fill service gaps; and developing and disseminating media to build awareness and promote greater visibility of Traumatic Brain Injury and associated Federal programs. |
| Federal Interagency Forum on Aging Related Statistics | Resource Development | ACL, AHRQ, CDC, CMS, OS, SAMHSA | NIA | This Interagency Forum was formed with the goal of bringing together Federal agencies that share a common interest in improving aging-related data. The specific goals of the Forum are to improve both the quality and use of data on the aging population. http://www.agingstats.gov/agingstatsdotnet/Main_Site/About/About_Forum.aspx |
| Federal Interagency Health Equity Team (FIHET) | Committee, Work group, Advisory group, or Task Force | ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | OD/OSP, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINR, OD/DPCPSI/ODP | Federal leadership for the National Partnership for Action to End Health Disparities (NPA) is provided by the Federal Interagency Health Equity Team (FIHET). The FIHET was established to foster communications and activities of the NPA within federal agencies and their partners; and to increase the efficiencies and effectiveness of related policies and programs at the national, state, tribal, and local levels. NIMH staff serve on the FIHET, including co-chairing the Leadership Subcommittee and participating on the Data, Research, and Evaluation Subcommittee. NICHD team members serve on various committees to provide input/recommendations on maternal and child health equity. http://minorityhealth.hhs.gov/npa/templates/browse.aspx?lvl=1&lvlid=36 |
| Federal Interagency Task Force on the Arts and Human Development | Other | ACF, ACL, SAMHSA | OD/OSP, NCCAM, NIA, NICHD, NIMH, OD/DPCPSI/OBSSR | Beginning in 2011, the National Education Association (NEA) has convened a Federal Interagency Task Force on the Arts and Human Development to encourage more and better research on how the arts can help people reach their full potential at all stages of life. Task force members represent multiple units across federal government, including the U.S. Department of Health and Human Services, the National Institutes of Health, the National Science Foundation, and the U.S. Department of Education, among others. To date, the Task Force has met quarterly to share ideas and information about research gaps and opportunities for understanding the arts'' role in improving health and educational outcomes throughout the lifespan. The Task Force has conducted a series of public webinars on compelling research and practices. Additionally, the group has begun a literature review of research on the arts and human development. And in November 2012, four Task Force member agencies hosted a first-ever convening at the National Academy of Sciences to review the current state of research on the arts, health, and well-being in older Americans. http://www.nea.gov/national/TaskForce/index.html |
| Federal Interagency Traumatic Brain Injury Research (FITBIR) Working Group | Other | CDC, HRSA, OS, SAMHSA | OD/OSP, CIT, NCATS, NHLBI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIGMS, NIMH, NINDS | The Federal Interagency Traumatic Brain Injury Research (FITBIR) network facilitates communication, coordination, and collaboration of Traumatic Brain Injury (TBI) research across agencies. Data sharing policies and strategies are developed by this working group. https://fitbir.nih.gov/ |
| Federal Interagency Workgroup on Child Abuse and Neglect | Committee, Work group, Advisory group, or Task Force | ACF, ACL, AHRQ, CDC, HRSA, IHS, OS, SAMHSA | OD/OSP, NIAAA, NICHD, NIDA, NIMH, OD/DPCPSI/OBSSR | The Federal Interagency Workgroup on Child Abuse and Neglect meets to provide a forum through which staff from relevant Federal agencies can communicate and exchange ideas concerning the prevention of child maltreatment and other related issues. The Workgroup collects information about Federal child maltreatment activities and provides a basis for collective action through which funding and resources can be maximized. http://www.acf.hhs.gov/programs/cb/resource/fediawg |
| Federal Interagency Workgroup on Teen Dating Violence (TDV) | Other | ACF, AHRQ, CDC, CMS, HRSA, OS, SAMHSA | OD/OSP, NIAAA, NICHD, NIDA, NIMH, NINR, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH | The federal government is coordinating efforts to address the problem of teen dating violence through this workgroup, which serves as a forum for information sharing, cooperation, and collaboration. It meets every 6 weeks to monitor research on Teen Dating Violence (TDV) and consider how federal agencies might contribute to fighting TDV. In 2009, this working group produced a trans-NIH program announcement (PA) on Research on Teen Dating Violence (TDV). http://www.nij.gov/topics/crime/intimate-partner-violence/teen-dating-violence/research-agenda.htm |
| Federal Interagency Working Group on Vitamin D | Other | AHRQ, CDC, FDA | NICHD, NEI | Workgroup supports research on the importance of vitamin D for health. |
| Federal Interagency Working Group on Women''s Health and the Environment | Other | CDC, FDA | NICHD, NCI, NIEHS, OD/DPCPSI/ORWH | This committee consists of representatives from various federal agencies and offices. The committee''s three main goals are: (1) to discuss and exchange information on ongoing activities in research, information dissemination and outreach, health care services, training, and public policy related to women''s health and the environment, (2) to ensure cooperation and consolidation of efforts between the various federal agencies and offices that work on the issue of women''s health and the environment, (3) to identify gaps, foster collaborations between agencies, and plan and implement activities that address identified needs. http://www.womenshealth.gov/about-us/who-we-are/groups-committees/environment.cfm |
| Federal mHealth Collaborative | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA | OD/DPCPSI/OBSSR, NCI, NHLBI, NIBIB, NIDA, NLM | Federal working group of agencies interested in mHealth technology and its potential for enhancing health care. Also involves resource development. http://www.hrsa.gov/healthit/mhealth.html |
| Federal Partners in Bullying Prevention, Intervention, and Recovery | Committee, Work group, Advisory group, or Task Force | ACF, CDC, HRSA, IHS, SAMHSA | OD/OSP, NIAAA, NICHD, NIDA, NIMH, OD/DPCPSI/ODP | This workgroup meets to provide a forum through which staff from relevant Federal agencies can communicate and exchange ideas concerning how to prevent or stop bullying in schools and communities. http://www.stopbullying.gov/ |
| Federal Partners in the Gulf Long-Term Follow-up (GuLF) Study Working Group | Committee, Work group, Advisory group, or Task Force | ACF, ATSDR, CDC, CMS, FDA, HRSA, OS, SAMHSA | OD/DPCPSI, CIT, NHGRI, NIEHS, NIMH, NLM, OD/DPCPSI/OSC | The Federal Partners in the Gulf Long-Term Follow-up (GuLF) Study Working Group is an interagency group of Federal agencies responding to potential health effects of the Deepwater Horizon oil spill disaster. The working group was convened to provide input on the design and conduct of the Gulf Long-Term Follow-up (GuLF) study, a longitudinal study of oil spill clean-up workers led by the National Institute of Environmental Health Sciences with support from the NIH Common Fund, NIH OD and BP. Working group members share ideas on ways to maximize interagency efficiency and effectiveness by working collaboratively on areas of common interest and sharing data and samples collected by their agencies, they identify data collection needs that could be met by the GuLF study rather than duplicate surveys to the same population, and they identify agency resources that could be brought together to improve the GuLF study. Scientific oversight for the study is provided by the National Academy of Science''s Institute of Medicine. This helps to facilitate information exchange and coordination among federal agencies with regards to understanding the toxicity and health effects associated with the of Gulf oil spill exposures among workers and affected communities. http://www.niehs.nih.gov/about/od/programs/gulfspill.cfm |
| Federal Primary Care Medical Home Collaborative (PCMH) | Committee, Work group, Advisory group, or Task Force | AHRQ, CMS, HRSA, IHS, SAMHSA | OD/DPCPSI/OBSSR, NCI, NHLBI, NIA, NIDA, NIDDK, NIMH | Federal working group designed to share information and develop multi-agency scientific and funding opportunities. Also includes resource development. http://pcmh.ahrq.gov/portal/server.pt?open=512&objID=1866&mode=2 |
| Federal Sudden Unexpected/Unexplained Infant Death (SUID) Sudden Infant Death Syndrome (SIDS) Workgroup | Other | ACF, CDC, HRSA, IHS, OS | NICHD | This workgroup is a collaboration of Federal Partners to coordinate efforts to reduce infant mortality from Sudden Infant Death Syndrome (SIDS) and Sudden Unexpected/Unexplained Infant Death (SUID), and to make the Federal effort to address SIDS and SUID more efficient and effective by assuring complete and consistent communication, avoiding duplication of effort, and integrating the varied perspectives and efforts of the different agencies. This workgroup address the public health challenges of SIDS and SUID and opportunities for prevention in the United States. The purpose of the partnership is to establish and enhance relationships among Federal agencies with responsibilities for SIDS and SUID. The partner agencies intend to work together to improve communication and coordination, and to collaborate on a range of activities designed to reduce, and, ultimately, eliminate SIDS and SUID, including the elimination of racial, ethnic and socio-economic disparities. |
| Federal Working Group on Bone Diseases | Other | AHRQ, CDC, CMS, FDA, OS | OD/OSP, CSR, NCATS, NCCAM, NCI, NEI, NIA, NIAAA, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, OD/DPCPSI/ORWH | An interagency committee focusing on osteoporosis, Paget''s disease, and other bone disorders. It offers a forum for sharing information, learning from each other and invited speakers, and facilitating the development, early in the planning stages, of collaborative research activities based on each agency''s mission. Serves to develop and foster collaborative activities among the government agencies in bone diseases. http://www.niams.nih.gov/About_us/committees/default.asp |
| Federal Working Group on Dietary Supplements | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA | OD/OSP, CC, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP | The Federal Working Group on Dietary Supplements is comprised of individuals from federal agencies that share information and discuss issues, initiatives, and research related to dietary supplements. The Working Group meets twice a year and serves as means of communication between the Office of Dietary Supplements (ODS) and its federal partners, reviewing and discussing Guidelines for Dietary Supplements (botanics, probiotics/prebiotics, vitamins) reference standards, collaborative initiatives, state of the science topics, conferences, and workshops. |
| Federal Working Group on International Migration Statistics and Research | Other | ACF, CDC, OS | NICHD | This working group brings together agencies from across the Executive Branch to share current work and to collaborate on joint projects to advance the federal government''s contribution in the area of international migration. |
| Federal Workplace Drug Testing, Mandatory Guidelines Scientific Analysis to Include the Oral Fluid Specimen | Other | SAMHSA | NIDA | Develop and implement a controlled clinical laboratory protocol to administer morphine-containing poppy seeds and Vicks Vapo-Inhaler to healthy normal participants and collect and analyze blood, urine & oral fluid for d-, l-methamphetamine & d-, l-amphetamine and opiates. |
| FedTel: Cross-Federal work group on telehealth | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS | NIBIB, NLM, OD/DPCPSI/OBSSR | The goal of this work group is to develop a coordinated view of what the Federal government is undertaking in telehealth, in an effort to identify possible collaboration mechanisms and share lessons learned across multiple agencies. Current topics of emphasis include Telehealth and HIT; Technology, Innovation and Standards; Public Education of Telehealth; and Access to Health Care. |
| Filovirus Animal Non-Clinical Group (FANG) | Other | CDC, FDA | NIAID | The Filovirus Animal Non-Clinical Group (FANG) focuses on the advanced development of Filovirus Medical Countermeasures (MCM), both vaccines and therapeutics. The FANG will focus on the product development tools and other interagency product development (PD) issues relevant to Food and Drug Administration approval of filovirus MCM. The Portfolio Advisory Committee (PAC), as a standing interagency working group, oversees the FANG. The FANG will develop strategies to address broadly applicable and interagency product development issues relevant to licensure of filovirus MCM. The FANG will develop consensus recommendations to facilitate standardization of reagents, methods, and procedures across multiple agencies and laboratories. |
| First National Centers for AIDS Research/APC ECHPP Conference (November 2012) | Meeting/ Workshop | OS | NIAID, NICHD, NIDA, NIMH | The meeting provided a forum for exchange of progress an administrative supplement awarded to the Centers for AIDS Research (CFARs) to conduct operational research funded with the local departments of health (DOHs) to address the National HIV/AIDS Strategy (NHAS). The meeting fostered collaboration among CFARs, DOHs and the federal government to help implement the NHAS. http://sphhs.gwu.edu/d-cfar/ECHPP_conf.cfm |
| Food Safety and Nutrition Working Group | Other | CDC, FDA, OS | NIDDK, NIEHS | The Food Safety and Nutrition Working Group (FSNWG) aims to highlight and promote awareness of an integrated approach to nutrition and food science in academia, and among nutritionists and food scientists; facilitate the alignment of research priorities to address food safety, food quality, and nutrition in single studies; and identify future research areas that can mesh food safety, food quality, and nutrition together. |
| Forum on Child and Family Statistics | Resource Development | ACF, AHRQ, CDC, HRSA, SAMHSA | NIMH, NICHD, NIDA | The Federal Interagency Forum on Child and Family Statistics, or the Forum, is a working group of Federal agencies that collect, analyze, and report data on issues related to children and families. The Forum''s signature report, America''s Children: Key National Indicators of Well-Being, provides annual updates on the well-being of children and families in the United States across a range of domains. http://childstats.gov |
| Functional Glycomics in HIV Vaccine Design | Meeting/ Workshop | FDA | NIAID, NCI, NIGMS | The purpose of this workshop was to explore new avenues for HIV vaccine discovery. Topics included the role and functions of the HIV envelope glycans in viral transmission and potential vulnerability, identification of glycans in induction and maturation of broadly neutralizing antibodies, new tools to characterize glycosylation patterns, and the role of glycans in immunoglobulin effector function. http://www.vaccineenterprise.org/hive/feature/955 |
| Gastric cancer incidence trends by anatomic subsite | Research Initiative | CDC | NCI | Collaboration on a joint analysis of gastric cancer incidence data for 1976-2007 from the NCI Surveillance, Epidemiology, and End Results (SEER) Program and the CDC National Program of Cancer Registries. |
| Gastrointestinal Drugs Advisory Committee (GIDAC) of the Division of Gastroenterology and Inborn Errors Products of the Center for Drug Evaluation and Research (CDER) of the FDA | Committee, Work group, Advisory group, or Task Force | FDA | CC | Gastrointestinal Drugs Advisory Committee (GIDAC) provides advice and recommendations to the FDA on the need for and design of clinical development programs necessary to support approval of parenteral lipid emulsion products as nutrition support. |
| Genetic, functional, and epidemiologic studies of chronic hepatitis C | Research Initiative | FDA | NCI | Interdisciplinary studies to determine the molecular and immunological mechanisms of action of interferon lambda region genetic variants in HCV infection. |
| Genetics in Environmental and Occupational Diseases | Research Initiative | CDC | NIEHS | These studies evaluate unique cohorts of individuals from professions associated with immune-mediated occupational diseases including asthma, respiratory and contact allergy, chronic beryllium disease, rhinitis, and silicosis. Occupational cohorts are being studied for a number of endpoints including, impact of genetic polymorphisms on inflammatory disease development and clinical outcomes, the role that genetic variations play in environmental and workplace related diseases and identification of unique immunological biomarkers for disease. |
| Genome in a Bottle Consortium | Resource Development | CDC, FDA | NCI, NHGRI, NLM | The "Genome in a Bottle Consortium" was organized to develop the reference materials, reference data, and reference methods needed to assess performance of human genome sequencing. http://www.nist.gov/mml/bbd/biomolecular/genome_in_a_bottle_consortium.cfm |
| Genomic Nursing State of the Science Advisory Panel | Committee, Work group, Advisory group, or Task Force | HRSA | NHGRI, NINR | A Genomic Nursing State of the Science Advisory Panel was convened in 2012 to develop the nursing research blueprint. The Advisory Panel, which met via two webinars and two in-person meetings, considered existing evidence from evidence reviews, testimony from key stake- holder groups, presentations from experts in research synthesis, and public comment. |
| Global Environmental and Occupational Health (GEOHealth) | Other | CDC | FIC, NIEHS | FIC, in collaboration with NIEHS and NIOSH/CDC, launched this program in order to support the development of leading institutions in the developing world that serve as regional hubs for collaborative research, data management, training, curriculum development and policy support in environmental and occupational health. The goal of the program is to catalyze a multi-national network of regional GEOHealth Hubs that are the lead resources for environmental and occupational health, attract and retain the best talent in the region, and provide the scientific evidence for policy formulation. http://www.fic.nih.gov/Programs/Pages/environmental-occupational.aspx |
| Global Health Security Advisory Group (GHSAG) | Committee, Work group, Advisory group, or Task Force | CDC, OS | OD/OSP, NIAID, NINDS | The Global Health Security Advisory Group (GHSAG) is a committee composed of high level representatives of the national health authorities for the G-8 block of countries. The GHSAG was formed to develop and implement concrete actions to improve global health security and serve as a network for rapid response to biological, chemical, radio-nuclear terrorism (CBRN) crises. http://www.ghsi.ca/english/index.asp |
| Global Strategic Plan to Prevent Harms Associated with Alcohol Misuse | Meeting/ Workshop | CDC, SAMHSA | NIAAA | NIAAA represented HHS at the World Health Organization coordinating with officials at CDC and SAMHSA to review Global Strategies to Prevent Harms Associated with Alcohol Misuse. |
| Go4Life | Public Education Campaign | ACL, AHRQ, CDC, OS, OSG | NIA, NCCAM, NEI, NHLBI, NIAMS, NIDDK, NIMH, NINDS | Go4Life, is an exercise and physical activity campaign from the National Institute on Aging at NIH, and is designed to help individuals fit exercise and physical activity into their daily life. Motivating older adults to become physically active for the first time, return to exercise after a break in their routines, or build more exercise and physical activity into weekly routines are the essential elements of Go4Life. Go4Life offers exercises, motivational tips, and free resources to help individuals get ready, start exercising, and keep going. The Go4Life campaign includes an evidence-based exercise guide in both English and Spanish, an exercise video, an interactive website, and a national outreach campaign. http://www.nia.nih.gov/Go4Life |
| Guidelines for Prevention of Mother to Child HIV Transmission; Guidelines for Pediatric Antiretroviral Treatment; Guidelines for Adult Antiretroviral Treatment; Guidelines for Prevention and Treatment of Opportunistic Infections in Adults | Other | CDC, FDA, HRSA | NICHD, NIAID | These are separate Working Groups for development of U.S. guidelines related to HIV infection and its treatment. These Working Groups are composed of external experts in the various areas covered as well as federal agency representatives, including CDC, HRSA, and FDA. |
| Guidelines for Prevention of perinatal group B streptococcal disease-neonatal evaluation | Research Initiative | CDC | NICHD | This IAA requires the technical assistance of the National Institute of Child Health and Development (NICHD) Neonatal Research network for current guidelines for prevention of group B streptococcal disease call for a limited neonatal evaluation including blood culture at birth and initiation of empiric antibiotic therapy for all newborns born to mothers with chorioamnionitist. |
| Harmonization of soluble transferrin receptor (STIR) measurements | Research Initiative | CDC | NICHD | This IAA is intended to conduct activities that will harmonize assays measuring soluble transferrin receptor (STfR), an important indicator to assess the global burden of iron deficiency in children and women of childbearing age. The goal of the harmonization process is to generate comparable data across multiple laboratories using currently available methodologies for measuring soluble transferrin receptor (STIR). |
| Health and Retirement Study (HRS) | Health Survey | CDC, CMS | NIA | This survey follows more than 20,000 men and women over 50, offering insight into the changing lives of the older U.S. population. Launched in 1992, this multidisciplinary, longitudinal study has become known as the Nation''s leading resource for data on the combined health and economic conditions of older Americans. http://www.nia.nih.gov/health/publication/growing-older-america-health-and-retirement-study |
| Health Behavior in School-Aged Children, 2009-2010 Survey (HBSC) including NEXT as an option | Health Survey | HRSA | NICHD | This IAA is to fund the Electronic Health Record (EHR) Pediatric Practice Based Research Network (PBRN) initiative. The purpose of this IAA is to fund, oversee, and manage a research grant on a topic of mutual interest to the agencies. The funds will be used to conduct comparative effectiveness research (CER) and epidemiologic assessments of the use of selected psychotropic medications and the most commonly prescribed asthma medications in pediatric populations, as well as possible associations between these medications and side effects in this population in an existing electronic health record (EHR) based pediatric practice-based research network. This agreement provides needed supplemental funding and HRSA staff experience to conduct the U.S. survey component according to the HBSC study protocol developed in collaboration with the World Health Organization. The NEXT study was included as an option in fy2012. NEXT is a 7-year longitudinal assessment of a representative sample of U.S. adolescent and young adults, starting when they are in in 10th grade. This research initiative involves collaboration with the Best Pharmaceuticals Act for Children. |
| Health Equity Seminar Series: Racial and Ethnic Disparities and Pregnancy Outcomes | Meeting/ Workshop | HRSA | NICHD | As a part of NICHD Health Disparities Seminar Series, the Institute’s Division of Scientific Programs (DSP) hosted a workshop to address prospective father’s role in pregnancy outcomes. This workshop brings together researchers, health care providers, and members of professional organizations to identify gaps in and barriers to research on this subject. The role of the father in child development has been well documented. However, much less attention has been paid to the role of fathers during pregnancy and child birth. This workshop took a transdisciplinary approach in discussing the role of expectant fathers in pregnancy outcomes, and how paternal involvement can impact differences in pregnancy outcomes. |
| Health Literacy Work Group | Other | ACL, AHRQ, CDC, FDA, IHS, SAMHSA | OD/OSP, NCI, NEI, NHGRI, NHLBI, NIA, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIMH, NINR, NLM, OD/DPCPSI/ODP | This work group meets several times a year and works to promote health literacy within the government for the benefit of the general population. http://www.surgeongeneral.gov/topics/healthliteracy/appxc.htm |
| Health Outcomes Among Children & Families Living in Rural Communities | Meeting/ Workshop | AHRQ, HRSA, IHS, OS | NICHD, NCI, NHLBI, NIDA, NIDCR, NIMH, NINR | This trans-agency conference brought together a panel of community members and experts from NIH Institutes and Centers, federal agencies, and organizations to identify gaps in research that address emerging differences between health outcomes for children and families living in rural communities compared to those in urban areas. Access to care and services remains a critical issue for improving the health of individuals who live in rural and underserved areas. A growing body of evidence supports the concept that a rural place of residence is associated with poor health outcomes and risky health behaviors. Further, multiple reports (e.g., Rural Healthy People 2010) have documented several unmet health needs of children living in rural communities. These children are reportedly less physically active and have higher rates of tobacco use, overweight/obesity, and dental caries than their urban counterparts. Further, differences in health behavior and outcomes can be exacerbated by poverty and low educational attainment within families living in rural areas. Although the NICHD currently supports research focused on overweight/obesity outcomes within this population, there is a need for collaborative research to fully understand the impact of all these health indicators on the long-term health of children living in rural areas. Additional research is also needed to further understand the barriers and challenges associated with the use of technological advances (e.g., telemedicine, telepsychiatry) to improve the quality-of-life of those living in rural areas. The initiative also addresses the Federal Interagency Health Equity Team (FIHET) goal of strengthening and broadening leadership for addressing health disparities at all levels by providing a model for the collaboration of federal agencies around common goals. |
| Health Services and Technology Assessment Text (HSTAT) | Resource Development | AHRQ, CDC, OSG, SAMHSA | NLM | NLM provides a free, web-based resource of full-text documents that provide information on health-care decision making. http://www.ncbi.nlm.nih.gov/books/NBK16710/ |
| Healthcare Systems (HCS) Research Collaboratory | Research Initiative | AHRQ, CDC, FDA | NIDCR, NCATS, NCCAM, NCI, NHGRI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR | The overall goal of the Common Fund’s Health Care Systems (HCS) Research Collaboratory program is to strengthen the national capacity to implement cost-effective large-scale research studies that engage health care delivery organizations as research partners. The aim of the program is to provide a framework of implementation methods and best practices that will enable the participation of many health care systems in clinical research, not to support a defined health care research network. Research conducted in partnership with health care systems is essential to strengthen the relevance of research results to health practice. http://commonfund.nih.gov/hcscollaboratory/index.aspx |
| HealthMap: Knowledge Management for Emerging Infectious Disease Intelligence | Research Initiative | OS | NLM | Leveraging previous NLM funded work under the HealthMap project, ASPR and OPEO co-funded an administrative supplement to and NLM/NIH grant to provide funding to Harvard University for a pilot project in which Harvard will develop real-time applications to collect, parse, analyze, and display open source data in order to address the national needs of emergency preparedness and response for hurricanes. http://www.healthmap.org |
| Healthy People 2010 - Kidney Disease | Public Education Campaign | CDC, CMS, FDA, HRSA, OS | NIDDK | The office of the Secretary of HHS leads the Healthy People 2010 initiative. The lead agency for most data activities is the CDC. However, for the kidney area, most of the information is provided by NIDDK through the United States Renal Data System. http://www.cdc.gov/nchs/about/otheract/hpdata2010/focusareas/fa04-ckd2.htm |
| Healthy People 2010/2020 Partnership | Other | AHRQ, CDC, CMS, HRSA, IHS, OS | NHLBI, NINDS | The Partnership provides the opportunity for several units of the Federal government to work on activities related to the Heart Disease and Stroke (HDS) components of the Healthy People initiative. In particular, the purpose of the activity is to catalyze progress toward achieving the Health People goals through the various phases of prevention, including prevention of the development of risk factors for HDS; detection and treatment of risk factors for HDS; early identification and treatment of HDS especially in the acute phases; and prevention of recurrence and complications of HDS. |
| Healthy People 2020 (Adolescent Health Work Group) | Meeting/ Workshop | CDC, HRSA | NICHD | A workgroup established under the Health People 2020 initiative. The goal of this workgroup is to improve the healthy development, health, safety, and well-being of adolescents and young adults. |
| Healthy People 2020 - Blood Diseases, Disorders, and Safety | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, OS | NHLBI | The purpose of this agreement is to support development and implementation of survey questions and measures to assess progress made toward the achievement of the Healthy People 2020 national objectives for blood diseases/disorders and safety. http://healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=4 |
| Healthy People 2020 - Environmental Health and Respiratory Disease Topic Areas | Committee, Work group, Advisory group, or Task Force | ATSDR, CDC, OS | NIEHS, NHLBI | Led workgroups, coordinated meetings, developed goals, reported to DHHS, collaborated with other federal agencies. http://www.healthypeople.gov/hp2020/ |
| Healthy People 2020 - Environmental Health Topic Area | Committee, Work group, Advisory group, or Task Force | AHRQ, ATSDR, CDC, FDA, OS | NIEHS | Healthy People provides science-based, 10-year national objectives for promoting health and preventing disease. Since 1979, Healthy People has set and monitored national health objectives to meet a broad range of health needs, encourage collaborations across sectors, guide individuals toward making informed health decisions, and measure the impact of our prevention activity. Currently, Healthy People 2010 is leading the way to achieve increased quality and years of healthy life and the elimination of health disparities. Healthy People 2020 is currently assessing the objectives of the past decade, measuring the impact of its prevention activity, and developing new 10-year targets. http://www.healthypeople.gov/hp2020/ |
| Healthy People 2020 - Respiratory Diseases | Committee, Work group, Advisory group, or Task Force | CDC | NHLBI, NIAID, NIEHS | The purpose of the collaborative activity is support development and implementation by the National Health Interview Survey (NHIS) of measures that could be used to assess progress towards achieving Healthy People 2020 respiratory/asthma objectives. The NHLBI and the National Center for Health Statistics collaborate on this activity. http://healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=36 |
| Healthy People 2020 - Sleep Health | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA, OSG | NHLBI, NCCAM, NIA, NICHD, NINDS, NINR | This activity supports the development and implementation of survey questions and measures to assess progress on achieving the Healthy People sleep health objectives. http://healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=38 |
| Healthy People 2020 Partnerships for Heart Disease and Stroke | Committee, Work group, Advisory group, or Task Force | CDC, OS | OD/OSP, NHLBI, NINDS | The purpose of the collaborative activity is to support the development by the National Health Interview Survey (NHIS) of measures that can be used to assess progress toward achieving Healthy People 2020 Heart Disease, Blood Pressure, and Cholesterol Objectives. The NIH, CDC, and the National Center for Health Statistics collaborate on this activity. http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=21 |
| Healthy People 2020-Dementias, Including Alzheimer''s Disease | Committee, Work group, Advisory group, or Task Force | CDC | NIA, NIMH, NINDS | This Healthy People 2020 topic will focus on increasing the awareness of the diagnosis of Alzheimer’s disease, and reducing the proportion of preventable hospitalizations in persons with diagnosed Alzheimer’s disease and other dementias. The goal is to reduce the morbidity and costs associated with, and maintain or enhance the quality of life for, persons with dementia, including Alzheimer’s disease. http://www.healthypeople.gov/2020/topicsobjectives2020/default.aspx |
| Healthy People 2020-Older Adults | Committee, Work group, Advisory group, or Task Force | ACL, CDC | NIA | This Healthy People 2020 topic is designed to develop an understanding of the health and health care needs and implications for older adults. The objectives overall will promote healthy outcomes in this population. The goal of these objectives is to improve the health, function, and quality of life of older adults. http://www.healthypeople.gov/2020/topicsobjectives2020/default.aspx |
| HEALTHY study | Research Initiative | CDC | NIDDK | HEALTHY is a 3-year study in 42 middle schools to determine if changes in school food services and physical education classes, along with classroom activities to promote behavior change, lower risk factors for type 2 diabetes in youth at high risk for the disease. Some risk factors for type 2 diabetes are modifiable, such as overweight and obesity, inactivity, high blood pressure, large waist size, and high blood levels of sugar and insulin. Other risk factors are not modifiable, such as family history and race or ethnicity. http://www.healthystudy.org |
| Healthy Vision Month | Public Education Campaign | CDC | NEI | Each May, the NEI sponsors Healthy Vision Month which is national observance designed to elevate eye health as a priority for Americans. NIH worked closely with CDC for the 2010 observance and worked together to create a Morbidity and Mortality Weekly Report (MMWR) article, develop information for their Vision Initiative website and provided online banners and buttons linking to the Healthy Vision Month (HVM) site and to the NEI for additional information. http://www.nei.nih.gov/nehep/resources/hvm/ |
| Hearing questions on the 2014 National Health Interview Survey | Health Survey | CDC | NIDCD | The purpose of this agreement is for the National Institute on Deafness and Other Communication Disorders (NIDCD) to provide financial support to the National Center for Health Statistics (NCHS). The FY2012 funds provide partial support for the National Health Interview Survey (NHIS) and contribute to the development, testing, and 2014 implementation of the Hearing questions. The Hearing questions for the 2014 NHIS will be similar in scope to the 2007 NHIS Hearing supplement for the sample adult and, also, will include some questions for report by the parent/caregiver the hearing about their “sampled” child (age range: birth to 17 years old). This project is a collaborative effort between NCHS and NIDCD. http://www.cdc.gov/nchs/nhis.htm |
| Heart Attack, Blood Pressure, and Cholesterol Questions in the 2013 National Health Interview Survey | Health Survey | CDC | NHLBI | The purpose of the collaborative activity is to support the development by the National Health Interview Survey (NHIS) of measures that can be used to assess progress toward achieving Healthy People 2020 Heart Attack, Blood Pressure, and Cholesterol Objectives. The NIH and the National Center for Health Statistics collaborate on this activity. http://www.cdc.gov/nchs/nhis.htm |
| Hematopoietic Stem Cell Transplantation Interagency Working Group | Other | FDA, HRSA | NCI, CC, NHLBI, NIAID, NIDDK | This working group reviews matters associated with hematopoietic stem cell transplantation. |
| Hemoglobinopathy Uniform Medical Language Ontology Project | Resource Development | AHRQ, CDC, FDA, HRSA, OS | NHLBI, NIAMS, NICHD, NLM | The purpose of the project is to create a uniform medical language ontology for hemoglobinopathies. The ontology would be a resource for federal programs and extramural communities (e.g., researchers) to use when developing data systems that incorporate data elements related to hemoglobinopathies. |
| Hepatitis B Research Network | Research Initiative | CDC | NIDDK | The Hepatitis B Research Network (HBRN), established in 2008 to advance understanding of disease processes and natural history of chronic hepatitis B, as well as to develop effective approaches to treatment with currently available therapies. The Network brings together clinical centers from throughout the U.S. and Canada. This multi-center Network is enrolling patients in multiple clinical trials in both adults and children with hepatitis B. http://www.hepbnet.org/ |
| HHS Advisory Committee for the Elimination of Tuberculosis | Other | AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA | NIAID | The Committee advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Committee makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. http://www.cdc.gov/maso/FACM/facmACET.htm |
| HHS Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, HRSA, OS | OD/OSP, CC, NHLBI | This federal advisory committee advises the Secretary of the Department of Health and Human Services and the Assistant Secretary for Health on a number of issues related to blood safety, including public health parameters related to the safety and availability of blood and blood products; broad public health, ethical, and legal issues related to transfusion and transplantation safety; and the effect of various economic factors on blood safety and availability. http://www.hhs.gov/ash/bloodsafety/advisorycommittee/ |
| HHS BARDA Radiological/Nuclear Integrated Program Team | Meeting/ Workshop | CDC, FDA, OS | NIAID | This Interagency Working Group established under Biomedical Advanced Research and Development Authority (BARDA) determines overall radiation countermeasures strategy and priorities. |
| HHS Behavioral Health Coordinating Committee | Committee, Work group, Advisory group, or Task Force | ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | OD/OSP, NIAAA, NIDA, NIMH, OD/DPCPSI/OBSSR, OD/OCPL | The HHS Behavioral Health Coordinating Committee is charged with coordinating behavioral health activities across HHS, and has five subcommittees addressing early intervention; prescription drug abuse; teenage drinking; integrating behavioral health care with primary care; and, behavioral health communications. NIMH and the ASPA are co-leads of the communications subcommittee. |
| HHS Behavioral Health Coordinating Committee Subcommittee for Communications | Committee, Work group, Advisory group, or Task Force | ACL, AHRQ, CDC, CMS, HRSA, OS, OSG, SAMHSA | OD/OSP, NIAAA, NIDA, NIMH, OD/DPCPSI/OBSSR | The communications subcommittee is developing tools to enhance cross-HHS communications on behavioral health with other federal agencies and the public. Initiatives include platforms for data sharing and dissemination across HHS agencies, and establishing common language for behavioral health. http://www.behavioralhealthglossary.com/ |
| HHS Biannual Dual Use Research of Concern (DURC) Inventory | Resource Development | CDC, FDA, OS | OD/OSP, CC, FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI | Completion of the Department''s biannual Dual Use Research of Concern (DURC) inventory report, as required by the US Government''s Policy for Oversight of Dual Use Research of Concern. |
| HHS Biotechnology Engagement Program (BTEP) | Research Initiative | CDC, FDA | NIAID, NCI | The Biotechnology Engagement Program (BTEP) supports scientific programs in the Former Soviet Union and the Commonwealth of Independent States to engage former weapons scientists and new investigators in collaborative research areas of common interest related to public health. |
| HHS Biovigilance Committee | Committee, Work group, Advisory group, or Task Force | CDC | CC, NHLBI | Develop systems for reporting adverse events resulting from blood transfusion or donation. |
| HHS Blood, Organ, and Tissue Senior Executive Council (BOTSEC) | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, OS | CC, NHLBI | The mission of the Blood, Organ, and Tissue Senior Executive Council (BOTSEC) is to serve as the department''s internal executive leadership coordination mechanism across all the staff and operating divisions involved in blood, organ, and tissue safety and blood product availability. The internal committee is also responsible for looking at providing timely recommendations on emerging issues that are taking place. It also provides decisional elements on proposed policies, public health threats, and issues related to blood, organ, and tissue safety and availability. The staff of the Public Health Service (PHS) operating divisions involved in blood, organ and tissues safety (BOTS) meet monthly by a teleconference call. |
| HHS Data Council | Other | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NIA, NIMH | Coordinates all health and human services data collection and analysis activities of the Department of Health and Human Services, including an integrated data collection strategy, coordination of health data standards and health and human services and privacy policy activities. |
| HHS Diagnostics Integrated Program Team (Dx IPT) | Other | CDC, FDA | NIAID | The Diagnostics Integrated Program Team (Dx IPT) was established by the USG Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Executive Committee (EEC). The DxIPT will advise leadership on investments in human health diagnostics, medical countermeasures to improve the response to chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza (PI), and emerging infectious diseases (EID). Members include Federal employees or contractors to the Federal Government with diverse expertise in diagnostics. In 2012, DxIPT was charged with two tasks: 1) to reevaluate the feasibility of anthrax diagnostics for asymptomatic infections and 2) to develop Q-TRLs (Quantitative Technological Readiness Levels) for diagnostics to represent milestones and activities for the product development lifecycle from discovery through post-approval. |
| HHS Dietary Guidance Review Committee | Other | ACF, CDC, FDA, HRSA, IHS, OS | NIDDK | This committee reviews draft nutrition materials developed by all federal agencies and fulfills the legislative mandate (1990 NNMRRA) to ensure that federal dietary guidance is consistent with the Dietary Guidelines for Americans and is scientifically accurate. |
| HHS Disability and Health workgroup for Healthy People 2020 | Other | CDC | NICHD | The purpose of this workgroup is to discuss the measurement of health and the targets for persons with disabilities. |
| HHS Health Literacy Working Group | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG | NEI, NCI, NLM, OD/OCPL | This Workgroup is comprised of various HHS agencies that work towards meeting the Department’s prevention goals and to accomplish the National Action Plan and the Healthy People 2020 Objective: Improve the health literacy of persons with inadequate or marginal literacy skills. |
| HHS HIV/AIDS Management Team | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG | OD/DPCPSI/OAR | Trans DHHS Committee charged with addressing issues of and/or related to AIDS. |
| HHS Influenza Diagnostics Working Group | Other | CDC, FDA | NIAID | This Working Group shares information on initiatives and programs funded across different federal agencies. |
| HHS Initiative on Multiple Chronic Conditions | Committee, Work group, Advisory group, or Task Force | CDC, CMS, FDA, OS | OD/OSP, NIA, OD/DPCPSI/OBSSR | Recognizing the importance of Multiple Chronic Conditions (MCC) to patients, caregivers, and the health care system, the Assistant Secretary for Health convened an HHS-wide work group on MCC to identify options for improving the health of this population. The work group, in conjunction with other stakeholders, developed Multiple Chronic Conditions: A Strategic Framework. The Framework serves as a national-level roadmap for assisting HHS programs and public and private stakeholders to improve the health of individuals with MCC. http://www.hhs.gov/ash/initiatives/mcc/ |
| HHS Lyme and Tick Borne Diseases Work Group | Other | CDC, FDA, OS | NIAID | This group involves members from agencies including CDC, FDA, NIH with the purpose of continued coordination and communication of activities, policy updates, events, agency highlights and other shared interests relating to Lyme Disease and other tick-borne diseases. |
| HHS meeting on International and Domestic Adoption | Meeting/ Workshop | ACF, CDC, OS, SAMHSA | NIDA, NIMH | Planning and hosting a multi-agency meeting titled "Federal Learning Exchange on Directions in Evidence-based Strategies for Youth Programs" for the purpose of developing a cross-agency perspective on lessons learned regarding the implementation of youth programs. |
| HHS National Promotores de Salud Initiative | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, HRSA, SAMHSA | NHLBI | Community health workers (CHWs) and promotores de salud are frontline public health workers who serve as a link between health/social services and communities to facilitate access to services and improve the quality and cultural competence of service delivery. The purpose of the collaborative activity was to establish the National Promotores de Salud Initiative in partnership with HHS agencies to: establish a steering committee, develop a national recognition for promotores, and develop a HHS Portal for promotores and a national database system to connect with the promotores networks. |
| HHS Nutrition Policy Board | Other | ACF, CDC, FDA, HRSA, IHS, OS, SAMHSA | NIDDK | This Board coordinates the Department''s nutrition policy development and program implementation and is the principle point of contact with USDA for nutrition policy. |
| HHS Quality Workgroup | Other | ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | OD/DPCPSI/OBSSR, FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM | Convened by the HHS to support the implementation of the provisions of the Affordable Care Act (ACA) by the various HHS Operating Divisions (OpDivs) and includes senior-level representatives from 22 HHS agencies. The workgroup reviews, consults, and makes recommendations to ensure current HHS programs and initiatives align to the National Quality Strategy. The workgroup consults on the identification of specific measures, targeted goals, and annual benchmarks for relevant agencies in achieving the national priorities, provides a forum for HHS agencies and Operating Divisions to develop and share agency-specific plans to achieve the national priorities. The Workgroup also will develop processes to assess and foster alignment of the efforts with States and private sector initiatives. http://www.ahrq.gov/index.html |
| HHS Tobacco Control Steering Committee | Other | CDC, FDA, HRSA, OS, OSG, SAMHSA | NIDA, NCI | This committee, led by the Department of Health and Human Services, coordinates and initiates tobacco control activities across agencies. Helped to develop the HHS Tobacco Control Strategic Action Plan and the Action Plan Progress Report. http://www.hhs.gov/ash/initiatives/tobacco/index.html |
| HHS Violence Against Women Steering Committee | Committee, Work group, Advisory group, or Task Force | ACF, AHRQ, CDC, HRSA, IHS, OS, OSG, SAMHSA | OD/OSP, NIA, NIAAA, NICHD, NIDA, NIMH, NLM, OD/DPCPSI, OD/DPCPSI/ORWH | This is the committee that represents HHS as part of the implementation of the Violence Against Women (VAW) Act. This committee collaborates with the Departmeny of Justice to implement the VAW Act. Each year, NIH funds approximately $34M in VAW research across the institutes and centers. http://womenshealth.gov/about-us/who-we-are/groups-committees/steering-committee.cfm |
| HHS Viral Hepatitis Interagency Working Group | Other | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NIDDK, CC, NCCAM, NCI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIMHD, OD/DPCPSI/OAR | The HHS Viral Hepatitis Interagency Working Group was created by the Office of the Assistant Secretary for Health to address a recent report sponsored by the Institute of Medicine entitled Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. The group meets to discuss collaborations and activities directed at achieving the goals for viral hepatitis research and control highlighted in the IOM report. http://iom.edu/Reports/2010/Hepatitis-and-Liver-Cancer-A-National-Strategy-for-Prevention-and-Control-of-Hepatitis-B-and-C.aspx |
| HHS Working Group on Tobacco Control in Behavioral Health | Other | CDC, FDA, HRSA, OS, SAMHSA | NIDA, NCI, NIMH | The working group is a subcommittee of the HHS Tobacco Control Steering Committee. It is co-chaired by NIDA and SAMHSA, and was formed to initiate and coordinate cross-agency activities to promote, in behavioral health settings, the implementation of tobacco free policies and the integration of tobacco cessation. |
| HHS-Trauma, Emergency Care and Emergency Medical Services working group | Other | OS | NICHD | This workgroup documents HHS wide emergency related activities (including research) for the Assistant Secretary''s informational purposes |
| HHS/BARDA Radiological/Nuclear Working Group on Blood and Tissue Products | Meeting/ Workshop | CDC, FDA, OS | NIAID | This working group coordinates requirements, needs, and research and development directions for blood and tissue products for mass casualty treatment after a radiation emergency. |
| HIV Prevention Trials Network feasibility study (HPTN 065) | Research Initiative | CDC | NIAID, NIDA, NIMH | HPTN 065 is a feasibility study of an enhanced testing, linkage to care, and treatment approach to HIV prevention in the US, an intervention approach known as TLC-Plus. The study will involve evaluation of the feasibility of some components and the effectiveness of others. TLC-Plus uses innovative approaches, including 1) a community focus, 2) multi-component strategies that include behavioral and biomedical interventions, 3) the use of routinely reported HIV surveillance data to determine key outcomes, and 4) a partnership with local Departments of Health and the Centers for Disease Control and Prevention. This study will serve as a proof-of-concept formative study. It will provide key information that could guide the design and anticipate the costs of a future, large, randomized, community-level clinical trial of full implementation of a test-and-treat strategy in the U.S. Findings from this study could also inform test-and-treat efforts in other developed countries with epidemics similar to that in the U.S. http://www.hptn.org/research_studies/hptn065.asp |
| HIV/AIDS Cancer Match Study | Research Initiative | CDC | NCI | Investigators have used data from the NCI HIV/AIDS Cancer Match Study, in conjunction with data from the CDC surveillance program on the number of HIV-infected people in the U.S., to estimate the contribution of the HIV epidemic to the occurrence of Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer. http://hivmatch.cancer.gov/ |
| HIV/AIDS Prevention Research Synthesis (PRS) Project | Resource Development | CDC, HRSA | NIMH, NIDA | The HIV/AIDS Prevention Research Synthesis (PRS) is collaboration between NIH, CDC, and HRSA involved the development of criteria for identifying evidence-based behavioral interventions for HIV medication adherence. These criteria were finalized in 2010 after a series of consultations with methodologists, HIV prevention researchers, and key federal partners. The revised criteria focus on quality of study design, quality of study implementation and analysis, and strength of evidence of efficacy. http://www.cdc.gov/hiv/topics/research/prs/ma-efficacy-criteria.htm |
| Hospice to Palliative Care: Maximizing Patient Preferences and Cost Savings | Research Initiative | AHRQ | CC | Redesign Medicare Hospice Benefit. The goal of the study is to provide rational, patient-defined, evidence-based recommendations to inform the redesign of the Medicare hospice benefit, transitioning policy from the current hospice benefit to a more patient-centered palliative care model. http://globalhealth.duke.edu/research/project?pid=149&s=105&p=10&t=0&loc=0&rfm=0 |
| HPV Working Group for the Advisory Committee on Immunization Practices (ACIP) | Research Initiative | CDC | NCI | Advisory Committee on Immunization Practices (ACIP) Work Groups (WGs) serve in a key scientific role in support of vaccine policy development by the ACIP. ACIP WGs conduct extensive background reviews of relevant research data to develop options for recommendations for use of vaccines in the civilian population of the United States. WGs are convened solely to gather scientific information related to vaccines and the diseases they prevent, to analyze relevant issues and data, and to draft policies or options for review, deliberation and vote by the ACIP. The duties of this position include: participation in teleconferences and meetings, as well as preparation time for these meetings. |
| HRSA National Health Service Corps Students to Service Loan Repayment Program | Other | HRSA | NICHD | Advises HRSA on the loan repayment program |
| HRSA-Supplemental funding-NEXT STUDY | Research Initiative | HRSA | NICHD | In this IAA, HRSA supports NICHD in performance of the NEXT Generation Health study. This IAA provides needed supplemental funding and HRSA staff experience to conduct this longitudinal study of a nationally representative cohort of 10th grade students in the US. NEXT is a 7-year longitudinal assessment of a representative samples of US adolescent and young adults, starting when they are in 10th grade. |
| Human Nutrition Research Information Management (HNRIM) System | Resource Development | CDC, FDA, HRSA | NIDDK | Human Nutrition Research Information Management (HNRIM) is a searchable database of nutrition research and research training activities supported by the federal government and maintained by the NIH Division of Nutrition Research Coordination (DNRC). http://hnrim.nih.gov |
| ICARE: Interagency Collaborative to Advance Research in Epilepsy | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, OS | OD/OSP, FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDA, NIGMS, NIMH, NINDS, NINR | The purpose of this group, which is led by the National Institute of Neurological Disorders and Stroke, is to increase communication among institutes and agencies sponsoring epilepsy-related research and explore opportunities for increased coordination. http://www.ninds.nih.gov/research/epilepsyweb/researchers/ICARE/index.htm |
| Image-guided Interventional Therapeutics | Research Initiative | FDA | CC, NCI | This collaboration will lead to safer and more effective treatment planning and performance of image-guided interventions and therapeutic drug delivery. The results of all of these studies of image guided interventions and related technologies and the models used to study them will have a direct impact on the effectiveness and consistency of the FDA Center for Devices and Radiological Health''s (CDRH) preclinical review of device applications while meeting the primary research goal of optimizing image guided interventions and pre-clinical modeling of those interventions. Regulatory science and translational therapeutics have overlapping goals when it comes to drugs + devices combination therapies. |
| Improving Technical Standards and Molecular Tools for Probiotics Research and Development | Research Initiative | FDA | NCCAM | In 2008, the USDA Agricultural Service initiated a Memorandum of Understanding (MOU) with NCCAM to exchange expertise in technology development and partner research initiatives to advance the field of probiotic biology and role in human health. The MOU consists of a five year plan defining common mission goals; expected benefits from the exchange of research expertise and resources; and demonstration projects based on NIH/NCCAM funded U01 cooperative agreements. The long-term goal of the MOU is to develop trans-agency networked initiatives. In 2012, the unique resources of USDA/ARS and the HMP investigators were successfully implemented as a parallel comparative biotechnologies validation and standardization prototype with targeted molecular approaches. |
| Industry-wide exposure assessment study of workers to carbon nanotubes and nanofibers | Research Initiative | CDC | NIEHS | This study will measure workplace exposures to carbon nanotubes and carbon nanofibers among a representative sample of US manufacturers and downstream users. |
| Influenza Vaccine Manufacturing Improvement Initiative | Other | CDC, FDA | NIAID | Influenza Vaccine Manufacturing Improvement Initiative is a research-based HHS interagency collaborative program with industry to 1) optimize influenza virus vaccine strains for production yield and 2) develop faster potency and sterility assays. |
| Institute of Medicine (IOM) Youth Concussions Project | Other | CDC | NICHD, NINDS | This project began from interest among members of the Institute of Medicine (IOM)/National Research Council (NRC) Board on Children, Youth, and Families (BCYF) in developing a new activity focused on the topic of sports concussions in youth. A series of conference calls were held in early March 2010 focused on the health and educational issues associated with concussions/mild brain trauma among school-ages populations. The IOM first wanted to explore the need for a workshop or study that could identify key research findings, examine current policies and programs, and offer informed guidance for clinical practices, sports management, and educational settings. Congressional staff have also expressed interest in encouraging IOM to conduct a research review in this area, comparable to the 2002 IOM workshop on the consequences of head impact in youth soccer. To date: 1) IOM has secured funds for "planning meeting" towards a workshop; 2) IOM invites NICHD to attend a planning for the planning meeting on October 1, 2010; and 3) IOM in interested is securing funds for workshop. |
| Institute on Systems Science and Health | Training Initiative | CDC | OD/DPCPSI/OBSSR, NIBIB, NIDA | This is a week long training institute for behavioral and social science research investigators to be introduced to systems science methodologies (agent-based modeling, system dynamic modeling, network analysis). http://obssr.od.nih.gov/training_and_education/issh/index.html |
| Inter-Agency Committee on Drug Control (ICDC) | Other | FDA, SAMHSA | NIDA | The Inter-Agency Committee on Drug Control (ICDC) serves to facilitate communication between government agencies, including NIDA, FDA, DEA, and SAMHSA regarding drug control policies and initiatives. |
| Inter-agency Council on Biomedical Imaging in Oncology (ICBIO) | Meeting/ Workshop | AHRQ, CMS, FDA | NCI | Organized by the Cancer Imaging Program of Division of Cancer Treatment and Diagnosis (DCTD), Interagency Council on Biomedical Imaging in Oncology (ICBIO) is a confidential informational meeting for entities, usually small companies, planning product development in cancer. The Interagency Council on Biomedical Imaging in Oncology brings together technology developers and representatives from the National Cancer Institute (NCI), Food and Drug Administration (FDA), and Centers for Medicare and Medicaid Services (CMS) to expedite the process of bringing new products to market, to provide advice from a multi-agency perspective on the spectrum of scientific, regulatory, and reimbursement issues related to developing imaging devices or technology. http://imaging.cancer.gov/programsandresources/specializedinitiatives/ICBIO/site |
| Interactive Publications | Resource Development | CDC | NLM | NLM collaborated with the CDC National Center for Vital Health Statistics to convert the CDC''s Health US in Brief to interactive form, which can be viewed using NLM''s Panorama software. Interactive Publications are scientific multimedia documents that give readers more information from an article than is available in the published form (electronic or print) by enabling interaction with the included media (tables, graphs, images, videos, biomedical image studies, etc.) NLM conducts research into models for highly interactive multimedia documents that could transform the next generation of publishing in biomedicine. We focus on the standards, formats, authoring and reading tools necessary for the creation and use of such interactive publications that, in addition to text, contain media objects relevant to biomedical research and clinical practice: video, audio, bitmapped images, interactive tables and graphs, and clinical DICOM images such as x-rays, CT, MRI, and ultrasound. http://www.cdc.gov/nchs/hdi.htm |
| Interagency Agreement with CDC for HPTN 052: A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples | Research Initiative | CDC | NIAID | These clinical studies are based on data collected in Africa and Thailand. There is a correlation between HIV viral load (blood levels) and HIV transmission. Specifically, the higher the viral load in the blood, the more likely the chance for transmission. Antiretroviral therapy (ART) reduces the viral load in the blood, as well as in genital secretions (for both men and women), and the drugs can be detected in semen and vaginal and cervical secretions. All of this information strongly suggests that ART may make HIV-infected people less contagious. HPTN 052 compares the HIV-infection rates of two groups of HIV-serodiscordant couples. |
| Interagency Animal Management Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA | OD/DPCPSI/OAR, NHLBI, NIAID, NIMHD, OD/DPCPSI/ORIP | Committee established to review experimental protocols for use of federally funded chimpanzees. |
| Interagency Artificial Pancreas Working Group | Other | FDA | OD/OSP, NIBIB, NICHD, NIDDK | The Interagency Artificial Pancreas Working Group is a group of multi-disciplined scientists and clinicians from the FDA and NIH to support the Artificial Pancreas Initiative. The goals of this initiative are to provide infrastructure for narrowing the gap between basic biomedical knowledge and clinical application of novel technologies, and to cross-fertilize and partner with stakeholders in order to identify and overcome the clinical and scientific challenges to the development of an artificial pancreas. Through collaborative efforts, such as workshops, the group strives to develop innovative strategies to achieve their goals. |
| Interagency Autism Coordinating Committee (IACC) | Committee, Work group, Advisory group, or Task Force | ACL, AHRQ, CDC, CMS, FDA, HRSA | OD/OSP, NICHD, NIDCD, NIEHS, NIMH, NINDS | The Interagency Autism Coordinating Committee (IACC) is a Federal advisory committee that coordinates all efforts within the Department of Health and Human Services concerning autism spectrum disorder (ASD). The IACC mission is to: (1) provide advice to the Secretary of Health and Human Services regarding Federal activities related to ASD; (2) facilitate the exchange of information on and coordination of ASD activities among the member agencies and organizations; and (3) increase public understanding of the member agencies'' activities, programs, policies, and research by providing a public forum for discussions related to ASD research and services. http://iacc.hhs.gov/about/index.shtml |
| Interagency Chemical Hazards Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NINDS | Working group on chemical hazards led by the Office of Science and Technology Policy (OSTP). |
| Interagency Chemical Risk Assessment Working Group | Committee, Work group, Advisory group, or Task Force | OS | NINDS, NIAID | Department of Homeland Security led effort to determine chemical hazards and develop Chemical Risk Threat Risk Assessment list of priority chemicals. |
| Interagency Committee on Emergency Medical Services for Children Research (ICER) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, OS, SAMHSA | OD/OSP, NHLBI, NIAAA, NIBIB, NICHD, NIDA, NIGMS, NIMH, NINDS, NINR, OD/DPCPSI | Interagency Committee on Emergency Medical Services for Children Research (ICER) is a federal collaborative effort begun in the mid-1990’s to improve the quality and quantity of Emergency Medical Services for Children (EMSC) research, to foster collaboration between federal agencies in highlighting EMSC research topics during development of research agendas, and to reduce barriers to the production of high quality EMSC research. http://www.childrensnational.org/files/PDF/EMSC/NationalActivities/ICER.pdf |
| Interagency Committee on Smoking and Health | Other | CDC, HRSA | NICHD, NCI, NHLBI, NIDA | The Interagency Committee on Smoking and Health (ICSH) coordinates Department of Health and Human Services research, educational programs, and other smoking and health effects with similar activities of other federal, state, local, and private agencies. http://www.cdc.gov/tobacco/icsh/index.htm |
| Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders (ICCFASD) | Other | ACF, AHRQ, CDC, HRSA, IHS, SAMHSA | OD/OSP, NIAAA, NICHD | The Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders (ICCFASD) was created in October 1996 in response to recommendations of an expert committee of the Institute of Medicine that NIAAA chair an effort to coordinate Federal activities on fetal alcohol syndrome (FAS) and other disorders associated with prenatal alcohol exposure. The Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders (ICCFASD) works to improve communication, cooperation, and collaboration among disciplines and federal agencies that address issues of health, education, developmental disability, research, justice, and social services relevant to FAS and related disorders caused by prenatal alcohol exposure. The ICCFASD meets twice a year and frequently arranges special conferences; the most recent was Oct. 31-Nov. 2, 2011 on Recognizing Alcohol-related neurodevelopmental disorder (ARND) in Primary Health Care of Children. http://www.niaaa.nih.gov/ICCFASD |
| Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt-Jakob Disease | Other | CDC, FDA | NIDDK, NICHD, NINDS | Coordinates federal efforts to understand how pituitary human growth hormone may have led to the development of Creutzfeldt-Jakob Disease in participants of the National Hormone and Pituitary Program. http://www.niddk.nih.gov/federal/planning/hgh/default.htm |
| Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) | Other | ACF, CDC, IHS, OS, OSG, SAMHSA | NIDA, NIAAA | The Consolidated Appropriations Act of 2004 directed the Secretary of Health and Human Services (HHS) to establish the Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD) and to issue an annual report summarizing all Federal agency activities related to preventing underage alcohol use. HHS made ICCPUD a standing committee to provide ongoing, high-level leadership on this issue and to serve as a mechanism for coordinating Federal efforts aimed at preventing and reducing underage drinking. The Substance Abuse and Mental Health Services Administration (SAMHSA) serves as the lead ICCPUD agency. https://www.stopalcoholabuse.gov/default.aspx |
| Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) | Research Initiative | ATSDR, CDC, FDA | NIEHS, NCI, NEI, NIAID, NLM | The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) is an interagency committee of 15 Federal agencies that carries out specific duties prescribed by the ICCVAM Authorization Act, P.L. 106-545. The ICCVAM is administered by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), a component of the NIEHS. NICEATM in collaboration with ICCVAM and its international collaborators in Japan, the EU, and Canada conducts research studies to evaluate the scientific validity of proposed new safety testing methods. NICEATM and ICCVAM also conduct international scientific peer review evaluations of proposed safety methods, and forward recommendations on scientific valid methods to Federal agencies, which must adopt the proposed methods or provide a basis for not adopting it. NICEATM and ICCVAM also organize scientific workshops to evaluate the current state of the science on a wide range of toxicological and other safety endpoints. http://iccvam.niehs.nih.gov/ |
| Interagency Council on Emergency Research | Other | AHRQ, HRSA | NICHD, NHLBI, NIGMS | Representation of NICHD and consultation on pediatric acute care research by PCCR Program. |
| Interagency Group on Alzheimer''s Disease and Related Dementias for implementation of the National Alzheimer''s Project Act | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA | NIA | This interagency group was established by HHS in response to the Congressional directive to address Alzheimer''s disease. Under the National Alzheimer''s Project Act, HHS created three sub-groups on Research, Long Term Services, and Clinical Services. The Veteran''s Administration, National Science Foundation, and Department of Defense are also involved in this effort. http://aspe.hhs.gov/daltcp/napa/ |
| Interagency Midazolam Product Coordination Team | Committee, Work group, Advisory group, or Task Force | FDA, OS | NINDS, NIAID | HHS-led effort to facilitate activities, both research and regulatory, related to the FDA approval midazolam for use in treating nerve agent exposure. |
| Interagency Modeling and Analysis Group | Committee, Work group, Advisory group, or Task Force | FDA | NIBIB, CSR, FIC, NCATS, NCI, NHGRI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NLM, OD/DPCPSI/OBSSR | The Interagency Modeling and Analysis Group (IMAG) is comprised of program directors from ten government agencies in the U.S. and Canada, including the National Institutes of Health (NIH), the National Science Foundation (NSF), Department of Energy (DOE), Department of Defense (DOD), the United States Department of Agriculture (USDA), the Canadian federal research network for Mathematics of Information Technology and Complex Systems (MITACS), the National Aeronautics and Space Administration (NASA), the United States Department of Veterans Administration (USDVA), the Food and Drug Administration (FDA), and the Intelligence Advanced Research Projects Activity (IARPA). The purpose of IMAG is to bring together program officers who have a shared interest in supporting modeling and analysis methods in biomedical, biological and behavioral systems. IMAG has promoted and supported a wide variety of modeling over the past 10 years, notably the multi-scale modeling (MSM) initiative, which was originally a multi-agency funding opportunity announcement and continued on by different IMAG agencies through separate funding opportunity announcements. |
| Interagency Pain Research Coordinating Committee (IPRCC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA | NINDS, NIDCR | The initial charge to the committee includes, 1) develop a summary of major advances in pain care research supported by Federal Agencies relevant to the diagnosis, prevention, and treatment of pain; 2) identify critical gaps and duplications in basic and clinical pain research across Federal Agencies; 3) make recommendations on how best to disseminate information on pain care; and 4) make recommendations on how to expand public-private partnerships to expand collaborative cross-cutting research. Federal and non-federal committee representatives and NIH staff developed a survey to address item 1 above and performed a portfolio analysis to address item 2 above. The committee was charged in 2012 with an additional task: to create a comprehensive, population health level strategy for pain prevention, treatment, management, and research. Volunteers from the IPRCC and professional associations established a working group to address the 2012 charge to the committee. http://iprcc.nih.gov/ |
| Interagency Select Agent Review Group (ISARG) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NIAID | This Review Group composed of members from FDA and relevant federal agencies, including CDC, Department of Justice and Department of State, recommends to NIAID whether facilities and procedures (e.g., registration, security risk assessments, safety plans, security plans, emergency response plans, training, transfers, record keeping, laboratory inspections, notification, etc) at NIAID-funded foreign research sites are comparable to those required by the Select Agent Regulations for domestic institutions before Select Agent work at the foreign site may proceed. |
| Interagency Subcommittee on Disability Statistics (ISDS) | Meeting/ Workshop | ACF, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NIDCD | A Government-wide group, the Federal Interagency Subcommittee on Disability Statistics (ISDS), meets monthly to discuss the issues related to identifying people with disabilities and coordinate research in this area. http://www.icdr.us/index.php?option=com_content&view=article&id=34&Itemid=62 |
| Interagency Subcommittee on Education (ISED) of the Interagency Committee on Disability Research (ICDR) | Other | ACF, AHRQ, CDC, HRSA | NICHD | The Interagency Committee on Disability Research (ICDR) is mandated to promote interagency coordination, collaboration, and communication. It must identify, assess, and seek to coordinate all Federal programs, activities, and projects, and plans for such programs, activities, and projects with respect to the conduct of research (including assistive technology research and research that incorporates the principles of universal design) related to rehabilitation of individuals with disabilities. The committee facilitates the effective exchange of information on disability and rehabilitation research activities among its member agencies. We coordinate activities that span the areas of assistive technology and universal design; medical rehabilitation; data and statistics; employment; health disparities, and education. The Interagency Subcommittee on Education (ISED), a subcommittee of ICDR, focuses on issues related to the education of persons with disabilities by collecting input from stakeholders to inform planning; identifying emerging research areas; assessing research gaps, synergies and duplications; and making recommendations to inform the federal research agenda. |
| Interagency Subcommittee on Medical Rehabilitation (ISMR) | Other | AHRQ, CDC | NICHD, NCATS, NCI, NEI, NHLBI, NIAMS, NIBIB, NIDA, NIDCD, NIMH, NINDS | The Interagency Subcommittee on Medical Rehabilitation (ISMR) is composed of representatives from federal agencies involved in disability and related research including rehabilitation research. After receiving input from targeted individuals, the Committee shall identify, assess, and seek to coordinate all Federal programs, activities, and projects, and plans for such programs, activities, and projects with respect to the conduct of research (including assistive technology research and research that incorporates the principles of universal design) related to rehabilitation of individuals with disabilities. |
| Interagency Task Force on Antimicrobial Resistance (ITFAR) | Other | CDC, FDA | NIAID | Interagency Task Force on Antimicrobial Resistance (ITFAR) is a coordinating committee within the Federal Government for research on antimicrobial resistance. |
| Interagency Working Group on Dual Use Research Oversight | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NIAID | Develops policy options and guidance for the US government''s oversight of dual use research of concern (DURC). |
| Interagency Working Group on Healthcare Quality | Other | ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | OD/DPCPSI/OBSSR, FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM | Includes representation from all major departments that examine issues regarding the quality of healthcare. |
| Interagency Working Group on Neuroscience | Other | CDC, FDA | OD/OSP, NIA, NIDA, NIMH, NINDS, NINR, OD/DPCPSI/OBSSR | By Executive Order, the White House Office of Science and Technology Policy (OSTP) established the Interagency Working Group on Neuroscience by action of the National Science and Technology Council (NSTC) to foster collaboration across agencies and to coordinate Federal investments in neuroscience research. The Interagency Working Group on Neuroscience will coordinate activities in neuroscience research across the Federal government with a focus on the fundamental understanding of learning, brain development and plasticity, and brain health and recovery. The working group will enhance Federal efforts related to: improving our understanding of learning and cognition and applying that to improvements in education and other areas; improving our understanding of a variety of neurological conditions and injuries; and developing appropriate resources, tools, techniques, interventions, and therapies to assist in research, treatment, and recovery. The NSTC working group includes members from the Departments of Agriculture, Defense, Education, Energy, Health and Human Services, Homeland Security, Justice, and Veterans Affairs, as well as the CIA, Environmental Protection Agency, NASA, the National Science Foundation, and the Office of the Director of National Intelligence. http://www.whitehouse.gov/sites/default/files/iwgn_charter.pdf |
| Interagency Working Group on Youth Programs | Committee, Work group, Advisory group, or Task Force | ACF, CDC | NIAAA, NIDA | The Interagency Working Group on Youth Programs (IWGYP), which is composed of representatives from 12 federal departments and 5 federal agencies that support programs and services focusing on youth. The IWGYP promotes the goal of positive, healthy outcomes for youth. http://findyouthinfo.gov/ |
| INTERMACS - Interagency Registry for Mechanically Assisted Circulatory Support | Resource Development | CMS, FDA | NHLBI | Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) is a national registry for patients who are receiving mechanical circulatory support device therapy to treat advanced heart failure. This registry was devised as a joint effort of the National Heart, Lung, and Blood Institute, the Centers for Medicare and Medicaid Services, the U.S. Food and Drug Administration, clinicians, scientists, and industry representatives, in conjunction with the University of Alabama at Birmingham and the United Network for Organ Sharing. http://www.intermacs.org/ |
| International Experience and Technical Assistance Training Program (IETA) | Meeting/ Workshop | CDC, FDA, HRSA, SAMHSA | NIMH | The International Experience and Technical Assistance (IETA) program is a developmental training program for Federal public health employees offered by the Center for Global Health at the CDC. Specifically, IETA is a professional development/technical assistance program that consists of three workshops and a supervised short-term overseas assignment with an international public health program. NIMH staff presented on professional experience with IETA program during a brown bag session for the CDC IETA program, Bethesda, MD, May 2012. http://www.cdc.gov/globalhealth/ieta/ |
| Intradepartmental Council for Native American Affairs (ICNAA) | Committee, Work group, Advisory group, or Task Force | OS | NIMHD | To support activities of the Intradepartmental Council for Native American Affairs (ICNAA), including tribal consultation sessions, and development of the annual tribal consultation report. http://www.hhs.gov/intergovernmental/tribal/abouticnaa/icnaa_mission.html |
| Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NIAID | The Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC) is a working group of subject matter experts from the Federal Government formed by the CDC Director to provide recommendations to the CDC''s Division of Select Agents and Toxins in three technical areas: 1) review requests for exclusion of attenuated strains, 2) review requests to conduct restricted experiments, and 3) review select agents and toxins. The Committee conducts a biannual review, required by the Select Agent Rule, of the Select Agents and Toxins list for HHS. Expert input from the ISATTAC and public comments are the primary inputs into this process. |
| Investigations into Health Effects Caused by Exposure to Indoor Air Reaction Products | Research Initiative | CDC | NIEHS | Ongoing studies are identifying and quantifying the volatile reaction products of gas-phase compounds present in the indoor environment, especially dicarbonyls, and investigating immunotoxic and hypersensitivity effects of these reaction products in both in vitro and in vivo models. |
| Investigations of early life determinants of pediatric and adult malignancies in a population | Research Initiative | CDC | NCI | In collaboration with investigators from the U.S. CDC and the China CDC, NCI is assessing risk of pediatric leukemia and other pediatric cancers in a large population of offspring of mothers enrolled in a community intervention program of peri-conception folic acid supplementation in China. Pediatric cancer risks will be compared in offspring of mothers treated versus offspring of mothers not treated with folic acid supplements. |
| Joint Committee and Joint Commission Meetings | Meeting/ Workshop | CDC, FDA, OS | NCI, FIC, NIAID | US State Department establishes collaborative agreements with foreign governments in fields of science and technology. These Joint Committee and Joint Commission Meetings (JCMs) facilitate discussion on selected topics creating cross-talk among the equivalent government agencies leading towards future collaborations. The OS through OGA organizes the DHHS OP/DIVs; FIC facilitates the NIH institute and center participation. For FY2011, JCMs were convened for Brazil, Colombia, and Mexico. |
| Joint Fellowship Program | Training Initiative | FDA | NCI | The objective of the NCI-FDA fellowships is to train a cadre of scientists in research and research-related regulatory review, policies, and regulations so that they develop a skill set that bridge the two disparate processes. Fellows will learn to build awareness of regulatory requirements into the early stages of the medical product development process and develop strategies to improve planning throughout research and regulatory review. http://iotftraining.nci.nih.gov/ |
| Kaposi sarcoma and HHV8 in sickle cell and other Ugandan populations | Research Initiative | CDC | NCI | Epidemiological studies are being conducted to assess small-area variation of HHV8 and to learn about socio-demographical and environmental risk factors for HHV8 and Kaposi sarcoma in Uganda. |
| Kidney Interagency Coordinating Committee (KICC) | Other | AHRQ, CDC, CMS, FDA, HRSA, IHS | NIDDK, NHLBI | The Kidney Interagency Coordinating Committee (KICC) Consists of Federal Representatives involved in chronic kidney disease (CKD) programs. KICC''s purpose is to encourage communication and collaboration to shape a more coordinated Federal response to CKD. http://www.nkdep.nih.gov/about/kicc/cdc-matrix.htm |
| Know Stroke in the Community | Public Education Campaign | CDC | NINDS | The NINDS developed the Know Stroke campaign to help educate the public about the symptoms of stroke and the importance of getting to the hospital quickly. The campaign includes outreach to consumers and health care professionals using mass media, grassroots outreach, partnerships, and community education. http://stroke.nih.gov/index.htm |
| Let''s Move/HHS Healthy Weight Task Force | Other | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NIDDK, NHLBI | The HHS Healthy Weight Task Force aims to improve dietary and physical activity behaviors through targeted sector initiatives |
| Linking Cardiovascular Health Study Data to CMS Data | Research Initiative | CMS | NHLBI | The Cardiovascular Health Study (CHS) is a population-based longitudinal study of risk factors for the development of cardiovascular disease (CVD) and stroke in 5,888 men and women aged 65 and older. Annual examinations through 1999 included measures of possible and proven cardiovascular disease risk factors and measures of subclinical disease. The cohort has been followed for coronary heart disease, stroke, congestive heart failure, peripheral arterial disease, and mortality. The study is currently supported by contract funding for infrastructural functions and by investigator-initiated grants and other outside sources for research projects. CMS data are being used to enhance CHS CVD outcomes research by enabling researchers to study determinants related to medical care access, quality, cost, and outcomes. Conference calls are conducted among staff of the study, the CMS, and the NHLBI to discuss the data availability, confidentiality, quality, distribution, and to identify research opportunities. http://www.chs-nhlbi.org/default.htm |
| Linking Atherosclerosis Risk in Communities (ARIC) Data to CMS Data | Research Initiative | CMS | NHLBI | The Atherosclerosis Risk in Communities (ARIC) study, which began in 1985, seeks to 1) monitor trends in the incidence and mortality of coronary heart disease and heart failure through a surveillance program in four communities and 2) assess determinants in development and progression of subclinical and clinical cardiovascular disease (CVD) through a cohort follow-up study of 15,796 white and African American persons aged 45-64 at baseline. Since 2005, CMS data has been provided through an interagency agreement. The data is being used to validate and capture all the heart failure cases in persons aged 65 yrs and older in the ARIC cohorts and to validate and capture morbidity and mortality status of these individuals. In addition, CMS data are being used to enhance ARIC CVD outcomes research by enabling researchers to study determinants related to medical care access, quality, cost, and outcomes. Conference calls are conducted among staff of the study, the CMS, and the NHLBI to discuss the data availability, confidentiality, quality, distribution, and to identify research opportunities. http://www.cscc.unc.edu/aric/ |
| Linking Framingham Heart Study Data to CMS Data | Research Initiative | CMS | NHLBI | The Framingham Heart study is a long-term, multigenerational study is designed to identify genetic and environmental factors influencing the development of cardiovascular and other diseases. Examination and testing of 5,209 residents of Framingham, Massachusetts, was initiated in 1948 and with approximately 700 members of the original cohort currently alive and under follow-up. An offspring cohort and a third generation cohort have been added. The project examines the incidence and prevalence of cardiovascular disease (CVD) and its risk factors, trends in CVD incidence and its risk factors over time, and family patterns of CVD and risk factors. Other objectives include the estimation of incidence rates of disease, a description of the natural history of CVD, including the sequence of clinical signs and systems that precede the clinically recognizable syndrome, and the consequences and course of clinically manifest disease. CMS data are being used to enhance Framingham CVD outcomes research by enabling researchers to study determinants related to medical care access, quality, cost, and outcomes. Conference calls are conducted among staff of the study, the CMS, and the NHLBI to discuss the data availability, confidentiality, quality, distribution, and to identify research opportunities. http://www.framinghamheartstudy.org/about/index.html |
| Linking Jackson Heart Study Data to CMS Data | Research Initiative | CMS | NHLBI | The Jackson Heart Study (JHS) is a multi-center investigation of predictors of cardiovascular disease (CVD) in 5301 African Americans living in counties surrounding the Jackson, MS, metropolitan area. The JHS was initiated in 1998 as a collaborative effort among three Jackson-area academic institutions. The JHS completed three back-to-back cohort examinations that have produced extensive longitudinal data on traditional and putative CVD risk factors, socioeconomic and sociocultural factors and biochemical analytes; measures of subclinical disease from echocardiography, cardiac magnetic resonance imaging (MRI), computed tomography (CT) scans of the heart, aorta and abdomen; and stored biological samples. In addition, the JHS has conducted annual cohort follow-up contacts for incident clinical events of interest, a variety of community education and outreach activities to promote healthy lifestyles to reduce disease risk burden, and level-appropriate training programs to promote and support public health research. Since 2011, CMS data has been provided through an interagency agreement to obtain services and expertise in acquisition and utilization of Medicare claims data for participants enrolled in the JHS. Combining the detailed clinical and epidemiological data of the JHS with the Medicare claims data allows (1) assessment of major events (hospitalizations, stroke, MI) for participants lost to follow-up, (2) validation of selected outcomes reported by participants, and (3) expansion of the JHS research agenda to address questions related to resource utilization among elderly JHS participants that could not be addressed using the JHS data or Medicare claims data alone. Conference calls are conducted among staff of the study, the CMS, and the NHLBI to discuss the data availability, confidentiality, quality, distribution, and to identify research opportunities. http://jhs.jsums.edu/jhsinfo/ |
| Linking Multi-Ethnic Study of Atherosclerosis Data to CMS Data | Research Initiative | CMS | NHLBI | The Multi-Ethnic Study of Atherosclerosis (MESA) investigates the prevalence, correlates, and progression of subclinical cardiovascular disease (CVD) and risk factors that predict progression to clinically overt CVD, and that predict progression of subclinical disease itself, in a population-based sample of 6,814 men and women aged 45-84 at baseline from four ethnic groups – white, African American, Hispanic, and Chinese. The cohort was recruited from six Field Centers in the US and characterized with respect to coronary calcification using computed tomography, ventricular mass and function using magnetic resonance imaging, and other measures at baseline. Several subclinical disease measures were repeated in 3 subsequent examinations, and fifth examination is underway (April 2010 – September 2011). Exam 5 includes a repeat cardiac MRI, including myocardial tagging to measure ventricular function. Approximately half of the cohort will undergo repeat cardiac CT and carotid ultrasound, supported by the EPA-funded ancillary study MESA Air Pollution. Participants will be followed for identification and characterization of incident CVD events and interventions received. CMS data are being used to enhance CHS CVD outcomes research by enabling researchers to study determinants related to medical care access, quality, cost, and outcomes. Conference calls are conducted among staff of the study, the CMS, and the NHLBI to discuss the data availability, confidentiality, quality, distribution, and to identify research opportunities. http://www.mesa-nhlbi.org |
| Linking Women''s Health Initiative Data to CMS Data | Research Initiative | CMS | NHLBI | The Women''s Health Initiative is a study of cardiovascular disease, cancer, and osteoporosis in postmenopausal women. Participant data from the NHLBI Women''s Health Initiative cohort is linked to Medicare data to allow researchers to identify clinical outcomes and to investigate the utilization and costs of medical services within the Medicare Program. Investigators are in negotiations with CMS to find the best way to share the data with qualified researchers. http://www.nhlbi.nih.gov/whi |
| Live Attenuated Leishmania donovani p27 Gene Knockout Parasites Are Nonpathogenic and Elicit Long-Term Protective Immunity in BALB/c Mice | Research Initiative | FDA | NHLBI | Leishmaniasis causes significant morbidity and mortality worldwide, and no vaccines against this disease are available. Previously, we had shown that the amastigote-specific protein p27 (Ldp27) is a component of an active cytochrome c oxidase complex in Leishmania donovani and that upon deletion of its gene the parasite had reduced virulence in vivo. In this study, we have shown that Ldp27(-/-) parasites do not survive beyond 20 wk in BALB/c mice and hence are safe as an immunogen. Upon virulent challenge, mice 12 wk postimmunization showed significantly lower parasite burden in the liver and spleen. When mice were challenged 20 wk postimmunization, a significant reduction in parasite burden was still noted, suggesting long-term protection by Ldp27(-/-) immunization. Immunization with Ldp27(-/-) induced both pro- and anti-inflammatory cytokine responses and activated splenocytes for enhanced leishmanicidal activity in association with NO production. Protection in both short- and long-term immunized mice after challenge with the wild-type parasite correlated with the stimulation of multifunctional Th1-type CD4 and CD8 T cells. Adoptive transfer of T cells from long-term immunized mice conferred protection against virulent challenge in naive recipient mice, suggesting involvement of memory T cell response in protection against Leishmania infection. Immunization of mice with Ldp27(-/-)also demonstrated cross-protection against Leishmania major and Leishmania braziliensis infection. Our data show that genetically modified live attenuated Ldp27(-/-) parasites are safe, induce protective immunity even in the absence of parasites, and can provide protection against homologous and heterologous Leishmania species. |
| Logical Observation Identifiers Names and Codes (LOINC) | Resource Development | AHRQ, CDC, CMS, HRSA, IHS, OS | NLM | This activity supports the maintenance, distribution, and continued development of Logical Observation Identifiers Names and Codes (LOINC®), a set of universal codes and names to identify laboratory and other clinical observations which facilitates the exchange and pooling of clinical results for clinical care, outcomes management, and research. The Regenstrief Institute, Inc, an internationally renowned healthcare and informatics research organization, maintains the LOINC database and supporting documentation, and the RELMA mapping program. http://www.nlm.nih.gov/research/umls/loinc_main.html |
| Long-term Oxygen Treatment Trial | Research Initiative | CMS | NHLBI | The Long-term Oxygen Treatment Trial is a randomized controlled clinical trial to assess the efficacy of around-the-clock, supplemental oxygen therapy in subjects with chronic obstructive pulmonary disease and moderately severe hypoxemia. NHLBI will administer and oversee the study, and Medicare will cover the costs of items and medical services that are generally available through that program to beneficiaries enrolled in the trial. http://www.nih.gov/news/pr/nov2006/nhlbi-20.htm |
| Longitudinal Study of Implantable Cardioverter-Defibrillators | Research Initiative | AHRQ | NHLBI | After randomized controlled trials demonstrated that implantable cardioverter-defibrillators (ICDs) reduce the risk of death in patients with left ventricular systolic dysfunction. The use of implantable cardioverter-defibrillators (ICDs) for primary prevention increased after randomized controlled trials demonstrated that they reduce the risk of death in patients with left ventricular systolic dysfunction. However, the extent to which the clinical characteristics and long-term outcomes of unselected, community-based patients with left ventricular systolic dysfunction undergoing primary prevention ICD implantation in a real-world setting compare with those of participants enrolled in the randomized, controlled trials is not well characterized. To address the issue, this study is being conducted in the Cardiovascular Research Network, in collaboration with AHRQ. |
| Lupus Federal Working Group | Meeting/ Workshop | AHRQ, CDC, FDA, HRSA, OS | NIAMS, NCCAM, NEI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIMHD, NINDS | The Lupus Federal Working Group, established on behalf of the HHS Secretary by the NIH, facilitates collaboration among NIH components, other Federal agencies, voluntary and professional organizations, and industry groups with an interest in lupus. http://www.niams.nih.gov/About_Us/Committees/lupus_fwg.asp |
| Maintenance of an Armadillo Colony | Other | HRSA | NIAID | The Maintenance of an Armadillo Colony contract supports basic research for leprosy. |
| Mapping of the SNOMED CT and ICD Clinical Terminology | Resource Development | CDC, OS | NLM | The U.S. Department of Health and Human Services (HHS) has set a goal for the nationwide implementation of an interoperable health information technology infrastructure to improve the quality and efficiency of health care. Achieving this goal will require that key clinical data elements are captured or recorded in detailed, standardized form (using standard vocabularies, codes, and formats) as close to their original sources (patients, health care providers, laboratories, diagnostic devices, etc.) as possible. If these standardized clinical data can also be used to generate HIPAA- compliant billing transactions automatically, this will provide another incentive for adoption of clinical data standards. For automated generation of bills from clinical data to become a reality, robust mappings from standard clinical terminologies to the HIPAA code sets must be created. http://www.nlm.nih.gov/research/umls/mapping_projects/snomedct_to_icd9cm_reimburse.html |
| Maternal and Child Health (MCH) Pediatric Research Network Program | Research Initiative | HRSA | NICHD | The purpose of this IAA is for NIH to contribute funding to the Health Resources and Services Administration (HRSA) to fund, oversee, and manage a cooperative agreement on a topic of mutual interest to the agencies. The funds will be used to support a pediatric practice-based applied research network that will engage in coordinated multi-centered research activities, focusing on translating research to practice, and cultivate new researchers from among the practice-based research network (PBRN) that successfully competed for the cooperative agreement to continue to develop and implement a training program to create research proposals, culminating in the submission of research proposals involving priority needs for pediatric therapeutics in accordance with the Best Pharmaceuticals for Children Act (BPCA), build infrastructure to further develop an existing affiliated electronic health record (EHR) based pediatric PBRN engaged in research endeavors of mutual interest to NIH and HRSA, and more swiftly evaluate and submit research proposals that should result in health and health services improvements within the pediatric population, particularly when applied directly into pediatric care and service settings. |
| Medical Expenditure Panel Survey (MEPS) | Health Survey | AHRQ | NCI | The Medical Expenditure Panel Survey (MEPS) is a set of large-scale surveys of families and individuals, their medical providers, and employers across the United States. MEPS is the most complete source of data on the cost and use of health care and health insurance coverage. http://meps.ahrq.gov/mepsweb/ |
| Medical Planning and Response to a Nuclear Detonation Working Group | Other | CDC, FDA, OS | NCI | This group developed educational materials related to emergency planning for nuclear detonations for Government use and publication. |
| Medicare benefit postcard developed by NEI and CMS | Public Education Campaign | CMS | NEI | NEI worked with CMS to develop and disseminate a Medicare benefit card in English and Spanish which describes eligibility for the Medicare benefit for glaucoma and diabetic eye disease. The postcards are distributed to Medicare beneficiaries, the general public, and to health professionals. http://www.nei.nih.gov/nehep/programs/visionandaging/medicare.asp |
| Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS | Other | FDA | NINDS | This MOU provides a mechanism for addressing cross-cutting issues related to therapy development for neurological disorders, from bench science to clinical trials and FDA approval and licensure. http://www.fda.gov/AboutFDA/PartnershipsCollaborations/MemorandaofUnderstandingMOUs/DomesticMOUs/ucm114903.htm |
| Mental Health Surveillance Study | Health Survey | SAMHSA | NIMH | The Mental Health Surveillance Study (MHSS) builds upon established federal survey platforms in order to expand the NIMH research portfolio in population-based mental health studies. The purpose of the MHSS will be to conduct additional calibration work on the survey data; to assess the feasibility of developing a longitudinal component for future surveys; and to produce up to seven reports related to mental health. In FY2012, NIMH participated in data collection activities by supplementing the MHSS sample with 1,000 clinical interviews. |
| Meta-Analysis of the Risk of Guillain-Barre Syndrome Following H1N1 Vaccination | Committee, Work group, Advisory group, or Task Force | FDA | NIAID | Statistical expertise is offered in the design and analysis of multiple safety studies to assess the risk of Guillain-Barre Syndrome following H1N1 vaccination. |
| Microphysiological Systems for Drug Efficacy and Toxicity Testing | Research Initiative | FDA | NCATS, NCI, NEI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NINDS, NINR, OD/DPCPSI, OD/DPCPSI/ORWH | The Microphysiological systems initiative aims to develop 3-D human tissue chips that accurately model the structure and function of human organs, such as the lung, liver and heart. Once developed, researchers can use these models to predict whether a candidate drug, vaccine or biologic agent is safe or toxic in humans in a faster and more cost-effective way than current methods. More than 30 percent of promising medications have failed in human clinical trials because they are determined to be toxic despite promising pre-clinical studies in animal models. These organs-on-chips will enable scientists to predict more accurately how effective a therapeutic candidate would be in clinical studies. To help streamline the therapeutic development pipeline, NIH, in collaboration with the Defense Advanced Research Projects Agency (DARPA) and the U.S. Food and Drug Administration, is leading this initiative to improve the process for predicting whether drugs will be safe in humans. http://www.ncats.nih.gov/research/reengineering/tissue-chip/tissue-chip.html |
| Microsystems Team | Other | FDA | NIDDK, NINDS | The NIH has identified a critical need for improved model systems to predict efficacy, safety, bioavailability, and toxicology outcomes for candidate therapeutics. This NIH FOA, supported by funds from the NIH Common Fund and participating NIH Institutes and Centers, invites applications for projects that will develop accurate cellular and organ microsystems representative of human physiology for the evaluation of drug efficacy and toxicity. By definition, these cellular and organ microsystems will have a multicellular architecture representing the characteristics and functions of the tissue of origin and will demonstrate a reproducible and viable operation under physiological conditions over a long culture period. It is anticipated that these bio-engineered human tissue models could lead to the development and commercialization of microsystems that will enable rapid and high fidelity evaluation of safety and efficacy for candidate therapeutics. http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-11-022.html |
| Million Hearts | Committee, Work group, Advisory group, or Task Force | ACL, AHRQ, CDC, CMS, FDA, HRSA, SAMHSA | NHLBI, NINDS | The NIH provided input via CMS and CDC on the development and implementation of the Million Hearts Initiative. http://millionhearts.hhs.gov/ |
| Mobile apps for data collection on adverse events of medication or device during public health emergencies | Resource Development | FDA | NLM | NLM and FDA established a partnership to explore the development, assessment, and utilization of mobile applications to disseminate and exchange scientific information and data concerning reported adverse events from the use of a medication or medical device approved under the Emergency Use Authorization in a public health emergency or disaster. |
| Models of Infectious Disease Agent Study (MIDAS) (RFA) | Research Initiative | CDC | NIGMS, FIC | Models of Infectious Disease Agent Study (MIDAS) is a collaboration of research and informatics groups to develop computational models of the interactions between infectious agents and their hosts, disease spread, prediction systems and response strategies. The models will be useful to policymakers, public health workers and other researchers who want to better understand and respond to emerging infectious diseases. If a disease outbreak occurs, the MIDAS network may be called upon to develop specific models to aid public officials in their decision-making processes. http://www.nigms.nih.gov/Research/FeaturedPrograms/MIDAS/ |
| Moving Towards a Coordinated HHS Approach to Sustainability: Strategies for Sustainable Change | Committee, Work group, Advisory group, or Task Force | CDC, HRSA, SAMHSA | NHLBI | The purpose of the collaborative activity was to plan a workshop with the HHS Office of Women''s Health entitled "Moving Towards a Coordinated HHS Approach to Sustainability: Strategies for Sustainable Change." |
| Mucosal Responses in the Context of Combination HIV-1 Prevention | Meeting/ Workshop | CDC | NIAID | This workshop will provide a unique opportunity for key investigators in the HIV vaccine and biomedical prevention fields to present current research data and approaches, and to discuss the best scientific path forward for developing combined HIV prevention modalities. The overall goal is to identify gaps to understand multicomponent prevention modalities that may be assessed in future clinical trials. Of particular interest are approaches designed to act synergistically and to identify modalities that may be potentially detrimental in regards to efficacy or safety. |
| Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group | Research Initiative | CMS, FDA | OD/OSP, NHLBI, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIEHS, OD/DPCPSI | This interagency working group, organized under the auspices of the Subcommittee on Biotechnology of the National Science and Technology Council (NTSC), coordinates federal funding, scientific meetings, regulatory guidance, standards development, funding efforts, and other key issues related to tissue engineering science. The working group enables Federal agencies involved in tissue engineering to stay informed of each other’s activities and coordinate efforts in a timely and efficient manner. In 2007, the working group published their federal-wide strategic plan for advancing tissue science and engineering. The working group is formally recognized by NIH/OD as a collaborative trans-NIH working group and is actively engaged with other agencies to accelerate progress in the tissue engineering field. http://www.tissueengineering.gov/ |
| Multi-Payer Claims Database | Resource Development | AHRQ, OS | NIA, OD/OSP | The goals of the Multi-Payer Claims Database (MPCD) Pilot is to evaluate the value of a multi-payer claims database for comparative effectiveness research. The database will combine public and private claims data, providing investigators with access to data on a broad patient population. |
| Multinational Influenza Seasonal Mortality Study (MISMS) Research | Research Initiative | OS | FIC, NHLBI, NIAID, NLM | Multinational Influenza Seasonal Mortality Study (MISMS) was originally initiated to analyze national and global mortality patterns associated with influenza virus circulation. The focus of MISMS has since expanded to evaluate the interaction between the epidemiology, ecology, and evolutionary dynamics of influenza, including natural selection, reassortment, migration, and antigenic change. Multinational and bilateral collaborations developed by MISMS collect, analyze, and disseminate research findings through scientific publications, training workshops, and communication tools for investigators and decision-makers. Our research findings inform numerous national governments, multilateral organizations, and research stakeholders on interventions for both pandemic and seasonal influenza. To date, data have been acquired from more than 30 countries (representing ~3.2 billion people), resulting in over 100 publications. http://www.origem.info/misms/index.php |
| Muscular Dystrophy Coordinating Committee (MDCC) | Committee, Work group, Advisory group, or Task Force | ACF, CDC, FDA, HRSA | NINDS, NHLBI, NIAMS, NICHD | Coordinate activities across NIH and with other Federal health programs and activities relevant to the various forms of muscular dystrophy. http://www.ninds.nih.gov/find_people/groups/mdcc/index.htm |
| Naloxone Workgroup | Research Initiative | CDC, FDA, SAMHSA | NIDA | The goal is to discuss ways to implement the use of naloxone as emergency treatment for opioid overdose. |
| Nanotechnology Characterization Laboratory | Research Initiative | FDA | NCI, NIEHS | The Nanotechnology Characterization Laboratory (NCL) performs and standardizes the preclinical characterization of nanomaterials intended for cancer therapeutics and diagnostics developed by researchers from academia, government, and industry. The NCL serves as a national resource and knowledge base for cancer researchers and facilitates the development and translation of nanoscale particles and devices for clinical applications. http://ncl.cancer.gov/ |
| National Action Alliance for Suicide Prevention (NAASP) | Committee, Work group, Advisory group, or Task Force | CDC, HRSA, IHS, OS, OSG, SAMHSA | NIMH, NIDA, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP | The National Action Alliance for Suicide Prevention (NAASP) is a public-private partnership for advancing the National Strategy for Suicide Prevention. The mission of the NAASP is to champion suicide prevention as a national priority; to catalyze efforts to implement high priority objectives of the NAASP; and to cultivate the resources needed to sustain progress. The NIMH Director is an ex officio member of the NAASP Executive Committee and Co-Chair of the NAASP Research Task Force. Additional NIMH staff serve on task forces pertaining to LGBT Youth, Military and Veterans, Youth in Justice Settings, and American Indian/Alaska Natives. http://actionallianceforsuicideprevention.org/ |
| National Advisory Board for Medical Rehabilitation Research | Committee, Work group, Advisory group, or Task Force | CDC, CMS | NICHD, CSR, NCATS, NCI, NHLBI, NIA, NIAMS, NIBIB, NIDCR, NINDS, NINR | The Board meets twice a year to advise the directors of NIH, NICHD, and National Center for Medical Rehabilitation Research (NCMRR) on matters and policies relating to the Center''s programs. The Board comprises 12 members representing health and scientific disciplines related to medical rehabilitation and 6 members representing persons with disabilities. http://www.nichd.nih.gov/about/advisory/nabmrr/pages/index.aspx |
| National ALS Registry | Resource Development | ATSDR, CDC | NINDS | The National ALS Registry is a Congressionally mandated registry for persons in the U.S. with ALS. It is the only population-based registry in the U.S. that collects information to help scientists learn more about who gets ALS and its causes. http://wwwn.cdc.gov/als/ |
| National Asthma Control Initiative/National Asthma Education and Prevention Program | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI, NIAID, NIEHS | The National Asthma Control Initiative (NACI) is a national effort to facilitate implementation of the National Asthma Education and Prevention Program (NAEPP) Expert Panel Report-3 Asthma Guidelines implementation panel report. The NAEPP, which was initiated in 1989, seeks to enhance the quality of life for patients with asthma and decrease asthma-related morbidity and mortality by improving asthma awareness, diagnosis, and treatment. http://www.nhlbi.nih.gov/health/prof/lung/asthma/naci/ |
| National Asthma Education and Prevention Program Federal Liaison Group on Asthma (FLGA) | Committee, Work group, Advisory group, or Task Force | AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS | OD/OSP, NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR | The Federal Liaison Group on Asthma is a subcommittee of the National Asthma Education and Prevention Program that is charged with addressing ways to strengthen and improve the coordination of asthma-related activities across agencies of the Federal Government. The group provides a forum for federal agencies with major interest in asthma to exchange ideas and explore collaborative activities. http://www.nhlbi.nih.gov/about/naepp/naep_pd.htm |
| National Blood Disorders Program | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, OS | NHLBI, NIMHD | The National Heart, Lung, and Blood Institute (NHLBI) established the National Blood Disorders Program (NBDP) in accordance with the Institute’s strategic plan of moving scientific discovery from causes to cures. The program’s purpose is to coordinate a national effort to improve the management of hematological disorders focused on the implementation of evidence-based clinical practice guidelines to prevent, detect, and treat, complications. |
| National Children''s Study | Research Initiative | CDC | NICHD | The NICHD leads a consortium of federal agencies in conducting the National Children''s Study (NSC). This study is a large longitudinal study on the environmental effects of children''s health. This IAA is an agreement between CDC and NICHD in supporting the NCS. The CDC will provide prescreening of collection, processing, and storage supplies for selected environmental contaminants. http://www.nationalchildrensstudy.gov/Pages/default.aspx |
| National Children''s Study Interagency Coordinating Committee | Other | CDC | NICHD, NIEHS | Initiated in 2000-2001, the NCS Interagency Coordinating Committee represents the lead agencies for the Study and oversees broad Study issues and ensures interagency collaboration. The representatives assure that at a high level, the mission and goals of the National Children''s Study are maintained over time and that they reflect the scientific priorities of the Study''s four lead agencies. The committee is made up of staff from the U.S. Department of Health and Human Services (including the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Environmental Health Sciences, of the National Institutes of Health, and the Centers for Disease Control and Prevention), and the U.S. Environmental Protection Agency. |
| National Coalition for Health Professional Education in Genetics (NCHPEG) | Public Education Campaign | HRSA | NHGRI, NCI, NEI, NICHD | Independent umbrella organization promoting education of health professionals regarding genetics and genomics. Also conducts relevant research activities. http://www.nchpeg.org |
| National Collaborative on Childhood Obesity Research (NCCOR) | Research Initiative | CDC | OD/OSP, NCI, NHLBI, NICHD, NIDDK, OD/DPCPSI/OBSSR | The National Collaborative on Childhood Obesity Research (NCCOR) brings together four of the nation’s leading research funders – the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Robert Wood Johnson Foundation (RWJF), and the United States Department of Agriculture (USDA) – to address the problem of childhood obesity in America. The mission of the National Collaborative on Childhood Obesity Research (NCCOR) is to improve the efficiency, effectiveness and application of childhood obesity research and to halt—and reverse—the current childhood obesity trend through enhanced coordination and collaboration. NCCOR focuses on efforts that have the potential to benefit children, teens, their families, and the communities in which they live. A special emphasis is put on the populations and communities in which obesity rates are highest and rising the fastest. NCCOR accelerates progress to reduce childhood obesity in the United States by maximizing outcomes from research, building the capacity for research and surveillance, creating and supporting the mechanisms and infrastructure needed for research translation and dissemination, and supporting evaluations. http://nccor.org/ |
| National Collaborative on Childhood Obesity Research committee | Other | CDC | NICHD, NCI, NHLBI, NIDDK, OD/DPCPSI/OBSSR | The mission of the National Collaborative on Childhood Research (NCCOR) is to improve the efficiency, effectiveness, and application of childhood obesity research, and to halt-and reverse-childhood obesity through enhanced coordination and collaboration. http://www.nhlbi.nih.gov/resources/obesity/trials/child-obesity.htm |
| National Collaborative on Childhood Obesity Research – Registry of Studies | Resource Development | CDC | NHLBI | This activity is currently in the beginning stages of development. The registry of studies will be a database housed within the National Collaborative on Childhood Obesity Research (NCCOR) website. The registry of studies will begin with descriptions of 4 or 5 key large outcome studies and/or evaluations targeting childhood obesity. The website will house the following minimum content: • Study name • Dates of study • Funding organizations • Contact individual • Populations studied (with sample sizes if possible) • Geographic locations (state and city if possible) • Major study questions and aims • Measures • Design • Analytic protocol • Intervention description • Brief study description Researchers will be able to search the database by the categories listed above. The registry will start with 4 to 5 of the largest studies being conducted by the National Collaborative on Childhood Obesity Research (NCCOR) partners (i.e., NIH, CDC, RWJF, USDA) and more studies will be added as resource become available. One of the studies to be featured in the Registry of studies will be the NHLBI-led Healthy Communities Study. |
| National Committee for Quality Assurance | Other | AHRQ | NICHD | This committee advises on quality assurance measures related to HIV. |
| National Consortium for Child and Adolescent Mental Health Services | Other | SAMHSA | NICHD | The purpose of this research initiative is for research collaboration to address child and adolescent mental health issues and services. |
| National Diabetes Education Program (NDEP) | Public Education Campaign | CDC | NIDDK | Established in 1997, the National Diabetes Education Program is a federally-funded program sponsored by the U.S. Department of Health and Human Services’ National Institutes of Health and the Centers for Disease Control and Prevention and includes over 200 partners at the federal, state and local levels, working together to improve the treatment and outcomes for people with diabetes, promote early diagnosis, and prevent or delay the onset of type 2 diabetes. http://www.ndep.nih.gov |
| National Food and Nutrient Analysis Program (NFNAP) | Research Initiative | CDC, FDA, IHS | OD/OSP, NCI, NEI, NHLBI, NIA, NICHD, NIDCR, NIDDK, OD/DPCPSI/ODP, OD/DPCPSI/ORWH | The five Specific Aims of the National Food and Nutrient Analysis Program (NFNAP) are to: 1) establish a monitoring program for Key Foods and critical nutrients. Key Foods are frequently consumed foods and ingredients, which contributed, collectively, more than 75% of the intake of any specific nutrient for the U.S. population; 2) conduct comprehensive analyses of selected Key Foods; 3) develop databases for high priority foods consumed by U.S. ethnic subpopulations; 4) develop databases for new bioactive components; and 5) develop a validated database for ingredients in dietary supplements. http://www.ars.usda.gov/SP2UserFiles/Place/12354500/FactSheets/NDL_FactSheet_NFNAP.pdf |
| National Forum for Heart Disease and Stroke Prevention | Committee, Work group, Advisory group, or Task Force | CDC | NHLBI, NHGRI, NINDS | The Forum was founded to implement a public health action plan to prevent heart disease and stroke. http://hearthealthystrokefree.org/ |
| National Health and Aging Trends Study (NHATS) | Health Survey | CMS, OS | NIA | National Health and Aging Trends Study (NHATS) will exam how the daily lives of older adults change as they age. This research will help scientists understand the social and economic consequences of late-life disability for individuals, families, and society. |
| National Health and Nutrition Examination Survey (NHANES) | Health Survey | CDC, FDA, OS | OD/OSP, NCI, NHLBI, NIA, NIDDK, OD/DPCPSI, OD/DPCPSI/ODP | A program of studies designed to assess the health and nutritional status of adults and children in the United States. The survey is unique in that it combines interviews and physical examinations. http://www.cdc.gov/nchs/nhanes.htm |
| National Health and Nutrition Examination Survey (NHANES) Cardiovascular Component | Health Survey | CDC | NHLBI, NCI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK | The purpose of this collaboration is to inform the NIH and the Nation on the status of key measures of cardiovascular, pulmonary, and sleep health and disease prevalent in the US civilian population, such as blood pressure, serum lipid levels, risk factors for disease, airway flow limitation, reports of efforts to control weight, and reports of sleep disturbances. The NIH identifies the most key cost-effective basic measures for these conditions and behaviors, relevant to its mission and amenable to being utilized in a mobile hospital setting. NIH staff work with National Center for Health Statistics (NCHS) staff to implement the most cost-effective of the measures, to monitor and help manage the survey in progress, and to evaluate and publish the resulting data. http://www.cdc.gov/nchs/nhanes/about_nhanes.htm |
| National Health and Nutrition Examination Survey (NHANES) components | Research Initiative | CDC | NCI, NHLBI, NIA, NIDDK, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH | For National Health and Nutrition Examination Survey (NHANES) 2011-14, NCI proposed and coordinated funding from multiple NIH institutes and the Department of Defense for two components: a new technology physical activity monitor to be worn on the wrist and measurement of muscle strength using a hand-grip dynamometer. The wrist-worn accelerometer will provide the first objective measurement of sleep duration in a nationally representative sample, in addition to measuring physical activity movement. The muscle-strength measure will provide an indicator of total body strength for children, adults, and older adults who are NHANES participants. http://riskfactor.cancer.gov/studies/nhanes/ |
| National Health and Nutrition Examination Survey 2010-2012: Chemosenses Component | Health Survey | CDC | NIDCD | The purpose of this agreement is to provide funding for a collaborative effort with the National Center for Health Statistics (NCHS) to pilot test the chemosenses component in persons age 40 and older, and implement in the survey pending a successful pilot. The chemosenses component will consist of 1) household interview questions to define the prevalence of self-reported taste and smell disorders, and to identify risk factors and confounders for the analysis of the taste and smell exam data; 2) smell testing using two modified Pocket Smell Identification Tests, a "scratch and sniff'' test with 8 odorants; and 3) taste testing performed using small amounts of liquids that can be spit out afterwards. For Taste testing, the respondent will be asked both to identify and to rate the intensity of the stimulus. (ADC12002001-1-0-0) http://www.cdc.gov/nchs/nhis.htm |
| National Health and Nutrition Examination Survey Oral Health Component: | Health Survey | CDC | NIDCR | Periodic oral health component of National Health and Nutrition Examination Survey (NHANES); enamel fluorosis imaging study for inclusion in future NHANES http://www.cdc.gov/nchs/nhanes.htm |
| National Health Interview Survey (NHIS) | Health Survey | CDC | OD/OSP, NCCAM, NCI, NHLBI, NIA, NIDDK, NIMH, NINDS | The National Health Interview Survey (NHIS), carried out by the CDC, is a national survey that annually monitors the Nation’s health through personal interviews of a representative sample of the civilian, non-institutionalized U.S. population. NCI periodically sponsors a Cancer Control Supplement (CCS) which is administered to a randomly selected sample of 39,000 adults. NIDDK provides support for the development of the diabetes interview components and funding for collection of data. Complementary and Alternative Medicine (CAM) related questions are posed to about 30,000 randomly selected NHIS participants every 5 years. The data from the survey provides many fascinating insights into the types of CAM people use, the reasons for which they turn to CAM, and changes that have occurred since the last time CAM questions were included in the survey. http://www.cdc.gov/nchs/nhis.htm |
| National Hispanic Science Network (NHSN) | Meeting/ Workshop | AHRQ, CDC, SAMHSA | NIDA, NCI, NEI, NIA, NIAAA, NIAID, NICHD, NIGMS, NIMH, NINDS, OD/DPCPSI/OAR | The National Hispanic Science Network (NHSN) is dedicated to improving the health equity of Hispanics. It has broad representation of academic and government agencies, including several NIH institutes and centers, CDC, SAMHSA, AHRQ. http://nhsn.med.miami.edu/x44.xml |
| National Institute on Deafness and Other Communication Disorders (NIDCD) Resources Directory | Resource Development | AHRQ, CDC, CMS | NIDCD | The NIDCD Resources Directory is designed to encourage networking among individuals and organizations with an interest in the diseases and disorders of human communication. The directory is maintained in an online database as well as published biannually in booklet form. The NIDCD pays to maintain and publish the directory; however, several HHS agencies are featured in it. http://www.nidcd.nih.gov/directory/ |
| National Interagency Confederation for Biological Research | Other | CDC, FDA | NCI, NIAID | The mission of the National Interagency Confederation for Biological Research is to develop unique knowledge, tools, and products by leveraging advanced technologies and innovative discoveries to secure and defend the health of the American people. http://www.detrick.army.mil/nicbr/index.cfm |
| National Kidney Disease Education Program | Public Education Campaign | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS | NIDDK, NHLBI | National Kidney Disease Education Program (NKDEP) is an initiative of the National Institutes of Health, designed to reduce the morbidity and mortality caused by kidney disease and its complications. NKDEP aims to improve early detection of chronic kidney disease (CKD), facilitate identification of patients at greatest risk for progression to kidney failure, promote evidence-based interventions to slow progression of CKD, and support the coordination of Federal responses to CKD. http://www.nkdep.nih.gov |
| National Longitudinal Mortality Study | Health Survey | CDC | NIA, NCI, NHLBI | A national, longitudinal, mortality study to study the effects of differentials in demographic and socio-economic characteristics on mortality. http://www.census.gov/did/www/nlms/ |
| National Maternal and Child Health Award Committee | Other | CDC | NICHD | This committee was formed to help select the recipients for maternal and child health awards. |
| National Prevention Strategy | Committee, Work group, Advisory group, or Task Force | ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA | NHLBI, NCI, NIDDK, OD/DPCPSI | The NIH provided input via an HHS committee on the development and implementation of the National Prevention Strategy. http://www.surgeongeneral.gov/initiatives/prevention/strategy/index.html |
| National Program to Reduce Cardiovascular Risk (NPRCR) Coordinating Committee | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS | NHLBI | The National Program to Reduce Cardiovascular Risk (NPRCR) Coordinating Committee is the leadership body for the broader NPRCR. The Committee seeks to reduce risk of cardiovascular disease through a national effort to implement evidence-based clinical practice guidelines and interventions to control cardiovascular risk factors (including high blood pressure, high blood cholesterol, and overweight/obesity) in clinical practice settings. Coordinating Committee members engage their respective organizations in Program activities. |
| National Program to Reduce Cardiovascular Risk (NPRCR) Federal Subcommittee | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, CMS, FDA, HRSA, IHS | NHLBI, NCI, NIDDK, NIMHD, NINDS, OD/DPCPSI/ODP | The subcommittee provides a forum for Federal agencies within HHS (including within NIH), to coordinate and collaborate on federal efforts aimed at reducing cardiovascular risk in the nation. |
| National Robotics Initiative | Research Initiative | FDA | OD/OSP, NCATS, NIA, NIBIB, NICHD, NINDS, NINR | The White House Office of Science and Technology Policy (OSTP) created the National Robotics Initiative to promote research in a variety of robot-related topics. This initiative is multifaceted and has included grant solicitations, workshops, meetings, and information exchange among the agencies involved. NIH joined as a major civilian aspect of this coordinated inter-agency plan which incorporates the following funding agencies: National Institutes of Health, National Science Foundation, National Aeronautics and Space Agency, U.S. Department of Agriculture (NIFA). Specifically, NIH has joined with NSF, USDA, and NASA to solicit R01 application in robotics. NICHD is focused on the human/machine interaction aspect of incorporating robots into the healthcare and rehabilitation systems, with particular emphasis on the needs of people with disabilities. http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503641&org=CISE |
| National Science Advisory Board for Biosecurity (NSABB) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NIAID | Advises USG on oversight of dual use life sciences research. http://oba.od.nih.gov/biosecurity/biosecurity.html |
| National Security Staff Dual Use Research of Concern Interagency Policy Committee (NSS DURC IPC) | Committee, Work group, Advisory group, or Task Force | CDC, OS | OD/OSP, NIAID | Develops policy options for the US Government''s oversight of dual use research of concern (DURC). |
| National Security Staff Dual Use Research of Concern Sub-Interagency Policy Committee (NSS DURC Sub-IPC) | Committee, Work group, Advisory group, or Task Force | CDC, OS | OD/OSP, NIAID | Develops policy options for the US Government''s oversight of dual use research of concern (DURC). |
| National Survey of Family Growth | Health Survey | ACF, CDC | NICHD | The National Survey of Family Growth (NSFG) gathers information on family life, marriage and divorce, pregnancy, infertility, use of contraception, and men''s and women''s health. The survey results are used by the U.S. Department of Health and Human Services and others to plan health services and education programs, and to do statistical studies of families, fertility, and health. http://www.cdc.gov/nchs/nsfg.htm |
| Native American Research Center for Health (NARCH) program | Research Initiative | AHRQ, HRSA, IHS, OS | OD/OSP, CSR, NCATS, NCCAM, NCI, NHGRI, NHLBI, NIAAA, NIAID, NIAMS, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NIMHD, OD/DPCPSI/OBSSR | Native American Research Center for Health (NARCH) is a grant program that provides funds to enhance research, research infrastructure and training among American Indian and Alaska native programs and academic partners. This NIH-wide program supports partnerships between American Indian (AI), Alaska Native (AN), or Tribally-based organizations and institutions that conduct intensive academic-level biomedical, behavioral and health services research in an effort to build a research infrastructure of core components for capacity building and to reduce health disparities in AI/AN communities. This funding mechanism develops opportunities for conducting research, research training and faculty development to meet the needs of American Indian/Alaska Native (AI/AN) communities. As a developmental process, Tribes and Tribal Organizations are able to build a research infrastructure, including a core component for capacity building and the possibility of reducing the many health disparities so prevalent in AI/AN communities. http://www.nigms.nih.gov/Training/NARCH/ |
| Natural Experiments and Effectiveness Studies in the Prevention and Control of Diabetes | Research Initiative | CDC | NIDDK | This project will focus on population-targeted interventions that health systems, communities, and governments can undertake to reduce the incidence of diabetes and its complications. This project will also strengthen the capacity of CDC and NIDDK to conduct vital health services and health policy research related to diabetes prevention and care. |
| Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM) | Research Initiative | CDC | NCI | The purpose of this study is to test the stored serum specimens of Air Force Health Study (AFHS) participants for Monoclonal gammopathy of undetermined significance (MGUS) and microRNAs using sensitive state-of-the-art laboratory methods. The serum specimens of the AFHS participants who are selected for this study will be retrieved and shipped to NCI. NCI will perform the tests. NIH/NCI will obtain IRB approval of the study protocol and analyze the serum sample to detect and quantify M-protein and expression levels of a panel of microRNAs. http://bethesdatrials.cancer.gov/clinical-research/search_detail.aspx?ProtocolID=NCI-10-C-0096 |
| NCI / FDA- Federal Investigator Registry of Biomedical Information Research Data (FIREBIRD) | Resource Development | FDA | NCI | An agreement has been reached by the FDA and the NCI to manage and share information about clinical investigators using the Federal Investigator Registry of Biomedical Information Research Data (FIREBIRD) system. Drug makers are encouraged to also submit information about investigators electronically to the new registry. FIREBIRD is the first module of an expected suite of software programs that will comprise a system called the Clinical Research Information Exchange (CRIX). CRIX is intended to support the biomedical and biopharmaceutical research community by streamlining the document and data exchange process. The resulting reduction of paperwork is expected to increase the efficiency and lower the cost of conducting clinical trials. https://cabig.nci.nih.gov/tools/FIREBIRD |
| NCI/FDA Memorandum of Understanding for Proteomics | Research Initiative | FDA | NCI | The purpose of this MOU is to create a framework to foster scientific and programmatic collaborations. The collaborations envisioned by this MOU involve proteomics science and technology applications such as instrument/technology validation, informatics, biological sample preparation, diagnostics, and discovery and validation of biomarkers for cancer development, therapeutics, and response. This MOU sets forth the basic principles under which the agencies intend to work together to foster partnership in: research and education; the exchange of ideas, information, and data; the development and use of proteomics technologies that may be used by the NCI and other sponsors in clinical applications. |
| Nested case-control study of lung cancer and diesel exhaust among non-metal miners | Research Initiative | CDC | NCI | A retrospective cohort mortality and nested case-control study of about 12,315 non-metal miners (278,041 person-years) to investigate risk of lung cancer in relation to quantitative measures of exposure to diesel exhaust. |
| Network for Improvement of Access to Treatment (NIATx) | Research Initiative | SAMHSA | NIDA, NIMHD | Research grant focused on helping drug abuse treatment organizations develop practice improvement procedures to get patients enrolled in treatment. http://www.niatx.net |
| Neural Interfaces Conference | Meeting/ Workshop | FDA | NIBIB, CSR, NEI, NIA, NICHD, NIDCD, NINDS | The Neural Interfaces research community consists of investigators, supported by grants or contracts, who are working in areas that include functional neuromuscular/electrical stimulation, auditory prosthesis, cortical prosthesis, neuromodulation, microelectrode array technology, brain computer/machine interfaces and other related areas. Conferences were held in 2010 and 2012. |
| Newborn Drug Development Planning committee | Other | FDA | NICHD, NHLBI, NLM | Primary responsibility for administering, contracting, and monitoring studies to develop Investigational New Drug (IND) application data for potential label modification. |
| Newborn Screening Coding and Terminology Guide | Resource Development | CDC, HRSA, OS | NLM, NHGRI, NHLBI, NICHD | This ongoing collaboration develops, supplements and publicizes a free online resource with guidance to help promote efficient electronic exchange of standardized newborn screening data. Related efforts include: studying the screening process for diseases including severe combined immunodeficiency (SCID), lysosomal storage disorders (LSDs), and critical congenital heart disease (CCHD), and developing standard codes for ordering and reporting the results of newborn screening for SCID, CCHD, and other conditions added to the Uniform Recommended Screening Panel by the Secretary''s Advisory Committee on Heritable Disorders in Newborns and Children. http://newbornscreeningcodes.nlm.nih.gov/ |
| Newborn Screening Committee | Other | CDC, HRSA | NICHD, NHLBI, NLM | The NIH, HRSA, CDC, the American College of Medical Genetics and the Genetic Alliance meet monthly, in person or online, to discuss and coordinate current activities and initiatives in newborn screening. Topics include the activities of the Newborn Screening Translational Research Network Coordinating Center, the Clearinghouse for Newborn Screening information, Sickle Cell Screening Programs, the CDC Quality Control program for Newborn Screening, and the Regional Newborn Screening Collaboratives. |
| NEWSteps Steering Committee | Other | HRSA | NICHD | Steering committee for NEWSteps. NEWSteps is a cooperative agreement related to newborn screening that HRSA funds. |
| NEXT Generation Health Study - Health Behavior in School-Age Children | Research Initiative | HRSA | OD/OSP, NCI, NHLBI, NIAAA, NICHD | NEXT is a 7-year longitudinal assessment of a representative sample of U.S. adolescent and young adults, starting when they are in the 10th grade. The goals of the NEXT longitudinal study include: to identify the trajectory of adolescent health status and health behaviors from mid-adolescence through the post high school years; to examine individual predictors of the onset of key adolescent risk behaviors and risk indicators during this period; to identify genetic, personal, family, school, and social/environmental factors that provide or sustain positive health behaviors; to identify transition points in health risk and risk behaviors and changes in family, school, and social/environmental precursors to these transitions, and to examine the role of potential gene-environment interactions in the development of health status and health behaviors. http://clinicaltrials.gov/ct2/show/NCT01031160 |
| Next-Generation DNA Sequencing as a Tool for Clinical Decision-Making in Cancer Patient Management | Meeting/ Workshop | FDA | NCI | This NCI-sponsored meeting brought together scientists, patient advocates and clinicians from academia, medical centers, industry and government to discuss the translation of this new technology into clinical tests useful for cancer diagnosis and treatment choices. |
| NIAID International Tuberculosis (TB) Working Group | Other | AHRQ, CDC, FDA, IHS, OS | NIAID, FIC, NHLBI, NICHD, NIDA | The Working Group focuses on coordinating Tuberculosis (TB) research, which includes studies to characterize drug resistance; the identification, preclinical development and clinical evaluation of new drugs, diagnostics, and vaccines; and studies of the epidemiology and transmission of TB, including research addressing HIV/TB co-infection and TB in high-risk populations. http://www.niaid.nih.gov/news/newsreleases/2008/pages/tb_priorities.aspx |
| NIAID-CDC Joint U.S. Partnership Implementing Tuberculosis (TB) Elimination Research (JUPITER) | Meeting/ Workshop | CDC | NIAID | Through weekly teleconferences, Joint U.S. Partnership Implementing Tuberculosis (TB) Elimination Research (JUPITER) facilitates cooperation, communication, and collaboration on tuberculosis among these government entities. This approach helps ensure that federal diabetes activities are coordinated and not duplicated, and stimulates collaborations where appropriate. |
| NICHD Health Equity Seminar Series: Jackson Heart Study Kids (JHS Kids): Lessons Learned Engaging Children and Families | Meeting/ Workshop | OS | NICHD | Jackson Heart Study Kids (JHS Kids) is a feasibility study that enrolls children and grandchildren of participants who took part or are taking part in the JHS, the largest study of heart disease risk factors among African Americans in Jackson, Mississippi. Investigators identify early life risk factors (environmental and hereditary) for obesity and heart disease to inform the design of appropriate early intervention and prevention strategies. Speakers shared their experiences with engaging families in this effort. |
| NIH and US Food and Drug Administration On-line Courses: The Science of Sex and Gender in Human Health | Training Initiative | FDA | NIDA, NCI, NINR, OD/DPCPSI/ORWH | This is an online series of courses that was designed to create a permanent foundation for sex and gender accountability in medical research and treatment by enabling researchers, clinicians, and students in the health professions to integrate knowledge of sex and gender differences and similarities into their research and practice. |
| NIH Guide for Grants and Contracts | Resource Development | AHRQ, CDC, FDA | OD/OER, CIT, CSR | The NIH Guide for Grants and Contracts is the official publication for NIH medical and behavioral grant policies, guidelines and funding opportunities, and is used by other HHS Agencies to disseminate FOAs to its 50,000 subscribers. http://grants.nih.gov/grants/guide/index.html |
| NIH Meeting On Physical Activity and Disease Prevention - How Do We Get People Moving More? | Meeting/ Workshop | CDC, OS, SAMHSA | NIDA, NCI, NHLBI, NIA, NIAAA, NICHD, NIMH | Planning and hosting a multi-agency meeting titled "Federal Learning Exchange on Directions in Evidence-based Strategies for Youth Programs" for the purpose of developing a cross-agency perspective on lessons learned regarding the implementation of youth programs. |
| NIH Recombinant DNA Advisory Committee | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | OD/OSP, NCI, NHGRI, NIAID, NINDS | Advises NIH on the safe and ethical conduct of basic and clinical research involving recombinant DNA. http://oba.od.nih.gov/rdna_rac/rac_about.html |
| NIH Translational Research Interest Group | Other | FDA | NCI, CC, CIT, CSR, NCATS, NCCAM, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI, OD/OER, OD/OIR, OD/OSP | As Chair of the NIH Translational Research Interest Group (TRIG), the NCI staff has coordinated Forums, Workshops, NIH Bench-to-Bedside Awardees’ Lecture Series, and Monthly Seminar Series to help bridge the gap between laboratory research and clinical applications; suggestions of topics and speakers for the Annual NIH Research Festivals; and nominations of speakers for the NIH Wednesday Afternoon Lecture Series and the NIH Director’s Lecture Series. The NCI staff has informed the TRIG members of scientific events coordinated with other NIH Scientific Interest Groups and Working Groups. http://sigs.nih.gov/trig/ |
| NIH-CDC-HRSA Working group | Other | CDC, HRSA | NICHD | Working group to coordinate activities related to care of HIV in adolescents in the US. |
| NIH-CMS Coordinating Committee for trials and data sharing | Other | CMS | NIDDK, NCATS, NCI, NIA | NIH and CMS meet periodically to discuss areas of common interest with respect to both clinical trials and research data. |
| NIH-FDA Interagency Clinical Outcome Assessments Working Group | Committee, Work group, Advisory group, or Task Force | FDA | OD/OSP, CC, NCCAM, NCI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/DPCPSI | The Interagency Clinical Outcome Assessments Working Group (ICOA WG) works to foster the development, evaluation, and qualification of Clinical Outcomes Assessments (COAs) for use in both medical product development and clinical research. COAs include any measurement tool that is not purely objective and may be patient-reported, clinician-reported, or observer-reported in nature. http://outcomes.cancer.gov/networks/fdanih/ |
| NIH-FDA Leadership Council | Committee, Work group, Advisory group, or Task Force | FDA | OD/OSP, NCI, NHLBI, NIAID, NIDDK, NIGMS, NIMH, NINDS | The Joint Leadership Council will work together to help ensure that regulatory considerations form an integral component of biomedical research planning, and that the latest science is integrated into the regulatory review process. Such collaboration and integration will advance the development of new products for the treatment, diagnosis and prevention of common and rare diseases and enhance the safety, quality, and efficiency of the clinical research and medical product approval enterprise. The formation of the Leadership Council represents a commitment on the part of both agencies to forge a new partnership and to leverage the strengths of each agency toward this common goal. http://www.nih.gov/news/health/sep2010/od-27.htm |
| NIH-FDA Tobacco Regulatory Science Workgroup | Committee, Work group, Advisory group, or Task Force | FDA | OD/OSP, CSR, FIC, NCI, NCMHD, NEI, NHGRI, NHLBI, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/DPCPSI, OD/DPCPSI/OBSSR | The FDA-NIH Tobacco Regulatory Science Workgroup was established in June 2011 through an NIH interagency partnership with the FDA''s Center for Tobacco Products. The FDA-NIH Tobacco Regulatory Science Workgroup is comprised of NIH staff and staff from FDA Center for Tobacco Products. The purpose of the group is to coordinate, develop, and disseminate information about the Tobacco Regulatory Science Program and to leverage the research experience and capability of NIH to maximize the opportunity available in authorities given in the Family Smoking Prevention and Tobacco Control Act to reduce tobacco related morbidity and mortality. The working group meets quarterly. http://prevention.nih.gov/tobacco |
| Northwest Portland Tribal Registry Project | Resource Development | IHS | NCI | Over the past 10 years, health care delivery for Northwest American Indians and Alaska Natives has evolved from a centralized system maintained by the Indian Health Service (IHS) to a diverse and complex environment. The Northwest Tribal Registry Project was developed in January 1999 by the Northwest Tribal Epidemiology Center, a tribally operated program located at the Northwest Portland Area Indian Health Board (NPAIHB) in Portland, Oregon. http://surveillance.cancer.gov/disparities/native/portland.html |
| Nutrition Coordinating Committee (NCC) | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA, IHS, OS | OD/OSP, CC, CSR, FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI, OD/DPCPSI/OBSSR | Nutrition Coordinating Committee (NCC) operates as an NIH-wide forum to review, stimulate, and encourage the support of nutrition research and training to better define the role of nutrition in the promotion and maintenance of health and in the prevention and treatment of disease. The NCC also plays a key role in the development of nutrition research policy at the NIH. NCC membership includes a representative and alternate from the 20 NIH Institutes and 7 Centers. In addition, offices and agencies within the DHHS, U.S. Department of Agriculture (USDA), and the Department of Defense (DOD) have also appointed liaison representatives to the Committee. The NCC meets monthly to provide an open forum for members to report on current and future nutrition research, policy activities, and research funding and training opportunities. http://dnrc.nih.gov/ |
| Occupational Exposure to Bisphenol A in the United States | Research Initiative | CDC | NIEHS | The purpose of this project is to assess occupational exposure to bisphenol A (BPA) in a cross-section of industries and jobs where BPA is either produced or processed. |
| Office for Human Research Protections (OHRP)-Office of Extramural Research (OER) Training Initiative | Meeting/ Workshop | OS | OD/OER | Office of Extramural Research (OER) collaborated with Office for Human Research Protections (OHRP) to provide comprehensive training at both NIH Regional Meetings for the extramural community on Human Research Participant Protections. |
| Office of AIDS Research (OAR) Advisory Council (OARAC) | Committee, Work group, Advisory group, or Task Force | CDC | OD/DPCPSI/OAR, NICHD | The Office of AIDS Research Advisory Council provides advice to the Director of the Office of AIDS Research (OAR) on the planning, coordination, and evaluation of research and other activities in respect to AIDS conducted or supported by the NIH. OARAC also advises the Secretary of Health and Human Services, the Assistant Secretary for Health, the Director of NIH, and the Director of OAR, on AIDS research programs, the development and annual review of the comprehensive plan for the conduct and support of all AIDS activities of the agencies of NIH, including research policies and priorities, and the coordination of domestic and international NIH AIDS efforts. http://www.oar.nih.gov/oarac/ |
| Office of Science and Technology Mo99 Stakeholders Working Group | Committee, Work group, Advisory group, or Task Force | CMS, FDA, OSG | NIBIB, NCI | Coordinate the efforts of multiple stakeholders (e.g., State Department, Department of Energy, Department of Homeland Security, Department of Health and Human Services, private sector) to establish a stable, long-term domestic supply of Mo99 (molybdenum-99) for medical purposes. Such a supply needs to be consistent with current international goals (to which the U.S.A. is an active participant) of reduction in the use of high-enriched uranium in all reactors, including Mo99 production facilities, as well as full cost recovery solutions. |
| Oral Health, Cancer Care, and You | Public Education Campaign | CDC | NIDCR, NCI, NINR | A series of publications to inform health care providers and patients about steps they can take before, during, and after cancer treatment to reduce the risk and impact of these often painful side effects. http://www.nidcr.nih.gov/OralHealth/Topics/CancerTreatment/ |
| Osteoporosis and Related Bone Diseases—National Resource Center | Resource Development | OS, OSG | OD/OSP, NIA, NIAMS, NICHD, NIDCR, NIDDK, OD/DPCPSI/ORWH | Provides patients, health professionals, and the public with an important link to resources and information on metabolic bone diseases, including osteoporosis, Paget’s disease of the bone, and osteogenesis imperfecta. http://www.bones.nih.gov |
| Package and Distribution of Nutritional Biochemistry for AREDS 2 | Research Initiative | OS | NEI | AREDS2 is a multi-center randomized trial designed to assess the effects of oral supplementation of high doses of macular xanthophylls (lutein and zeaxanthin) and/or omega-3 LCPUFAs (DHA and EPA) for the treatment of AMD and cataract. The primary objective of AREDS2 is to evaluate the effect of dietary xanthophylls (lutein/zeaxanthin) and/or omega-3 LCPUFAs (DHA and EPA) on progression to advanced AMD. This objective will be accomplished by collecting and assessing the data on approximately 4,000 AREDS2 participants aged 50 to 85 years, who at the time of enrollment have either: 1) bilateral large drusen or 2) large drusen in one eye and advanced AMD (neovascular AMD or central geographic atrophy) in the fellow eye. https://web.emmes.com/study/areds2/resources/areds2_mop.pdf |
| Partners in Information Access for the Public Health Workforce | Resource Development | AHRQ, CDC, HRSA, OS | NLM | Partners in Information Access for the Public Health Workforce is a collaboration of U.S. government agencies, public health organizations, and health sciences libraries which provides timely, convenient access to selected public health resources on the Internet. http://phpartners.org/ |
| Patient-Reported Outcomes Measurement Information System (PROMIS) | Research Initiative | FDA | OD/OSP, NCCAM, NCI, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIGMS, NIMH, NINDS, OD/DPCPSI, OD/DPCPSI/OSC | The Patient-Reported Outcomes Measurement Information System (PROMIS) is a network of NIH-funded primary research sites and coordinating centers working collaboratively to develop a series of dynamic tools to reliably and validly measure patient-reported outcomes (PROs). PROMIS provides an opportunity to improve healthcare outcomes by giving decision makers hard data on how healthcare affects what patients are able to do and how they feel. The FDA has been invited to contribute to the scientific steering committee meetings as an interested partner. http://www.nihpromis.org/default.aspx |
| Pediatric Emergency Care Applied Research Network (PECARN) | Research Initiative | HRSA | NICHD | Study of resuscitation practice and relationship to fulminant cerebral edema. Pediatric Critical Care and Rehabilitation (PCCR) program director is program official for the trial. This is a multisite clinical trial. The application was received as part of PAR HD 08-261/Emergency Medical Services for Children (EMSC). http://www.pecarn.org/ |
| PEPFAR Implementation Science Network | Research Initiative | CDC | OD/DPCPSI/ORWH, FIC, NICHD, NIMH | 2010 WHO recommendations to provide antiretroviral prophylaxis or treatment to mothers or infants during the breastfeeding period have not been adopted in resource poor countries. The goal of this study is to evaluate the effect of a "feeding buddy" to support mothers to adhere to prevention of mother to child HIV transmission. This is a prospective cohort intervention study set within a comprehensive ongoing national program addressing maternal and child health. |
| Pertussis Working Group | Other | CDC, FDA | NIAID | The objective of the Pertussis Working Group is to share information and promote collaborations among HHS agencies in order to better understand the recent resurgence of pertussis in the United States and identify potential strategies to address the problem. |
| Phenylketonuria (PKU) and Pregnancy | Meeting/ Workshop | AHRQ | NICHD | Phenylketonuria (PKU) is a disorder of metabolism that can cause intellectual and developmental disabilities (IDD) if not treated. In PKU, the body cannot process the amino acid, phenylalanine (Phe), a component of the proteins found in foods. If the Phe level gets too high, the brain can become damaged. For nearly 50 years, newborn screening programs have successfully identified infants with PKU within days of birth, allowing treatment via dietary protein restriction to begin almost immediately, thereby preventing IDD. In October 2000, the NIH published a Consensus Development Conference Statement on the screening and management of PKU. Since then, new treatments and medications have emerged. To assist clinicians in making treatment decisions, NIH has revisited the 2000 guidelines. Five working groups composed of 8–12 topical experts, public members, and federal stakeholders were convened to explore the expanded body of literature and address important questions regarding treatment of PKU. The working groups were organized around the following topics: Diet Control and Management Pharmacologic Interventions PKU and Pregnancy Long-Term Outcomes and Management across the Lifespan Molecular Testing, New Technologies, and Epidemiologic Considerations These working groups presented their findings during this conference. In a parallel and collaborative effort, an Evidence-based Practice Center (EPC) of the Agency for Healthcare Research and Quality (AHRQ) has conducted an evidence-based review of the comparative effectiveness of treatment for PKU, including diet and sapropterin dihydrochloride. Together, the PKU Scientific Review Conference and the AHRQ EPC report will examine evidence on important issues related to management of PKU. Public input will be solicited and a final document will be published. This conference will consider the state of the science, recent research findings, current treatments, and future research needs related to PKU. |
| Phenylketonuria (PKU) Scientific Workshop | Meeting/ Workshop | AHRQ, FDA, HRSA | NCATS, NHGRI, NICHD, NIDDK, NINDS, NINR | In October 2000, the NIH published a Consensus Development Conference Statement for screening and management of PKU. Since then, new treatments, including pharmacological, have emerged. To assist clinicians in making treatment decisions, NIH has revisited the guidelines. Five working groups were convened to explore an expanded body of literature and address important questions regarding treatment of PKU. These working groups will present their findings during the conference on February 22-23, 2012. https://www.team-share.net/phenylketonuria_scientific_review_conference/Overview.aspx |
| PHS MSM Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA | NHLBI | The working group is developing guidelines and strategies to improve HIV/STD programs for men who have sex with men (MSM). |
| Physical Activity and Disease Prevention: Identifying Research Priorities | Meeting/ Workshop | AHRQ, CDC, OS | OD/DPCPSI/ODP, NCI, NHLBI, NIA, NIBIB, NICHD, NIDA | This workshop was coordinated and funded by the National Institutes of Health (NIH) Office of Disease Prevention (ODP) to convene NIH and federal partners to examine: barriers to achieving the federal Physical Activity Guidelines, effective evidence-based interventions for initiating and sustaining physical activity, NIH’s physical activity research portfolio, and current and emerging research methodologies. The workshop focused on NIH’s interest in supporting innovative research to improve physical activity assessment and research methods used with diverse age and racial/ethnic populations as well as prioritizing the NIH physical activity research agenda. The meeting was held on December 13-14, 2012. http://prevention.nih.gov/workshops/2012/physical_activity/default.aspx |
| Pillbox | Resource Development | FDA | NLM | The National Library of Medicine and the Food and Drug Administration have established a collaborative relationship to enhance patient safety through the linking of digital images of prescription solid dosage form medications to the Structured Product Labeling (SPL) files and the substance information of those pharmaceuticals. http://pillbox.nlm.nih.gov/ |
| Pink Ribbon Red Ribbon (PRRR) | Meeting/ Workshop | CDC | NCI | The Pink Ribbon Red Ribbon (PRRR) is a partnership to leverage public and private sector investments to address breast and cervical cancers in developing countries. It is being implemented in several countries in sub-Saharan Africa. NCI and CDC provide technical assistance in implementation strategies to the PRRR countries. This assistance involves drafting guidelines for monitoring and evaluation of prevention and treatment services as well as developing communication strategies. |
| Playful Learning Group | Other | ACF | NICHD | Collaboration to improve learning in children. |
| Pluripotent Stem Cells in Translation: Early Decisions | Meeting/ Workshop | FDA | NINDS, NHLBI, NIDCR, OD/DPCPSI | The National Institutes of Health (NIH) and the Food and Drug Administration (FDA) are organizing a series of workshops that will engage the broader research community regarding requirements necessary for translation of pluripotent stem cell-derived products into the clinic. The first workshop, held March 2011, focused on establishment of stem cell lines and banks, covering safety and regulatory issues related to how the original cell line derivation is done in the case of embryonic stem cells, and how the cells are reprogrammed in the case of iPS cells. The second workshop, held July 10-11, 2012, focused on preclinical safety and proof of concept testing, including, among other topics, clinical relevance of the animal models, selection of cell dose levels, impact of host microenvironment, and cell fate post-administration. A third, and final, workshop is expected to focus on clinical trial design including safety monitoring, immunogenicity, immunosuppressant use and immune monitoring. http://www.fda.gov/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/ucm241380.htm |
| Polyhalogenated aromatic hydrocarbons (PHAH) and thyroid cancer | Research Initiative | CDC | NCI | Polyhalogenated aromatic hydrocarbons (PHAHs) are being measured in banked serum/plasma samples from cohort studies to evaluate the association with thyroid cancer incidence. |
| Population Assessment of Tobacco and Health Study | Health Survey | FDA | NIDA | The Population Assessment of Tobacco and Health (PATH) Study is the first large-scale National Institutes of Health (NIH)/Food and Drug Administration (FDA) collaboration since Congress granted FDA the authority to regulate tobacco products in the Family Smoking Prevention and Tobacco Control Act (FSPTCA) in 2009. The PATH Study is a national longitudinal cohort study that will follow an estimated 59,000 U.S. household residents ages 12 years and older for at least three years. Objectives are to assess initiation and use patterns; to study trends in tobacco-product use cessation and relapse; to monitor behavioral and health impacts, including in risk perceptions and other tobacco-related attitudes; and to assess differences in tobacco-related attitudes, behaviors, and health outcomes among racial/ethnic, gender, and age subgroups. The PATH Study will also collect biospecimens from adults to analyze biomarkers of tobacco use and related health outcomes. By measuring and accurately reporting on the social, behavioral, and health effects associated with tobacco-product use in the U.S., the PATH Study will provide an empirical evidence base to help inform FDA’s decisions about changes tobacco products in meeting the objectives of the 2009 FSPTCA. http://www.PATHStudyInfo.nih.gov |
| Post-traumatic Stress Disorder (PTSD)/Trauma Brain Injury (TBI) Workgroup | Committee, Work group, Advisory group, or Task Force | OS | NIMH, NIAAA, NIDA, NINDS | A 2012 White House Executive Order titled, "Improving Access to Mental Health Services for Veterans, Service Members, and Military Families" emphasized support of service members, veterans, and their families as a “top priority,” and called for an urgent increase in the Departments of Health and Human Services (HHS), Defense (DOD), and Veteran’s Affairs (VA) research commitments and collaborations to address the problems of PTSD, TBI, and suicide in military populations. Section 5 of this Executive Order requested a National Research Action Plan to develop biomarkers, define the pathophysiology, and create new treatments for PTSD. HHS has charged NIMH to lead this effort along with a parallel effort for TBI led by NINDS, with both Institutes working closely with the VA and DOD. Fortunately, prior investments interrogating the molecular, genomic, and circuitry changes that give rise to PTSD in the context of environmental factors provide the requisite foundation to respond to this White House request for biomarkers for risk prediction, as well as new targets for medications and other therapies to treat PTSD. Such an investment has the potential to revolutionize the care for individuals at high risk for PTSD, and prevent the development of chronic complex treatment resistant PTSD. http://www.whitehouse.gov/the-press-office/2012/08/31/executive-order-improving-access-mental-health-services-veterans-service |
| Practical Oral Care for People with Developmental Disabilities | Public Education Campaign | CDC | NIDCR, NICHD | A series of publications designed to equip dental professionals in the community with the information they need to deliver quality oral health care to people with special needs. http://www.nidcr.nih.gov/OralHealth/Topics/DevelopmentalDisabilities |
| Pre-Exposure Prophylaxis (PrEP) Implementation in Youth | Other | CDC | NICHD | Advises on Pre-Exposure Prophylaxis (PrEP) activities in youth. |
| President''s Commission on the Study of Bioethical Issues (PCSBI) | Committee, Work group, Advisory group, or Task Force | OS | CC | Christine Grady participates as a Commissioner on the President''s Commission on the Study of Bioethical Issues (PCSBI). The Commission advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. The Commission seeks to identify and promote policies and practices that ensure scientific research, health care delivery, and technological innovation are conducted in a socially and ethically responsible manner. The Commission undertakes study of issues presented to them by the President and the Secretary of HHS. http://www.bioethics.gov/ |
| President’s Emergency Plan for AIDS Relief (PEPFAR) Implementation Science | Research Initiative | CDC | NIAID, NCI, NICHD, NIMH, OD/DPCPSI/OAR | In FY11 an NIH/PEPFAR RFA was issued for 3 year grant projects on Implementation Science in PEPFAR. Funding began in FY12. This RFA went out concurrently with a CDC RFA. The two agencies worked together to ensure awards were complementary and that there was no overlap. http://www.pepfar.gov/ |
| President’s Emergency Plan for AIDS Relief (PEPFAR) Implementation Science / Combination Prevention | Research Initiative | CDC | NIAID, NIDA | This PEPFAR activity focuses on testing treatment as prevention on the population level in South Africa and Zambia. This activity was initiated through the HPTN, with support of multiple NIH ICs, PEFPAR, and the Bill & Melinda Gates Foundation. The RFA was issued concurrently with a CDC RFA for combination prevention, and the agencies have worked together to ensure that the studies are complementary and do not overlap. http://www.pepfar.gov/ |
| President’s Emergency Plan for AIDS Relief (PEPFAR) Public Health Evaluation Activities | Research Initiative | CDC, HRSA, SAMHSA | NIAID, FIC, NCI, NIAAA, NIDA, NIMH, OD/DPCPSI/OAR | PEFPAR is governed by intra-agency groups, including NIH, CDC, and HRSA for HHS. CDC has a large role as an implementing partner for PEPFAR, while NIH has limited its activities to providing technical expertise on issues related to safety and efficacy of elements for PEPFAR programs, and to facilitating evaluation of PEPFAR through NIH funded investigators. The Agencies work together to set research and evaluation priorities for PEPFAR. This has been done through the PHE process, and supplement awards through NIH Institutes and Centers to address specific questions and data analysis requests. NIH takes an active role in reviewing and making recommendations for the PHE process. CDC and HRSA were actively involved in the review process for the NIH supplement applications. http://www.pepfar.gov/ |
| Prevention Research Centers (PRC) | Research Initiative | CDC | NCI | The Prevention Research Centers (PRC) program funds community-based research projects at 37 academic research centers across the United States; 5 developmental and 32 comprehensive centers. These centers: • Conduct research projects that promote health and prevent disease • Build research teams of multidisciplinary faculty • Seek solutions, strategies, and policies that address public health problems • Participate in research networks that address priority health issues, such as healthy aging, cancer prevention & control, and obesity prevention • Build long-term relationships for engaging communities as partners in research • Conduct research in directions guided by advisory boards of community leaders • Develop and deliver trainings that enhance the public health workforce • Conduct additional research funded by other federal agencies, foundations, and nonprofit organizations http://www.cdc.gov/prc/ |
| Prevention Research Coordinating Committee (PRCC) | Committee, Work group, Advisory group, or Task Force | AHRQ, ATSDR, CDC, OS | OD/OSP, CC, CIT, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/DPCPSI/ORWH, OD/OLPA | The NIH Prevention Research Coordinating Committee (PRCC) serves as a venue for exchanging programmatic and scientific information of interest to the NIH, as well as for planning and implementation of collaborative activities. The PRCC promotes prevention research designed to yield results directly applicable to identifying and assessing risk, and to developing interventions for preventing or ameliorating high-risk behaviors and exposures, the occurrence of disease/disorder/injury, or the progression of detectable but asymptomatic disease. Prevention research also includes research studies to develop and evaluate disease prevention and health promotion recommendations and public health programs. http://prevention.nih.gov/prcc.aspx |
| Prevention Scientists Promoting Global Health: Emerging Visions for Today and Tomorrow | Meeting/ Workshop | CDC | NIAAA, NCI, NHLBI, NICHD, NIDA, NIMH | The Society for Prevention Research envisions a wellness-oriented society in which evidenced-based programs and policies are continuously applied to improve the health and well being of its citizens. The SPR Annual Meeting provides unique opportunities to advance this vision by providing an integrated forum for: the exchange of new concepts, methods, and results from prevention and public health-related research; and communication between scientists, public policy leaders and practitioners concerning the implementation of evidence-based preventive interventions. http://www.preventionresearch.org/2012-annual-meeting/ |
| Prevention with Positives Intervention HIV Clinics (Y01-MH-1318) | Research Initiative | CDC | NIMH, NIAID | The Prevention with Positives Intervention HIV Clinics is a contract with the CDC to conduct an HIV clinic-based comparison of a comprehensive prevention program for people living with HIV targeting multiple health behaviors (sexual risk, medication adherence, clinic attendance) and health outcomes (viral load, retention in care). |
| Profiling of Compounds Against Isolates of Cryptcoccus galti & C. neoformans | Research Initiative | CDC | NCATS | Test compounds against isolates of C. gattii and C. neoformans. The panel of isolates consists of 300 genotyped isolates of C. gattii from all over the world and 100 isolates of C. neoformans which originated in South Africa. Each isolate would be tested once following the broth microdilution protocol as outlined in the Clinical and Laboratory Standards (CL5I) document M27-A3 (Clincal Laboratory Standards Institute, 2008). All isolates tested would already have fluconazole Minimum Inhibitor Concentration (MIC) data available for comparison. http://www.ncats.nih.gov/research/rare-diseases/trnd/trnd.html |
| Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE) | Other | ACF, CDC, FDA, OS, SAMHSA | OD/OSP, NIAID, NIAMS, NICHD, NINDS, NLM | The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) determines the various Medical Countermeasures (MCMs) that are needed and oversees their development and procurement. The PHEMCE also advances national preparedness against chemical, biological, radiological, nuclear (CBRN) and emerging infectious disease (EID) threats, including pandemic influenza, by coordinating medical countermeasure related efforts within HHS and in cooperation with interagency PHEMCE partners. In order to accomplish this objective, the PHEMCE uses a multitier approach. Each tier comprises multiple agencies within HHS and/ or DHS that work together in a collaborative fashion to further the preparedness of the nation. The first tier includes the Biological, Chemical, Radiological/Nuclear Working Groups; the Blood/Tissue MCM Requirements Working Group; and Integrated Program Teams (IPTs). The Working Groups (WG) utilize scenario-based analyses to determine which medical countermeasures are needed for the SNS, or affiliated repositories. The IPTs provide an end-to-end vision of medical countermeasures needed for a particular threat type (e.g., anthrax, rad/nuc, etc.). The scope of their work includes setting requirements for the stockpiling of MCMs, MCM delivery and dispensing and monitoring MCM development. The IPTs also advise the Enterprise Executive Committee as to threat- or capability-specific MCM priorities for improving preparedness, to inform leadership consideration of cross-threat prioritizations and strategic goal setting. Agencies represented on the PHEMCE WGs and IPTs include; National Institute of Health(NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Department of Defense (DOD), Assistant Secretary for Preparedness and Response (ASPR), Biomedical Advanced Research and Development Authority (BARDA), Department of Homeland Security (DHS) and the Department of Veterans Affairs (VA). The second tier of this process is the Enterprise Executive Committee (EEC). The EEC is comprised of senior program managers across the partner agencies. It provides the critical interface and organizing capability between the strategic focus of the Enterprise Senior Council (ESC) and the tactical-level efforts conducted within the subordinate IPTs and WGs. This committee serves as a Senior Advisor-level coordination mechanism across the federal agencies involved in PHEMCE-related activities to facilitate vetting and prioritization of policy decision materials to be presented to the ESC. The third and most senior tier of the PHEMCE and the forum for cooperation and overall mission fulfillment is the Enterprise Senior Council (ESC). Structurally, the ESC is led by the Assistant Secretary for Preparedness and Response and comprised of the senior leadership of National Institute of Allergy and Infectious Disease (NIAID) within the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA) with comparable senior level representatives from the Department of Defense (DoD) , the Department of Homeland Security (DHS), the Department of Veterans Affairs (VA) , and the U.S. Department of Agriculture (USDA) As the most senior level in the PHEMCE structure, this group approves major policies, product requirements, and large-scale procurement actions. It also oversees strategic reviews of the activities in each of the major threat portfolios (e.g., anthrax, smallpox, rad/nuc) and is the final reporting body for high priority actions identified as gaps in these reviews. |
| Public Health Dimensions of Epilepsy | Other | ACF, CDC, FDA, OS | NINDS, NIA, NICHD, NIMH | The Institute of Medicine convened an ad hoc committee to recommend priorities in public health, healthcare and human services, and health literacy and public awareness for the epilepsies and to propose strategies to address these priorities. The committee''s report was published March 30, 2012: http://www.iom.edu/Reports/2012/Epilepsy-Across-the-Spectrum.aspx. http://iom.edu/Activities/Disease/Epilepsy.aspx |
| Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Blood and Tissue Product Requirements Working Group | Meeting/ Workshop | CDC, FDA, OS | NIAID | This Working Group coordinates requirements, needs, and research and development directions for blood and tissue products for mass casualty treatment after a radiation emergency. |
| Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Integrated Product Development Team (IPT) | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NINDS, NIAID | The HHS Public Health Emergency Medical Countermeasures Enterprise (HHS PHEMCE) leads the mission to develop and acquire medical countermeasures that will improve public health emergency preparedness as well as prevent and mitigate the adverse health consequences associated with chemical, biological, radiological and nuclear (CBRN), and naturally occurring threats. https://www.medicalcountermeasures.gov/ |
| Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Requirements Working Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, OS | NINDS, NIAID, NICHD, NIEHS | The HHS Public Health Emergency Medical Countermeasures Enterprise (HHS PHEMCE) leads the mission to develop and acquire medical countermeasures that will improve public health emergency preparedness as well as prevent and mitigate the adverse health consequences associated with chemical, biological, radiological and nuclear (CBRN), and naturally occurring threats. https://www.medicalcountermeasures.gov/ |
| Public Health Prevention of HIV Risk Behaviors Technical Working Group | Committee, Work group, Advisory group, or Task Force | CDC, SAMHSA | NIAAA, NIDA | Collaboration with the Office of Global AIDS Coordination (OGAC), CDC to identify and implement effective HIV prevention and treatment interventions among alcohol abusing and dependent populations. http://www.aids.gov/ |
| Quantitative data mining for drug-adverse event safety signal detection using MEDLINE | Research Initiative | FDA | NLM | The objective of this initiative between NLM''s Cognitive Science Branch and the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA) is to develop a mutually beneficial automated data mining analytical tool in which NLM’s electronic databases and resources (including MEDLINE) are utilized to support the FDA’s mission related to enhancing postmarket drug safety surveillance and safe use. http://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/ucm162057.htm |
| RABRAT (Radiobiology Bioterrorism Research and Training Group) | Meeting/ Workshop | FDA, OS | NCI | Monthly meetings to discuss research initiatives, funding opportunities, training, conferences, publications and other events and information related to preparing the U.S. Government to respond to nuclear terrorism. |
| Racial and Ethnic Approaches to Community Health Across the U. S. (REACH US) | Research Initiative | CDC | NIMHD | The purpose of the Racial and Ethical Approaches to Community Health Across the US (REACH U.S.) Program is for organizations serving racial and ethnic minority populations at increased risk for infant mortality, diabetes, cardiovascular diseases, Asthma, Hepatitis B, deficits in breast and cervical screening and management, deficits in child and/or adult immunization rates to develop, implement, and evaluate innovative community level intervention demonstrations which could be effective in eliminating health disparities. The racial and ethnic groups targeted by REACH U.S. include: African-Americans, Asian-Americans, Hawaiian Pacific Islanders, Hispanic-Americans, and American Indians or Alaskan Native populations. http://www.cdc.gov/reach/ |
| Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008 | Research Initiative | CDC | NCI | An analysis of the National Program of Cancer Registries database to assess census division differences by race (white, black) in trends of prostate cancer. |
| Radiation Emergency Medical Management (REMM) | Resource Development | CDC, OS | NLM, NCI | This activity is to develop a comprehensive web resource. Radiation Emergency Medical Management (REMM) is a mechanism to collect, evaluate, collate, store and make available electronically to health care professionals immediate, up-to-date, evidence-based clinical information they would use to treat civilian patients and others affected by radiation incidents. http://www.remm.nlm.gov/ |
| Radiation Exposure Screening and Education Program (RESEP) | Meeting/ Workshop | HRSA | NCI | NCI participated in the Radiation Exposure Screening and Education Program (RESEP) workshop (Rockville, MD Sept. 11-13, 2012) and delivered a presentation on “Exposure to Iodine-131 from Nuclear Weapons Tests and the Risk of Thyroid Cancer and Other Diseases". |
| Radiation/Nuclear Biodosimetry Team | Meeting/ Workshop | OS | NIAID | no description provided |
| Radiation/Nuclear Integrated Project Team | Meeting/ Workshop | OS | NIAID | NIAID participates on the Integrated Project Team for Radiation/Nuclear Radiation Nuclear topics to provide subject matter expertise, advice, and guidance on medical countermeasure development, requirements, and preparedness/response. |
| Radiation/Nuclear Technical Evaluation Review Panel | Meeting/ Workshop | OS | NIAID | NIAID participates on the Radiation/Nuclear Technical Evaluation Review Panel to review white papers and proposals received by HHS/Biomedical Advanced Research and Development Authority (BARDA) for the development of radiation nuclear medical countermeasures. NIAID provides scientific and programmatic critiques and reviews of selected submissions. |
| Randomized Intervention in Children with Vesicoureteral Reflux (RIVUR) | Research Initiative | OS | NIDDK | The multicenter, randomized, double-blind, placebo-controlled RIVUR trial is designed to determine whether daily antimicrobial prophylaxis is superior to placebo in preventing recurrence of UTI in children with VUR. The study is designed to recruit 600 children (approximately 300 in each treatment group) over an 18-24 month period. The primary endpoint is recurrence of UTI. Quality of life, compliance, safety parameters, utilization of health resources, and change in VUR will be assessed periodically throughout the study. http://www.rivur.net |
| Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center | Training Initiative | FDA | CC, NCI, NIAID, NIMH, NINDS | This activity is sponsored by the Clinical Pharmacology Program, Office of Clinical Research Training and Medical Education (OCRTME) at the NIH Clinical Center and it consists of elective rotations at the Office of Clinical Pharmacology (OCP) and the Office of New Drugs (OND)- FDA/CDER for NIH staff with a primary focus on clinical fellows and research fellows who expressed an interest in learning more about FDA regulatory sciences applicable to drug development research. Rotating fellows are mentored by FDA staff on the required elements of an Investigational New Drug (IND) application and the key elements of the FDA review process from a regulatory perspective. This program also established a mechanism for FDA scientific reviewers at the OCP to rotate at the NIH Clinical Center and to interact with members of a clinical research team, thus acquiring a better perspective on clinical research protocol implementation and the requirements of an Institutional Review Board (IRB) at the NIH. http://intranet.cc.nih.gov/clinicalresearchtraining/curriculumcert/FDAClinPharm.pdf |
| Reentry Research Network | Other | ACF, SAMHSA | NIDA, OD/DPCPSI/OBSSR | This is a subgroup that reports to the Federal Interagency Reentry Council. The purpose of this group is to bring together numerous federal agencies to make communities safer, assist those returning from prison and jail in becoming productive, tax-paying citizens, and save taxpayer dollars by lowering the direct and collateral costs of incarceration. |
| REGARDS Study - Occupational Supplement | Health Survey | CDC | NINDS | The goal of this study is to identify the extent to which occupational exposure contributes to cardiovascular disease in a racially diverse, population-based sample, with emphasis on health disparities secondary to racial/ethnic characteristics. http://www.regardsstudy.org/ |
| Regional Grant Writing and Scientific Peer Review Workshop | Meeting/ Workshop | CDC | NCI, CSR, FIC, NHLBI, NIAID, NICHD, NIDA, NIMH, NINDS, OD/DPCPSI/OAR, OD/DPCPSI/ODP | The Center for Global Health of the U.S. National Cancer Institute (NCI) in collaboration with the South African Medical Research Council (SAMRC) will hold regional grant writing and peer review workshop to encourage investigators to address public health issues through research. The objectives of the workshop are to (1) increase the participation of scientists from mid- to low-resource countries in the research grant process; (2) develop strategies for sustainable research support and collaborations, and; (3) use competitive research as a tool to address global health issues. |
| Registry of Patient Registries (RoPR) Project | Resource Development | AHRQ | OD/OSP, NIDDK, NLM | The AHRQ Registry of Patient Registries (RoPR) is a system for tracking “patient registries” that is compatible with the ClinicalTrials.gov clinical study registry operated by NLM. Since November 2012, data providers registering “observational studies” at ClinicalTrials.gov can indicate (1) whether the studies also meet AHRQ’s definition of a “patient registry” and, (2) provide more detailed (optional) information about the patient registry using the separate RoPR Data Entry System. Users of the ClinicalTrials.gov Web site are able to search for registered observational studies that are identified as patient registries. In the future, users will also be able to link from a record at ClinicalTrials.gov to the corresponding record containing a detailed description of the patient registry at RoPR, if available. As part of this project, broad consultations were carried out with relevant groups. NIDDK staff participated extensively in these consultations. http://www.outcome.com/ropr.htm |
| Research in diabetes mellitus, its complications, and obesity | Research Initiative | IHS | NIDDK | The objectives are to identify the determinants and understand the progression of type 2 diabetes, obesity, and other chronic diseases in Pima Indians. |
| Research on Research Integrity Program | Research Initiative | OS | NIEHS, NIDCR | Handle the administrative responsibilities for soliciting, reviewing, funding, and managing the RRI program in collaboration with the DHHS Office of Research Integrity (ORI). |
| Research to Improve Health and Longevity of People with Severe Mental Illness | Meeting/ Workshop | AHRQ, CMS, SAMHSA | NIMH, NCI, NHLBI, NIDA, NIDDK | In September 2012, NIMH convened a meeting to assess the state of the science in preventing and treating medical comorbidities in people with severe mental illness (SMI) and identify the most critically needed research to reduce premature mortality in this vulnerable group. NIMH brought together representatives from other NIH Institutes, who also served on the meeting’s planning group, along with leading researchers on medical comorbidities in people with SMI and on prevention and treatment within the general population for diabetes, heart disease, tobacco use, and drug abuse. They were joined by policy leaders, advocates for people with SMI; community mental health center leaders and representatives from key federal agencies, including SAMHSA and AHRQ. http://www.nimh.nih.gov/research-funding/scientific-meetings/2012/research-to-improve-health-and-longevity-of-people-with-severe-mental-illness.shtml |
| Research-Tested Intervention Program Database (RTIPs) | Resource Development | SAMHSA | NCI | Research-Tested Intervention Program Database (RTIPs) is a searchable database of cancer control interventions and program materials and is designed to provide program planners and public health practitioners easy and immediate access to research-tested materials. http://rtips.cancer.gov/rtips/index.do |
| Respiratory/Asthma Question in the 2013 National Health Interview Survey | Health Survey | CDC | NHLBI | The purpose of the collaborative activity is support development and implementation by the National Health Interview Survey (NHIS) of measures that could be used to assess progress towards achieving Healthy People 2020 respiratory/asthma objectives. The NHLBI and the National Center for Health Statistics collaborate on this activity. http://www.cdc.gov/nchs/nhis.htm |
| Revision of CDC Guidelines | Other | CDC | CC | The collaboration serves to revise guidelines for managing occupational exposures to HIV and managing healthcare workers infected with hepatitis B. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6103a1.htm?s_cid=rr6103a1_e |
| RuSH (Registry and Surveillance System in Hemoglobinopathies) | Resource Development | CDC, HRSA, OS | NHLBI, NICHD, NIDDK | Registry and Surveillance System in Hemoglobinopathies (RuSH) is a database of information on people living with hemoglobinopathies (sickle cell disease and thalassemia) in six states. http://www.cdc.gov/ncbddd/hemoglobinopathies/documents/RuSHfactsheet2010.pdf |
| Ruth L. Kirschstein National Research Service Award Program | Training Initiative | AHRQ, HRSA | OD/OER | Predoctoral and postdoctoral training in biomedical, behavioral, and clinical research, including health services and primary care research, is supported by a portion of NIH''s Kirschstein-National Research Service Award Program (NRSA) funds. These funds are annually transferred to AHRQ and HRSA by the NIH Budget Office in accordance with Public Law 111-8, Section 219 of the Health Service Act. http://grants.nih.gov/training/nrsa.htm |
| RxNorm | Resource Development | FDA | NLM | RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software. By providing links between these vocabularies, RxNorm can mediate messages between systems not using the same software and vocabulary. http://www.nlm.nih.gov/research/umls/rxnorm/ |
| Sabbatical in Clinical Research Management Program | Training Initiative | FDA, OS | CC, FIC, NCATS, NEI, NIAID, NLM | Experienced investigators come to the NIH to learn about management of a clinical research enterprise, including topics such as planning and budget development, protocol writing and tracking and scientific review. Sabbaticals are self-directed, meaning that the participant chooses from a list of electives and helps determine how much time to spend studying each topic. The electives are offered by leaders at the NIH and other HHS agencies with the NIH Clinical Center being the most heavily involved. http://www.cc.nih.gov/training/sabbatical/index.html |
| Safety and Efficacy Evaluations of Topical Microbicide (TM)/Biomedical Prevention (BP) Products in the Repeat Low-Dose Macaque SIV/SHIV Infection Model | Research Initiative | CDC | NIAID | The NIAID and CDC recognize the need to perform preclinical safety and efficacy evaluations of candidate products in the repeat low-dose (RLD) macaque SIV/SHIV infection model that has been established by CDC. NIAID established an interagency agreement with CDC in order to: 1) conduct safety and efficacy evaluations of TM/BP products in the RLD macaque model -- including pharmacokinetic/pharmacodynamic analyses of candidate biomedical prevention products; 2) utilize relevant macaque species, virus strains, and routes of infection to accomplish the proposed evaluations; and 3) perform other macaque studies as needed. |
| Safety Reporting Portal | Resource Development | FDA | OD/OSP | Development of a portal to streamline the process of reporting pre- and post-market safety data to the FDA and NIH and to serve as a prototype for a federal-wide system. The Portal is an important policy innovation and major step forward in the effort to eliminate unnecessary complexities and inefficiencies associated with the current system of reporting adverse events. The Portal uses a harmonized set of terms, the Basal Adverse Event Report, to provide a single, web-based interface for standardized electronic reporting of adverse events and unanticipated problems to NIH and FDA and also enables the transmission of reports to local oversight bodies such as IRBs and DSMBs. https://www.safetyreporting.hhs.gov |
| Science Research and New Technology for Development Meeting | Meeting/ Workshop | CDC | NIAID, FIC | This Workshop brought researchers together to discuss ways to bridge the gap between science and programs in Mali. |
| Screening and Brief Intervention Models to Address Unhealthy Drug Use (SBIRT) | Research Initiative | SAMHSA | NIDA | Randomized controlled 3 arm trial to determine the efficacy of Screening and Brief Intervention Models to Address Unhealthy Drug Use (SBIRT) using the SAMHSA funded SBIRT program in Massachusetts. http://www.samhsa.gov/samhsanewsletter/Volume_17_Number_6/SBIRT.aspx |
| SEARCH for Diabetes in Youth | Research Initiative | CDC | NIDDK | SEARCH is a multi-center study that identifies cases of diabetes in children/youth, providing data on incidence and prevalence in the United States as well as data on diabetes management and complications. http://www.searchfordiabetes.org |
| SEER-Medicare Database | Resource Development | CMS | NCI | The SEER-Medicare data are a unique resource that can be used for research related to the health care provided to persons with cancer. The database results from the linkage of two large population-based data sources: the Surveillance, Epidemiology, and End Results (SEER) cancer registries data and the Medicare enrollment and claims files. http://healthservices.cancer.gov/seermedicare/ |
| Sex differences in esophageal cancer incidence rates by census region in the United States, 1999-2008 | Research Initiative | CDC | NCI | An analysis of the National Program of Cancer Registries database to assess census region sex differences in trends of esophageal squamous cell carcinoma and esophageal adenocarcinoma. |
| Sleep Disorders Research Advisory Board | Committee, Work group, Advisory group, or Task Force | CDC | NHLBI, NCATS, NCCAM, NCI, NIA, NICHD, NIDA, NIDDK, NINDS, NINR, OD/DPCPSI/OBSSR, OD/DPCPSI/ORWH | The Advisory Board shall advise, assist, consult with, and make recommendations to the Director of the National Institutes of Health, through the Director of the Institute, and the Director of the Center concerning matters relating to the scientific activities carried out by and through the Center and the policies respecting such activities, including recommendations. (42 USC § 285b–7) http://www.nhlbi.nih.gov/meetings/sdrab/index.htm |
| Smokefree.gov | Other | CDC | NCI, OD/DPCPSI/OBSSR | Smokefree.gov is intended to help individuals quit smoking. Different people need different resources as they try to quit. The information and professional assistance available on this Web site can help to support both immediate and long-term needs as individuals become, and remain, a nonsmoker. Smokefree.gov allows individuals to choose the help that best fits their needs, including immediate assistance in the form of: • A step-by-step quit smoking guide • Information about a wide range of topics related to smoking and quitting • An interactive U.S. map highlighting smoking information in your state • LiveHelp, National Cancer Institute''s instant messaging service • National Cancer Institute''s telephone quitline, 1-877-44U-QUIT • Local and state telephone quitlines, 1-800-QUIT-NOW • Publications to download, print, or order http://smokefree.gov/ |
| Smoking Cessation Services during CDC TIPS II Campaign | Public Education Campaign | CDC | NCI | To assist in ensuring that 1-800-QUIT-NOW''s counseling services and NCI''s text messaging service and web site (Smokefree.gov) have adequate capacity to meet the expected increased demand for services during the CDC TIPS Campaigns |
| SNOMED CT (Systematized Nomenclature of Medicine) International and Support Services | Resource Development | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | NLM | This activity provides support for SNOMED CT (Systematized Nomenclature of Medicine -- Clinical Terms), a systematically organized computer processable collection of medical terminology covering most areas of clinical information such as diseases, findings, procedures, microorganisms, pharmaceuticals etc. It allows a consistent way to index, store, retrieve, and aggregate clinical data across specialties and sites of care. It also helps organizing the content of medical records, reducing the variability in the way data is captured, encoded and used for clinical care of patients and research. http://www.nlm.nih.gov/research/umls/Snomed/snomed_main.html |
| Social Determinants of Health Working Group for Healthy People 2020 | Committee, Work group, Advisory group, or Task Force | CDC, SAMHSA | NIAAA, NCI, NHLBI, NIAMS | The overarching goals for Healthy People 2020 incorporate a focus on social determinants of health as well as on health outcomes and risk factors. The Working Group intends to develop objectives for the social determinants and methods to ensure their integration across all Healthy People 2020 objectives. http://healthypeople.gov/2020/ |
| Society for Prevention Research Annual Meetings | Meeting/ Workshop | ACF, CDC | NIDA, NCI, NIAAA, NICHD, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP | The Society for Prevention Research was formed in 1991 and has grown from a small group of researchers focused on drug and alcohol abuse prevention and mental health to become a leading scientific organization devoted to advancing prevention science, with 700+ members and a multidisciplinary prevention focus that emphasizes drug abuse, mental health and HIV/AIDS prevention in addition to diverse, public health domains (e.g., obesity, violence, translational science). The annual meetings promote cross-fertilization of theory, methods, and intervention and provide an opportunity to enhance understanding of the underlying mechanisms of health-related issues with the goal of building the science of effective strategies, and for prevention and health promotion. http://preventionscience.org |
| Specialized Centers of Research (SCOR) on Sex and Gender Factors Affecting Women''s Health | Research Initiative | FDA | OD/DPCPSI/ORWH, NIAMS, NICHD, NIDA, NIDDK, NIMH | The Specialized Centers of Research (SCOR) programs are large Center Programs (P50) that consist of 11 Centers that conduct interdisciplinary research focused on health issues that affect women and examine sex/gender contributions to health and disease. The currently funded SCORs are interdepartmental, intercollegiate, interinstitutional and focus on sex differences in musculoskeletal health, tobacco, addiction, substance abuse, reproductive health, urinary tract, depression, metabolic disorders and pain. The SCOR mechanism promotes collaborative research among scientists with varied expertise in order to achieve research objectives that are less likely to occur through other grant mechanisms. http://orwh.od.nih.gov/interdisciplinary/SCORs.html |
| Standards for Genetic Testing Report | Research Initiative | AHRQ, CDC, OS | NLM, NHGRI | This activity aims to develop a standard reporting format, using LOINC and HL7, for Electronic Medical Records (EMR) health information exchange, NLM''s Personal Health Record Project and activities of the Office of the Secretary. |
| State Cancer Profiles | Resource Development | CDC | NCI | The objective of the State Cancer Profiles Web site is to provide a system to characterize the cancer burden in a standardized manner in order to motivate action, integrate surveillance into cancer control planning, characterize areas and demographic groups, and expose health disparities. The focus is on cancer sites for which there are evidence based control interventions. Interactive graphics and maps provide visual support for deciding where to focus cancer control efforts. http://statecancerprofiles.cancer.gov/ |
| Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of Youth with Undiagnosed HIV Infection (SMILE in CARING for YOUTH) | Research Initiative | CDC | NICHD, NIDA, NIMH | The Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) was awarded grant money to expand their project of increasing availability of HIV testing for adolescents 12-24 and the provision of adolescent-focused healthcare services for those adolescents who are diagnosed with HIV infection. The project''s expansion includes all the ATN sites across the US. NICHD is collecting data to evaluate the effectiveness of adolescent oriented linkage to care services for the HIV infected adolescents. This collaboration has the potential to improve the health of American youth, both by identifying those with undiagnosed HIV and bringing them into adolescent-friendly treatment programs and by reducing the chances of them further spreading the virus to others. There is a committee "SMILE in CARING for YOUTH that monitors activities related to NIH-CDC collaboration on enhancing treatment and retention in care of HIV youth. |
| Strategic Prevention Framework State Incentive Grant | Research Initiative | SAMHSA | NIDA | Interagency Agency Agreement to support national cross-site evaluation of SAMHSA''s Strategic Prevention Framework (SPF) State Incentive Grant (SIG) Prevention initiative. http://www.samhsa.gov/prevention/spf.aspx |
| Structured Data Capture Initiative, under the Standards and Interoperability (S&I) Framework | Resource Development | AHRQ, CDC, FDA, OS | NLM | NLM is collaborating with the Office of the National Coordinator for Health Information Technology (ONC) and AHRQ under the auspices of ONC''s S&I Framework. This initiative will develop and validate a standards-based data architecture so that a structured set of data can be accessed from EHRs and be stored for merger with comparable data for other purposes, including: electronic Case Report Form (eCRF) used for clinical research including Patient Centered Outcomes Research (PCOR); Incident Report used for patient safety reporting leveraging AHRQ ‘Common Formats’; and Surveillance Case Report Form used for public health reporting of infectious diseases. http://wiki.siframework.org/Structured+Data+Capture+Initiative |
| Studies in the Treatment of Anthrax Edema Toxin Associated Shock: The Role of Conventional Hemodynamic Support Alone or Together with a PA Directed mAb | Research Initiative | FDA | CC | Production of edema toxin by B. anthracis is a key pathogenic component in the hemodynamic compromise and resistance to conventional hemodynamic support leading to death during all severe forms of anthrax infection, including inhalational disease. The aim of the present collaboration was to define employing a large animal model the efficacy of conventional hemodynamic support for anthrax edema toxin induced shock and to determine whether the use of protective antigen directed monoclonal antibody (PA-mAb) can increase the efficacy of conventional hemodynamic support. |
| Study of Cancer Among United States Firefighters | Research Initiative | CDC | NCI | A retrospective cohort study to evaluate the relationship between occupational exposures of firefighters and cancer risk. |
| Subcommittee on Nanoscale Science, Engineering, and Technology | Committee, Work group, Advisory group, or Task Force | CDC, FDA | OD/OSP, NCI, NHGRI, NIBIB, NIEHS | This subcommittee of the National Science and Technology Council''s Committee on Technology is responsible for coordinating the National Nanotechnology Initiative (NNI). The NNI was established in 2001 to coordinate federal research and development in nanotechnology by providing a vision of the long-term benefits and opportunities offered by nanotechnology and acting as a locus for communication, cooperation, and collaboration between federal agencies involved in nanotechnology research and development. In 2011, the NSET developed a strategic plan that encompasses a comprehensive nanotechnology R&D initiative built on shared goals, priorities, and strategies that complement agency-specific missions and activities. http://www.nano.gov/nset |
| Subpopulations and Intermediate Outcome Measures in Chronic Obstructive Pulmonary Disease (COPD) | Research Initiative | FDA | NHLBI | SPIROMICS (SubPopulations and Intermediate Outcome Measures In Chronic Obstructive Pulmonary Disease Study) is an observational study of COPD that seeks to identify practical intermediate outcome measures and mechanistically homogeneous subgroups of patients with the disease. The study was developed in cooperation with the FDA and will be implemented with industrial partners. http://www.cscc.unc.edu/spir/about.php |
| Substance Abuse and Mental Health Services Administration (SAMHSA) Recovery Month | Public Education Campaign | SAMHSA | NIDA | Substance Abuse and Mental Health Services Administration (SAMHSA''s) annual public health observance for people in recovery from substance abuse; NIDA is part of SAMHSA''s inter-agency planning committee and a promotional partner. http://www.recoverymonth.gov/ |
| Suicide Research Consortium | Committee, Work group, Advisory group, or Task Force | CDC, IHS, SAMHSA | NIAAA, NIMH | The consortium coordinates program development in suicide research, stimulates extramural research on suicide, and disseminates science-based information on suicidology. |
| Support for the Federal Interagency Forum on Child and Family Statistics | Other | ACF, AHRQ, CDC, HRSA, OS | NICHD, NIMH | The purpose of this IAA is to provide funds to support the work of the Federal Interagency Forum on Child and Family Statistics (Forum). The purpose of the Forum is to foster collaboration among Federal agencies that produce or use statistical data on children and families and seeks to improve both the quality and use of data on children and families. NICHD participates on a committee called "Interagency Forum for Child and Family Statistics". http://childstats.gov/ |
| Surgeon General''s Call to Action to Prevent Prescription Drug Abuse among Youth: The Dangers of Improper Use of Controlled Medications | Other | CDC, OSG, SAMHSA | NIDA | The Call to Action addresses youth motivations for abuse, environmental influences in the culture at large, and other factors such as drug sharing by friends and family members, which may be helping to fuel this epidemic. It also outlines strategies pertaining both to developing and implementing prevention programs, creating national and local media campaigns, and improving clinician education and the use of Prescription Drug Monitoring Programs to help prevent doctor shopping and drug diversion. Action items are included for all sectors of the community. |
| Surveillance, Epidemiology, and End Results (SEER) Program | Resource Development | CDC | NCI | Surveillance, Epidemiology, and End Results (SEER) is the premier source for cancer statistics in the United States. It collects information on incidence, prevalence and survival from specific geographic areas representing 26 percent of the US population. Through SEER, we develop reports on all of these information areas plus cancer mortality for the entire country. The site is intended for anyone interested in US cancer statistics or cancer surveillance methods. http://seer.cancer.gov/ |
| Systematic Review Data Repository (SRDR) | Resource Development | AHRQ | NLM | NLM is collaborating with AHRQ on the Evidence-based Practice Center (EPC) at Tufts Medical Center to construct a Web-based electronic repository of systematic review data. As envisioned, this resource would serve as both an archive and data extraction tool, enabling the creation of a central database of systematic review findings, which would be made available to a range of audiences in an effort to facilitate evidence reviews and thus improve and speed policy-making with regards to healthcare. http://srdr.ahrq.gov/ |
| Targeting of Interleukin-13 Receptor a2 for Treatment of Head and Neck Squamous Cell Carcinoma Induced by Conditional Deletion of TGF-ß and PTEN Signaling | Research Initiative | FDA | NIDCR, NIDCD | The activity will test new animal models of head and neck squamous cell cancer with targeted treatments using Interleukin-13 Receptor alpha 2 antagonists. |
| Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities | Meeting/ Workshop | ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG | NHLBI, NCMHD, NIAID, NICHD, NIEHS, NINR | The Action Plan to Reduce Asthma Disparities promotes collaboration and coordination among federal agencies to leverage existing resources to address the multi-leveled causes of asthma disparities. The Action Plan outlines four key strategies to improve the quality of care for children who have asthma and promote community programs and resources to support clinicians, children, and their families in following best practices for asthma management. http://www.asthmacommunitynetwork.org |
| Technical Advisory Group | Committee, Work group, Advisory group, or Task Force | ACF | NICHD | Advise Administration on Children and Families (ACF) on contract with Mathematica that is evaluating selected comprehensive sexuality education interventions. |
| Technical and clinical consultation to Indian Health Service in kidney disease. | Public Education Campaign | IHS | NIDDK | NIDDK senior staff member serves as Chief Clinical Consultant for Nephrology for the Indian Health Service. |
| Technical Consultation on Hepatitus C Virus (HCV) Infection in Young injecting drug users (IDUs) | Meeting/ Workshop | CDC, OS, SAMHSA | NIDA, NIAID, NIDDK | Bring Federal and non-Federal clinician/researchers from academia, state public health departments and community to present and discuss current research and other information on an emerging epidemic of viral hepatitis (HCV) infection in the 15-30 year group. http://www.drugabuse.gov |
| Ten years post PKU Consensus Conference: State of the Science (committee) | Other | AHRQ, CDC, FDA, HRSA | NICHD, NHGRI, NIDDK, NINDS | The purpose of this collaboration is to have a scientific discussion to address management of phenylketonuria (PKU) in light of recent research findings. Screening and management guidelines for PKU were last published as the result of a Consensus Conference held in October 2000, and there have been new developments since that time. This new discussion will consider the state of the science in the areas of diet control and management; pharmacologic interventions; PKU and pregnancy; long-term cognitive outcomes and follow-up; and molecular testing, new technologies, and epidemiologic considerations. We are convening working groups to generate and address specific questions related to these topics. In parallel, an AHRQ Evidence-based Practice Committee is independently evaluating the use of newly available pharmaceutical interventions relative to dietary interventions for PKU, with the NIH as a partner in this process. We plan to host a conference in late 2011 (or early 2012) after the AHRQ review process, to discuss the conclusions and recommendations of the working groups. |
| Text 4 Baby Program Evaluation Technical Advisory Group | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, OS, SAMHSA | NICHD | Formal program evaluation of the Text 4 Baby initiative, which provides health info to pregnant women and young mothers via text message. |
| The Armed Forces Radiobiology Research Institute (AFRRI) Good Laboratory Practices (GLP) Project Integrated Project Team | Meeting/ Workshop | OS | NIAID | NIAID participates on the Armed Forces Radiobiology Research Institute (AFRRI) Good Laboratory Practices (GLP) Integrated Project Team to collaborate and provide subject matter expertise, advice, and guidance on establishing a QA program at AFRRI for GLP compliance. |
| The CDC Dental, Oral, and Craniofacial Data Resource Center (DRC) | Resource Development | CDC | NIDCR | Publicly accessible database, query system, and survey catalog for population-based oral health surveys http://drc.hhs.gov |
| The CDC Preconception Health and Health Care Initiative | Research Initiative | CDC, CMS | NICHD | The purpose of the Preconception Health and Health Care Initiative is to facilitate collaboration, develop recommendations, and identify and address obstacles and opportunities: clinical, public health, consumer, policy and finance, and research for preconception health and health care. NICHD collaborated with CDC to develop a research agenda for Preconception Health and Health Care. |
| The Environmental Determinants of Diabetes in the Young (TEDDY) | Research Initiative | CDC | NIDDK, NIAID, NICHD, NIEHS | This consortium is organizing international efforts to identify infectious agents, dietary factors, or other environmental factors that trigger type 1 diabetes in genetically susceptible people. The study enrolled over 8,000 newborns and is following them for 15 years to identify environmental triggers of type 1 diabetes. http://www.teddystudy.org |
| The Federal Tuberculosis Task Force | Other | AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA | OD/OSP, FIC, NCATS, NHLBI, NIAAA, NIAID, NICHD, NIDA | The Federal Tuberculosis (TB) Task Force is a coalition composed of the federal agencies and organizations involved in U.S. TB control efforts. Established in 1991, the Task Force facilitates coordination of activities between federal agencies. It was created by the Director of the Centers for Disease Control and Prevention (CDC) to address the outbreaks of multidrug-resistant (MDR) TB occurring during 1985-1992 surge in TB cases. http://www.cdc.gov/tb/about/taskforce.htm |
| The Foundation for the NIH Biomarkers Consortium | Research Initiative | CMS, FDA | NIBIB, NCI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDDK, NIMH, NINDS | The Biomarkers Consortium develops, validates, and qualifies biological markers (biomarkers) to speed the development of medicines and therapies for detection, prevention, diagnosis, and treatment of disease and improve patient care. The NIH Public Private Partnership Program coordinates NIH participation in the sponsored Biomarkers Foundation for the National Institutes of Health (FNIH) consortium. The consortium is an umbrella which encompasses research projects, ongoing working groups, as well as occasional workshops and conferences. http://biomarkersconsortium.org/ |
| The Health Effects of Sodium Reduction | Other | CDC, FDA | NHLBI, NIDDK | Teleconference to discuss studies reporting adverse or no effects of sodium reduction on normal and hypertensive population. |
| The Healthy Brain Initiative | Public Education Campaign | ACL, CDC | NIA | A call to action and a guide to assist in implementing a coordinated approach to moving cognitive health into public health practice. http://www.cdc.gov/aging/healthybrain/index.htm |
| The Healthy Communities Study: How Communities Shape Children’s Health BAA NHLBI-HC-10-15 | Research Initiative | CDC | NHLBI, NCI, NICHD, NIDDK, OD/DPCPSI/OBSSR | The Healthy Communities Study is an observational study of communities conducted over five years that aims to (1) determine the associations between community programs/policies and Body Mass Index (BMI), diet, and physical activity in children; (2) identify the community, family, child factors that modify or mediate the associations between community programs/policies and BMI, diet, and physical activity in children, and (3) assess the associations between program/policies and BMI, diet, and physical activity in children in communities that have a high proportion of African American, Latino, and/or low income residents. Over 200 communities and about 20,000 elementary and middle school aged children and their parents will be part of the HCS. A HCS community is defined as a high school catchment area. Data will be collected on 81 children within each community (9 children per grade). The study examines quantitative and qualitative information obtained from community-based initiatives, community characteristics (e.g., school environment), and from child and parent assessments and measurements of children’s physical activity levels, dietary practices of children, and children’s and parent’s BMI. This study is not designed to evaluate any one specific program, policy or community, but will instead systematically assess if components or characteristics of representative programs/policies in communities across the country are related to BMI, diet, and physical activity in children. http://www.nhlbi.nih.gov/resources/obesity/pop-studies/hcs.htm |
| The impact of tobacco use on oral health and the oral microbiome | Research Initiative | CDC | NCI | FDA Intramural Center of Tobacco Regulatory Science Award Program funded a project examining how tobacco affects oral health and the oral microbiome in the National Health and Nutrition Examination Survey (NHANES) study. |
| The Incidence of Breast and Other Cancers Among Female Flight Attendants | Research Initiative | CDC | NCI | A cohort study of approximately 10,000 Pan Am flight attendants to determine cancer incidence (primarily breast cancer) associated with cosmic radiation and circadian disruption from their work. |
| The Medical Education Partnership Initiative (MEPI) | Training Initiative | CDC, HRSA | OD/OSP, FIC, NCATS, NCCAM, NCI, NHGRI, NHLBI, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OAR, OD/DPCPSI/ORWH, OD/DPCPSI/OSC | The Medical Education Partnership Initiative (MEPI) supports foreign institutions in Sub-Saharan African countries that receive PEPFAR support and their partners to develop or expand and enhance models of medical education. These models are intended to support PEPFAR’s goal of increasing the number of new health care workers by 140,000, strengthen medical education systems in the countries in which they exist, and build clinical and research capacity in Africa as part of a retention strategy for faculty of medical schools and clinical professors. http://www.fic.nih.gov/programs/Pages/medical-education-africa.aspx |
| The National Ambulatory Medical Care Survey (NAMCS) | Health Survey | CDC | NCCAM | The National Ambulatory Medical Care Survey (NAMCS) is a national survey designed to meet the need for objective, reliable information about the provision and use of ambulatory medical care services in the United States. Findings are based on a sample of visits to non-federal employed office-based physicians who are primarily engaged in direct patient care. In 2012, a series of questions were added to assess what types of complementary health practices are used physician offices and the referral patterns to complementary health care providers such a chiropractors and acupuncturists. http://www.cdc.gov/nchs/ahcd.htm |
| The National Committee on Vital and Health Statistics (NCVHS) | Other | AHRQ, CDC, CMS | OD/DPCPSI/OBSSR | The National Committee on Vital and Health Statistics (NCVHS) serves as the statutory [42 U.S.C. 242k(k)]public advisory body to the Secretary of Health and Human Services in the area of health data and statistics. In that capacity, the Committee provides advice and assistance to the Department and serves as a forum for interaction with interested private sector groups on a variety of key health data issues. |
| The NIH Bone Marrow Stromal Cell Transplantation Center (BMSC) | Research Initiative | FDA | NIDCR, CC, NCI, NHLBI, NIAID, NIAMS, NIBIB, NINDS | The mission of the NIH Bone Marrow Stromal Cell (BMSC) Transplantation is to develop clinical grade bone marrow stromal cells for use in clinical trials that utilizes the ability of these cells to exert immunomodulatory and immunosuppressive effects that are beneficial for the treatment of a number of diseases and disorders, and to provide assistance to clinical investigators in the preparation of regulator documents for institutional review boards (IRBs) and the FDA. http://sigs.nih.gov/bmsctc/Pages/default.aspx |
| The Pharmacology Research Associate (PRAT) Program | Training Initiative | FDA | NIGMS | Funding provided for the support of Pharmacology Research Associate (PRAT) as a second year fellow in the laboratory at the Food and Drug Administration (FDA). http://www.nigms.nih.gov/Training/PRAT.htm |
| The Science of Sex and Gender in Human Health | Committee, Work group, Advisory group, or Task Force | FDA | OD/DPCPSI/ORWH | This is a Web-based course that offers a basic scientific understanding of the major physiological differences between the sexes; their influence on illness and health outcomes; and their implications for policy, medical research, and health care. http://sexandgendercourse.od.nih.gov/ |
| The Trans-NIH Rare Diseases Working Group | Committee, Work group, Advisory group, or Task Force | FDA | OD/OSP, CC, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM | The Trans-NIH Rare Diseases Working Group was established in 2004. This working group assists the Office of Rare Diseases Research in carrying out its mission by addressing a set of goals that build on partnerships Office of Rare Diseases Research (ORDR) has developed with NIH Institutes, Centers, and Offices, HHS agencies, and other organizations that address issues in rare diseases research such as identifying research opportunities and advances in rare diseases research; promoting coordination and cooperation in joint research efforts among the NIH institutes, centers, and offices and the research entities they support. Trans-NIH Rare Diseases Working Group was established in 2004. http://dpcpsi.nih.gov/collaboration/committees.aspx |
| The U.S. Surgeon General''s Report: The Health Consequences: 50 Years of Progress | Other | CDC | OD/DPCPSI/OBSSR | Contributing author to Chapter 15 “Tobacco Control Simulation Models” |
| The United Nations 57th Session of the Commission on the Status of Women (CSW) | Other | ACF, CDC | NIDA | The HHS Office of Global Affairs–International Health Action for a Healthier US is the lead office for HHS efforts. This office invited representatives from several HHS agencies to prepare for representing HHS at the Commission on the Status of Women (CSW) meeting in March 2013 in NY. http://www.un.org/womenwatch/daw/csw/index.html |
| The United States Renal Data System (USRDS) | Resource Development | CMS, HRSA | NIDDK | The United States Renal Data System (USRDS) is a national data system that collects, analyzes, and distributes information about chronic kidney disease and end-stage renal disease (ESRD) in the United States. The missions of the USRDS are: (1) To characterize the total renal patient population and describe the distribution of patients by socio-demographic variables across treatment modalities; (2) To report on the incidence, prevalence, mortality rates, and trends over time of renal disease by primary diagnosis, treatment modality and other variables; (3) To develop and analyze data on the effect of various modalities of treatment by disease and patient group categories; (4) To identify problems and opportunities for more focused special studies of renal research issues; (5) To conduct cost effectiveness studies and other economic studies of ESRD; and (6) To make the data available to investigators, and by supporting investigator-initiated projects, to conduct biomedical and economic analyses of ESRD patients. http://www.usrds.org |
| Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group | Committee, Work group, Advisory group, or Task Force | FDA | NCATS, CC, NICHD, NINDS | A group of NIH''s Therapeutics for Rare and Neglected Diseases (TRND) staff and FDA staff from the Center for Drug Evaluation and Research (CDER) meet on a semi-monthly basis to discuss projects for the TRND program. The purpose of this working group is to discuss the scientific progress on each project toward the eventual goal of an Investigational New Drug Application for each project. Results of experiments are discussed, and TRND staff takes the feedback of FDA/CDER staff into consideration when developing future project plans. http://www.ncats.nih.gov/research/rare-diseases/trnd/trnd.html |
| Think Tank on the Identifiability of Biospecimens and “-Omic” Data | Meeting/ Workshop | FDA, OS | NCI, NHGRI | Concerns regarding the potential identifiability of individuals from genomic or other "-omic" data, and from donated biospecimens coupled with publicly accessible information, have given rise to privacy policies and data security requirements which could limit the pace of progress in cancer research. The NCI Think Tank on the Identifiability of Biospecimens and "-Omic" Data was a 2-day workshop that gathered experts from various disciplines: researchers, ethicists, privacy law experts, patient advocates, and industry representatives, to review the state of the science and to explore the ramifications of suggested policy alternatives. http://epi.grants.cancer.gov/workshops/identifiability/ |
| Third Pan-American Dengue Research Network Meeting | Meeting/ Workshop | CDC, FDA | NIAID | The September 2012 meeting provided a forum in which attendees exchanged information on basic and applied dengue research, identified research gaps and priorities, and ways to promote and stimulate research collaborations in the Americas. http://eventos.aviatur.com.co/dengue/index.html |
| Tobacco and Nicotine Research Interest Group (TANRIG) | Other | CDC, FDA, SAMHSA | NIDA, NCI, NHGRI, NHLBI, NIAAA, NIAID, NICHD, NIEHS, NIMH, NINR, OD/DPCPSI/OBSSR | Tobacco and Nicotine Research Interest Group (TANRIG) was formed in January 2003 with the goal of increasing collaboration, coordination, and communication of tobacco- and nicotine-related research among NIH institutes and centers, as well as with other relevant HHS agencies. http://sigs.nih.gov/tobacco/Pages/default.aspx |
| Tobacco Policy Modeling Workshop | Meeting/ Workshop | FDA | OD/DPCPSI/OBSSR, NCI, NIDA | The purpose of this Office of Behavioral and Social Sciences Research-led (OBSSR) meeting is to bring together systems science experts with tobacco control experts and government officials in order to: 1) assist in forming cross-disciplinary collaborations, 2) allow funding agencies to identify their programmatic priorities suited to exploration with modeling and simulation methods, and 3) develop recommendations for addressing challenges and capitalizing on opportunities in tobacco control using modeling and simulation methods. |
| Tobacco Product Interagency Agreement | Other | FDA | NCI | The FDA Center for Tobacco Products (CTP) and the NCI Office of Communications and Education are collaborating on an Interagency Agreement in which CTP will provide funds to NCI to provide planning, formative research, target messaging, creative content, outreach strategies, and communications support for a campaign to prevent underage tobacco use as it relates to FDA’s authorities under the Tobacco Control Act. Primary focus areas include multi-ethnic journalist training and outreach; development of a partnership strategy, digital strategy, social marketing tools; digital gaming best practices, and formation of a CTP communications workgroup comprised of subject matter experts. |
| Tobacco Regulatory Science Program (TRSP) | Research Initiative | FDA | OD/DPCPSI/ODP, NCI, OD/OER | Located in the NIH Office of Disease Prevention, the Tobacco Regulatory Science Program (TRSP) coordinates the trans-NIH collaborative effort with the Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) to conduct research to support its regulatory activities over tobacco products. Within the framework of the Tobacco Control Act, the NIH and FDA formed an interagency partnership to foster tobacco regulatory research. The NIH has the infrastructure for the solicitation, review, and management of research. The FDA has expertise in tobacco regulatory science and the authority and resources to support research responsive to FDA’s regulatory authority. Support from FDA was used to fund grants and to provide administrative support and oversight to manage Funding Opportunity Announcements (FOA), application review, policy implementation and oversight, and communicating and reporting to a variety of sources. http://prevention.nih.gov/tobacco/default.aspx |
| Tobacco Training Workgroup Subgroup of the NIH-FDA Tobacco Regulatory Science Workgroup | Committee, Work group, Advisory group, or Task Force | FDA | OD/DPCPSI/OBSSR, NCI, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM | The Tobacco Training Workgroup Subgroup is focused on development of research training initiatives that fall within the scope of FDA''s Center for Tobacco Products and are administered by NIH. |
| Topic Refinement Panel for Peripheral Artery Disease (AHRQ) and Duke University Evidence-based Practice Center | Meeting/ Workshop | AHRQ | NHLBI | The Duke University Evidence-Based Practice Center (EPC) is working with the Agency for Healthcare Research and Quality (AHRQ) to conduct a comparative effectiveness review on the topic of Treatment Strategies for Patients With Peripheral Artery Disease (PAD). The Technical Expert Panel (TEP) members provide expertise in the project research area to support the team of EPC investigators. TEP participation consists of attending 1-2 teleconferences over the course of roughly 12 months to discuss the protocol, key questions, analytical framework, literature search strategy, and other project-specific questions regarding report structure and data to be abstracted from the literature for inclusion in the report. |
| Toxicology in the 21st Century (Tox21) Program | Research Initiative | FDA | OD/OSP, NCATS, NIEHS | The Tox21 initiative, championed by the National Center for Advancing Translational Sciences (NCATS), the National Institute of Environmental Health Sciences (NIEHS), the U.S. Environmental Protection Agency (EPA), and the Food and Drug Administration (FDA), was formed to develop high-throughput screening tests that measure cellular harm caused by environmental chemicals. The goals of the Tox21 initiative are to identify patterns of compound-induced biological response in order to characterize toxicity and disease pathways, facilitate cross-species extrapolation, and model low dose extrapolation, to prioritize compounds for more extensive toxicological evaluation, and finally, to develop predictive models for biological response in humans. http://www.ncats.nih.gov/research/reengineering/tox21/tox21.html |
| Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) | Other | CDC, FDA, OS | NIAID | The presidential declaration issued at the 2009 EU-US summit called for the creation of “a transatlantic task force on urgent antimicrobial resistance issues focused on appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities, prevention of both healthcare- and community-associated drug-resistant infections, and strategies for improving the pipeline of new antimicrobial drugs, which could be better addressed by intensified cooperation between us”. The objectives of the Task Force are to increase the mutual understanding of US and EU activities and programs relevant to the antimicrobial resistance issues identified in the declaration to deepen the transatlantic dialogue, to provide opportunities to learn from each other, and to promote information exchange, coordination and co-operation. http://ecdc.europa.eu/en/activities/diseaseprogrammes/tatfar/pages/index.aspx?MasterPage=1 |
| Trans-NIH American Indian and Alaska Native Health Communications and Information Workgroup | Meeting/ Workshop | IHS | NIAMS, NCATS, NCI, NEI, NHGRI, NHLBI, NIA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIGMS, NINDS, NLM | Provides a forum for health education and communications staff from across NIH to share strategies and learn effective approaches to develop and disseminate health information designed for American Indian and Alaska Native communities. |
| Trans-NIH Plan for HIV-Related Research | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA, OS | OD/OSP, CC, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OAR, OD/DPCPSI/ORIP, OD/DPCPSI/ORWH | Authorized by section 2353 of the Public Health Service Act, this annual collaborative planning process establishes scientific priorities for all NIH AIDS research. Broad input is solicited from scientists from NIH, other government agencies, and non-governmental organizations, as well as community representatives and other experts from the United States and abroad. http://www.oar.nih.gov/strategicplan/ |
| Transition to Fatherhood | Research Initiative | OS | NICHD | This research examines the social and economic consequences of teenage or early fatherhood. This research began with an interagency agreement and is an administrative supplement to the NICHD Transition to Fatherhood Grant-5P01HD045610-05 that assists in developing better pregnancy prevention policies for young men by improving understanding of the social and economic consequences of early and premature transitions to fatherhood. This grant supplement will undertake secondary data analysis of multiple longitudinal datasets to examine if the consequences of premature parenting are different for men than for women. This information is needed in order to inform the development of effective pregnancy prevention strategies for young men. http://projectreporter.nih.gov/project_info_description.cfm?aid=8311271 |
| Translational Research to Help Older Adults Maintain their Health and Independence in the Community | Research Initiative | ACL | NIA | The National Institute on Aging (NIA) and the Administration on Aging (AoA) have partnered to solicit applications using the NIH R01 award mechanism for translational research that moves evidence-based research findings toward the development of new interventions, programs, policies, practices, and tools that can be used by community-based organizations to help elderly individuals remain healthy and independent, and living in their own homes and communities. The goal of this initiative is to support translational research involving collaborations between academic research centers and community-based organizations with expertise serving the elderly (such as city and state health departments, city/town leadership councils, and Area Agencies on Aging) that will enhance our understanding of practical tools, techniques, programs and policies that communities across the nation can use to more effectively respond to needs of their aging populations. http://grants.nih.gov/grants/guide/pa-files/PA-11-123.html |
| Transplant Cancer Match Study | Research Initiative | HRSA | NCI | A study linking databases of U.S. transplant recipients, donors, and wait list candidates to multiple U.S. cancer registries to evaluate the spectrum of cancer risk in transplant recipients. http://transplantmatch.cancer.gov/ |
| Traumatic Brain Injury Common Data Elements Standards - Interagency Steering Committee | Resource Development | CDC | NINDS, CIT | The Traumatic Brain Injury (TBI) Common Data Elements (CDE) Standards – Interagency Steering Committee provides oversight to a federal scientific initiative to develop and utilize common data elements for TBI. http://www.commondataelements.ninds.nih.gov/TBI.aspx#6 |
| Treating for Two: Safe Medication Use in Pregnancy Initiative | Committee, Work group, Advisory group, or Task Force | AHRQ, CDC, FDA, HRSA | OD/DPCPSI/ORWH, NICHD | The initiative provides expert input for the development of a conference on systematic, evidence-based review of specific medications used during pregnancy and adverse fetal outcomes. |
| Treatment guidelines for opioid and alcohol dependence pharmacotherapy | Training Initiative | SAMHSA | NIDA, NIAAA | Development and publication of guidelines for health care providers on how to treat opioid and alcohol dependence. |
| Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) | Research Initiative | CDC | NIDDK | Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) is a multi-center clinical research study examining the safety and efficacy of three treatment options for type 2 diabetes in the pediatric population. TODAY was initiated due to the increase in type 2 diabetes in children and adolescents, which itself is linked to the rise in obesity. http://todaystudy.org |
| Trends in Health and Aging | Resource Development | CDC | NIA | A data archive of trend tables with health indicators displayed over time and by age, sex, and race/ethnicity. A Web-based tool developed and maintained by the National Center for Health Statistics, attempts to connect consumers of information on health and aging with suppliers of such data by providing user-friendly access to up-to-date information on the health and well-being of older Americans. |
| Trends in hormone concentrations in U.S. men and relationship to endocrine disrupting chemicals in the NHANES population | Research Initiative | CDC | NCI | An examination of serum hormone levels of men in the NHANES population to determine whether levels have declined over time and whether they correlate with serum levels of endocrine disrupting chemicals. |
| Tribal Epidemiology Centers Program | Research Initiative | IHS | NIMHD | To develop Epidemiology Centers and public health infrastructure for AI/AN communities. http://www.ihs.gov/epi/index.cfm?module=epi_tec_tecs |
| Tribal Health Research Advisory Council (HRAC) | Committee, Work group, Advisory group, or Task Force | OS | NIMHD | To support the activities of the Council, including obtaining input from tribal leaders on health research priorities and needs, and dissemination of information. http://minorityhealth.hhs.gov/hrac/ |
| Tuberculosis (TB) Diagnostics Research Forum | Other | CDC | NIAID | The purpose of the Forum is to communicate, coordinate, and collaborate to address issues of Tuberculosis (TB) diagnostics, especially drug susceptibility testing (DST) for new drugs and regimens. The initial focus was to bring together researchers, clinicians, clinical trial groups, government, and non‐government organizations with both the drug and diagnostic industry to advance the field of pyrazinamide (PZA) DST to meet the needs of clinical trials scheduled for 2013. In addition, the Forum will expand to other drugs including FQ and new anti-tuberculosis drugs in the pipeline. |
| Tuberculosis (TB) Therapeutics Research Coordination Forum | Other | CDC | NIAID | The purpose of the Tuberculosis (TB) Therapeutics Research Coordination Forum (“the Forum”) is to support and sustain discussion, information sharing, and decision making to coordinate clinical trials of new Tuberculosis (TB) drug combinations. The overall goal is to advance new therapies rapidly and cost-effectively while maintaining the highest standards of scientific rigor. The Forum will work to coordinate planning among the major non-commercial sponsors and their research groups to ensure rapid and efficient Phase II evaluations of drug combinations. |
| U.S. Department of Health and Human Services -- Overview of Violence Against Women Activities Report 2010-2011 | Other | CDC, CMS, HRSA, IHS | NIDA, NIA, NIAAA, NICHD, NIMH, NINR | This report is prepared by representatives of all HHS agencies involved in activities focused on prevention of violence against women. http://www.womenshealth.gov/publications/federal-reports/onedepartment-vaw-2010-2011.pdf |
| U.S. Government Interagency Working Group on Nanotechnology Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC) | Committee, Work group, Advisory group, or Task Force | CDC, FDA | OD/OSP, NCI, NHGRI, NIBIB, NIEHS | The NSET Subcommittee and NEHI Working Group provide leadership in establishing the national nanotechnology environmental, health, and safety research agenda and in communicating data and information related to environmental and health aspects of nanotechnology between National Nanotechnology Initiative (NNI) agencies and with the public. NNI activities support the development of new tools and methods required for the research that will enable risk analysis and assist in regulatory decision-making. NNI agencies engage and interact with regional, state, and local groups, educational institutions, industry-supported groups, and non-governmental organizations to enhance the impact and value of NNI efforts and to provide a collaborative approach. http://www.nano.gov/nehi |
| U.S. Government response to Fukushima nuclear crisis | Public Education Campaign | OS | NCI | Scientists were deployed in 2011 for two weeks to the U.S. Embassy in Tokyo, Japan, as part of the U.S. Government response to protect U.S. citizens abroad during a nuclear crisis. http://japan2.usembassy.gov/e/acs/tacs-health.html |
| U.S.-Brazil Joint Commission Meeting on Science and Technology - Working Group on Public Health | Meeting/ Workshop | CDC, OS | NIAID, NCI | The Working Group on Public Health was established under the JCM to identify and address public health issues of mutual interest and priority. |
| Understanding the Context of Health in Persons with Multiple Chronic Conditions | Meeting/ Workshop | ACL, AHRQ, CDC, CMS, IHS, OS | OD/DPCPSI/OBSSR, NCCAM, NCI, NHLBI, NIA | Meeting to develop a research agenda to explore the role of context in health with persons with multiple chronic conditions. |
| Unified Medical Language System Metathesaurus (UMLS) | Resource Development | AHRQ, CDC, CMS, FDA | NLM | NLM''s Unified Medical Language System (UMLS®) facilitates the development of computer systems that behave as if they understand the meaning of the language of biomedicine and health. To that end, NLM produces and distributes the UMLS Knowledge Sources (databases) and associated software tools (programs) for use by system developers in building or enhancing electronic information systems that create, process, retrieve, integrate, and/or aggregate biomedical and health data and information, as well as in informatics research. By design, the UMLS Knowledge Sources are multi-purpose. |
| United States Government (USG) Interagency Forensics Advisory Board | Other | FDA | NIAID | The goal of the Interagency Forensics Advisory is to discuss strategies for the United States Government (USG) in the area of microbial forensics and attribution investigations. One of the first agenda items concerned microbial repositories across the USG with a focus on challenges and gaps. |
| Urology Interagency Coordinating Committee | Other | AHRQ, CDC, CMS, FDA | NCCAM, NCI, NIA, NICHD, NIDDK, NINDS | Public law 99-158 establishes a need for the Urology Interagency Coordinating Committee (UICC) and emphasizes the importance of interagency coordinating meetings. Meetings focus on interagency collaboration to elicit ideas from meeting participants to enhance current research directions within the NIH and form partnerships among agencies. |
| US Government Evidence Summit: Protecting Children Outside of Family Care | Meeting/ Workshop | CDC, HRSA | NIMH, FIC, NHLBI, NICHD, OD/DPCPSI/ODP | Recognizing that all governments need evidence to inform efficacious, effective, and sustainable policies, strategies, and programs to support appropriate action on behalf of children living outside family care, the overarching goal of this Evidence Summit is to provide expert review of the evidence on effective systems to identify, assess, assist, and monitor such children in lower- and middle-income countries. |
| US-Ireland Research & Development Partnership | Research Initiative | OS | NHLBI, NHGRI, NIBIB, NIDDK | The goal of the partnership is to stimulate collaborative research between the U.S. and Ireland in the area of cystic fibrosis, diabetes, and nanotechnology. Government agencies and non-profit organizations, including NHLBI, NIDDK, NSF, Cystic Fibrosis Foundation, R&D Office (Northern Ireland), Dept. of Enterprise, Trade, and Employment, Health Research Board, Science Foundation Ireland and Inter-Trade Ireland, participate. As an outgrowth of the U.S.-Ireland R&D Partnership, a grant proposal on the role of anaerobic bacterial infection in CF was submitted to NIH which involves U.S.-Ireland tripartite scientific collaboration. |
| Value Set Authority Center | Resource Development | AHRQ, CMS, OS | NLM | The NLM provides an online repository of value sets (code sets from standardized medical vocabularies) that are used for clinical quality measurement in the CMS Electronic Health Records (EHR) Incentive Program (meaningful use). Under this initiative, NLM will provide the ability to author new value sets and edit existing value sets, as well as assist in maintaining the currency of existing value sets. http://vsac.nlm.nih.gov |
| Ventilator-Associated Pneumonia | Meeting/ Workshop | CDC | CC | A series of meetings were held to develop a practical new national surveillance definition for ventilator-associated pneumonia. http://www.cdc.gov/nhsn/PDFs/Newsletters/VAE-Newsletter-September2012.pdf |
| We Can! (Ways to Enhance Children’s Activity and Nutrition) | Public Education Campaign | CDC, HRSA | NHLBI, NCI, NICHD, NIDDK | Through the We Can! program, the NIH and other HHS partner agencies disseminate strategies, tools, and resources to community organizations, the general public, healthcare providers, and other groups. Strategies focus on three behaviors: eating right, moving more, and reducing screen time to help prevent obesity in youth. Parents and caregivers of 8-13 year olds are the primary focus of the program''s outreach. http://www.nhlbi.nih.gov/health/public/heart/obesity/wecan/ |
| White House Interagency Committee on the Implementation of the US Strategy to Prevent and Respond to Gender-Based Violence Globally | Other | ACF, CDC | NIDA, OD/DPCPSI/ORWH | This is an Interagency Working Group to address gender-based violence, which shall coordinate implementation of the Strategy by the executive departments and agencies that are members of the Working Group (member agencies) in accordance with the priorities set forth in section 3 of the Executive Order 13623. http://www.presidency.ucsb.edu/ws/index.php?pid=101708 |
| WHO World Mental Health Surveys Consortium | Other | SAMHSA | NIDA, NIMH | The World Mental Health (WMH) Survey Initiative is a project of the Assessment, Classification, and Epidemiology (ACE) Group at the World Health Organization (WHO) coordinating the implementation and analysis of general population epidemiologic surveys of mental, substance use, and behavioral disorders in countries in all WHO Regions. NIH provides representatives to this body. NIDA also participates in the Drug Dependence and Nosology Subgroups. http://www.hcp.med.harvard.edu/wmh/ |
| Wireless Medical Technologies | Committee, Work group, Advisory group, or Task Force | FDA, OS | NIBIB, CIT, NIA, NIAAA, NIAID, NICHD, NIMH, NINDS, NLM | The Wireless Medical Technologies Working Group was launched as follow-up to the Personal Motion Technologies for Healthy Independent Living workshop in 2010. The working group provides a forum for information sharing among federal agencies to better understand challenges and barriers to wireless medical technology adoption including issues of engineering development, regulatory issues governing safety, effectiveness and communication, relevant standards, and reimbursement. |
| Women and Reentry Steering Committee | Other | ACF, CDC, CMS, HRSA | NIDA, OD/DPCPSI/OBSSR | This is a subgroup that reports to the Federal Interagency Reentry Council. The purpose of this group is to bring together numerous federal agencies to make communities safer, assist those returning from prison and jail in becoming productive, tax-paying citizens, and save taxpayer dollars by lowering the direct and collateral costs of incarceration. |
| Work Group on Harmonizing Hemoglobinopathy Data Sets | Committee, Work group, Advisory group, or Task Force | CDC, HRSA | NLM, NCATS, NHLBI, NICHD, NIGMS, OD/OER | The mission of the Workgroup for Harmonizing Hemoglobinopathy Data Sets is to create a resource for federal programs and extramural communities to use in data systems which incorporate data elements in hemoglobinopathies. Specifically this entails establishing a Hemoglobinopathies Uniform Medical Language including: - Identifying specific goals and objectives for the kind of data that are required by these programs - Case definitions for electronic data systems at all levels - Consensus about conditions and data elements to be included - Differentiation between data needs for surveillance and for registries/biorepository |
| Work, Family and Health Network | Research Initiative | ACF, CDC | NICHD, NIA | The Administration for Children and Families, Office of Planning, Research and Evaluation is providing NICHD funds to partially support the "Work, Family, and Health Network," a research project of NICHD. This project is examining the effects of a workplace intervention designed to reduce work-family conflict and thereby improve the health and well-being of employees and their families. There is a modification agreement and the purpose of the modification agreement is to provide continuation of research support for the Work, Family and Health Network (WFHN) "Limited Competition for Evaluating the Health Benefits of Workplace Policies and Practices." The WFHN evaluated the health benefits of workplace policies and practices aimed at ameliorating work-family conflict. http://www.kpchr.org/WORKFAMILYHEALTHNETWORK/public/default.aspx |
| Workgroup on Research Related to Evidence Based Policy | Other | ACF, CDC, OS | NIDA | This workgroup focuses on research issues surrounding evidence-based policy. Discussions generally include cross cutting questions-- e.g., What is evidence-based? What are key lessons that have been learned as evidence-based policy has been rolled out? In addition, this group provides update on meetings and projects related to evidence-based policy. |
| Working Group on the Intersection of HIV/AIDS, Violence Against Women and Gender-related Health Disparities | Other | ACF, CDC | NIDA, OD/DPCPSI/OAR, OD/DPCPSI/ORWH | This work group is in response to the Presidential Memorandum calling for executive departments and agencies to build on their current work addressing the intersection of HIV/AIDS, Violence Against Women and Girls and Gender-related Health Disparities by improving data collection, research, intervention strategies, and training. http://www.whitehouse.gov/the-press-office/2012/03/30/presidential-memorandum-establishing-working-group-intersection-hivaids- |
| Working Groups to Develop Federal HIV/AIDS Prevention and Treatment Guidelines | Committee, Work group, Advisory group, or Task Force | CDC, FDA, HRSA | OD/DPCPSI/OAR, NICHD, NIMH | Working Groups of HIV experts from across the country, including physicians, pharmacists, researchers, and HIV treatment advocates responsible for writing, reviewing, and updating HIV/AIDS prevention and treatment guidelines. http://www.aidsinfo.nih.gov/Guidelines/?MenuItem=Guidelines&Search=On |
| Workshop on Natural History Studies of Rare Diseases: Meeting the Needs of Drug Development and Research | Meeting/ Workshop | FDA | NCATS, CC, NICHD, NINDS | Natural history (NH) studies are an important tool for understanding the etiology, range of manifestations, and progression of rare diseases. Well-conducted NH studies can yield information on biomarkers and other correlates of clinical outcome. Obtaining maximum value to support drug development programs depends on conducting these NH studies early, often long before potential therapeutic agents are identified for development. Comprehensive, good quality NH studies designed with an eye toward supporting drug development programs can avoid some of the common problems that lead to stalled, slow, or inefficient drug development for rare diseases. This workshop aims to bring together thought leaders in the design, conduct, and evaluation of natural history studies to discuss the role of these studies in the development of therapeutic candidates. https://events-support.com/events/Natural_History_Studies |
An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government
organization in the United States.
A .gov website belongs to an official government
organization in the United States.
Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.